{"meta":{"query_hash":"ded5295a5df6","filters":{"venue":"Journal of Comparative Effectiveness Research"},"cohort_total":135,"direct_labels_cover":2,"predictions_cover":135,"exported":135,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ded5295a5df6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Comparative+Effectiveness+Research"},"results":[{"id":"W1877489180","doi":"10.2217/cer.15.38","title":"Systematic overview of cost–effectiveness thresholds in ten countries across four continents","year":2015,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Comparative effectiveness research; MEDLINE; Pathology; Alternative medicine","score_opus":0.7926023616127016,"score_gpt":0.6204472118303856,"score_spread":0.17215514978231594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1877489180","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049293667,0.8813899,0.011729481,0.002314228,0.0003746008,0.003959716,0.04471029,0.0002996292,0.005928459],"genre_scores_gemma":[0.5425656,0.37643012,0.03222252,0.0024236632,0.0002551082,0.011688653,0.033805065,0.00016444294,0.0004448186],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.91912705,0.028153285,0.03744525,0.004057117,0.009973461,0.0012438638],"domain_scores_gemma":[0.7795656,0.16182213,0.031591345,0.0047328062,0.021295272,0.0009929284],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.066208705,0.0015181705,0.0063483473,0.037932254,0.000493303,0.0035411068,0.0018130791,0.0015012037,0.0027513155],"category_scores_gemma":[0.19233753,0.001207418,0.00925846,0.035455287,0.0010290806,0.003376006,0.0031370658,0.0015645496,0.0003190524],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018761134,0.00009629547,0.095678285,0.47629642,0.047581486,0.00028901853,0.0016671673,0.004071355,0.00050596904,0.0044600694,0.015819408,0.35165843],"study_design_scores_gemma":[0.0011219102,0.0010206874,0.2601941,0.5547906,0.09324811,0.0013511967,0.0033777903,0.0029171794,0.0019815632,0.0065884576,0.0730793,0.0003290712],"about_ca_topic_score_codex":0.008177321,"about_ca_topic_score_gemma":0.010443218,"teacher_disagreement_score":0.9337913,"about_ca_system_score_codex":0.004617918,"about_ca_system_score_gemma":0.00875383,"threshold_uncertainty_score":0.35014927},"labels":[],"label_agreement":null},{"id":"W1918795463","doi":"10.2217/cer.15.40","title":"Performance of the disease risk score in a cohort study with policy-induced selection bias","year":2015,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto; Toronto Public Health; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Selection bias; Propensity score matching; Cohort; Cohort study; Selection (genetic algorithm); Disease; Demography; Internal medicine; Pathology","score_opus":0.2018569255815383,"score_gpt":0.4763414049829235,"score_spread":0.2744844794013852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918795463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8801781,0.007714802,0.10108818,0.0032864434,0.00089489564,0.0011364454,0.0010055539,0.0002642437,0.0044311997],"genre_scores_gemma":[0.9834214,0.00031535994,0.014705781,0.0005649012,0.00014221003,0.00020823911,0.000309517,0.000023464398,0.00030917008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.5496324,0.3967024,0.018319676,0.016769227,0.01616295,0.0024133767],"domain_scores_gemma":[0.3327758,0.51836205,0.07300352,0.05781665,0.016024886,0.0020170824],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.39848706,0.001400639,0.0018987537,0.0027817742,0.0015647656,0.0035219672,0.0028074794,0.003063447,0.0018922403],"category_scores_gemma":[0.5250786,0.0010130652,0.0059743607,0.0026274456,0.0031814778,0.0024056127,0.0035406863,0.0017728532,0.00029472154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054024197,0.00013908163,0.9496339,0.0006595078,0.012756229,0.0002390199,0.00085111876,0.00395444,0.000718412,0.0025529654,0.0005822349,0.022510763],"study_design_scores_gemma":[0.001812993,0.010351439,0.8751663,0.00092377927,0.018333536,0.001714813,0.0013773213,0.07080449,0.00414023,0.007867715,0.0071807015,0.00032678922],"about_ca_topic_score_codex":0.0068949186,"about_ca_topic_score_gemma":0.0060199685,"teacher_disagreement_score":0.6015129,"about_ca_system_score_codex":0.0012909982,"about_ca_system_score_gemma":0.0032193076,"threshold_uncertainty_score":0.74177253},"labels":[],"label_agreement":null},{"id":"W1980477074","doi":"10.2217/cer.12.68","title":"Complex questions command complex analyses: comparative effectiveness of drug treatment strategies in atrial fibrillation","year":2012,"lang":"en","type":"editorial","venue":"Journal of Comparative Effectiveness Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Atrial fibrillation; Drug; Comparative effectiveness research; Internal medicine; Intensive care medicine; Cardiology; Pharmacology; Alternative medicine","score_opus":0.3658750221936212,"score_gpt":0.5605074714917893,"score_spread":0.19463244929816803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980477074","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009819964,0.023172284,0.0004631327,0.032050546,0.9435415,0.000046573197,0.000091485876,0.00008559752,0.00045054662],"genre_scores_gemma":[0.0015217416,0.011475841,0.00068906345,0.029445056,0.95529383,0.0000885628,0.000038466824,0.000056444787,0.0013910136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9722836,0.0137257865,0.004837805,0.001846352,0.0066401036,0.00066637405],"domain_scores_gemma":[0.67594737,0.28983784,0.00495524,0.0031456598,0.02220576,0.0039081373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0529045,0.0061628907,0.0127725,0.0047006137,0.0032429872,0.008939826,0.00839123,0.025237422,0.0074583204],"category_scores_gemma":[0.18427323,0.0025434617,0.007314804,0.0033775496,0.00599334,0.0059142644,0.0016239495,0.034278184,0.003087067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043340324,0.000049956485,0.00008751021,0.0028174277,0.0006610684,0.00019324548,0.000066324574,0.00010778937,0.00007562349,0.0010119267,0.98214334,0.012352469],"study_design_scores_gemma":[0.0048897653,0.0006077266,0.0032266714,0.011947603,0.006308557,0.0016728835,0.000492943,0.0031491162,0.0006034528,0.015859833,0.9508267,0.00041474903],"about_ca_topic_score_codex":0.0033144571,"about_ca_topic_score_gemma":0.008280431,"teacher_disagreement_score":0.0529045,"about_ca_system_score_codex":0.0049364436,"about_ca_system_score_gemma":0.0053603053,"threshold_uncertainty_score":0.2797891},"labels":[],"label_agreement":null},{"id":"W2002611374","doi":"10.2217/cer.13.93","title":"Comparative effectiveness research in antineoplastic-induced nausea and vomiting control in children","year":2014,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Nausea and vomiting management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Antiemetic; Nausea; Vomiting; Intensive care medicine; Adverse effect; Psychological intervention; Anesthesia; Psychiatry; Pharmacology","score_opus":0.2884027624500407,"score_gpt":0.5531594896994838,"score_spread":0.2647567272494431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002611374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003675359,0.9988662,0.00006774514,0.000120943965,0.000060830625,0.000045931687,0.00003251297,0.0000013459232,0.000437004],"genre_scores_gemma":[0.0065321475,0.9922465,0.00074451626,0.0002013253,0.0000757047,0.00010198098,0.00003778878,0.0000017571429,0.00005829467],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98840964,0.006035559,0.002849781,0.00056808774,0.0019591826,0.00017766394],"domain_scores_gemma":[0.9576259,0.037223198,0.0027787995,0.00041167258,0.0017657422,0.00019452462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015396532,0.0007926033,0.004054698,0.00500022,0.0003286463,0.0020415685,0.0013286177,0.001387477,0.005447825],"category_scores_gemma":[0.045442823,0.00041493864,0.003275382,0.005377093,0.0007364159,0.001629959,0.0008633203,0.0013698733,0.00024552207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007673333,0.00015352879,0.0009198661,0.52373725,0.0074907467,0.00009207797,0.00025853745,0.0002134952,0.00034576427,0.0039807437,0.0022572696,0.45978332],"study_design_scores_gemma":[0.0014259386,0.0029575932,0.014482375,0.7046678,0.060211133,0.0018310706,0.001036449,0.00031589658,0.0014778866,0.004252242,0.20725226,0.0000892742],"about_ca_topic_score_codex":0.0020357235,"about_ca_topic_score_gemma":0.003285488,"teacher_disagreement_score":0.015396532,"about_ca_system_score_codex":0.0021005385,"about_ca_system_score_gemma":0.004520586,"threshold_uncertainty_score":0.08142561},"labels":[],"label_agreement":null},{"id":"W2003321779","doi":"10.2217/cer.14.76","title":"EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review","year":2015,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; MEDLINE; Quality of life (healthcare); Population; Family medicine; Cancer; Gerontology; Clinical psychology; Internal medicine; Environmental health; Nursing","score_opus":0.22569149329793603,"score_gpt":0.5681167581685256,"score_spread":0.34242526487058955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003321779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018117123,0.99938226,0.00004347131,0.000115903036,0.000033237513,0.000054642464,0.00006316436,0.0000017726696,0.00012429542],"genre_scores_gemma":[0.0024783057,0.9966755,0.00034061418,0.00016879967,0.00004354011,0.00015645086,0.00009441823,0.0000014104021,0.00004090211],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99449325,0.0017823512,0.0017624912,0.00035412953,0.0014617787,0.00014600003],"domain_scores_gemma":[0.9825033,0.012994682,0.0025083295,0.00015744557,0.0016737952,0.00016243414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009442612,0.0012979462,0.00613562,0.012697086,0.0005126538,0.0017139766,0.0019825744,0.0016553907,0.0038897237],"category_scores_gemma":[0.029240815,0.0006329221,0.004120486,0.013559611,0.0006158727,0.0019811096,0.0012193455,0.0011829844,0.0003713874],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021147204,0.00007211144,0.0012538341,0.5827119,0.0028942067,0.00011205903,0.00015646267,0.00018473947,0.000121997095,0.0005314698,0.005980339,0.4057695],"study_design_scores_gemma":[0.00031001243,0.00041258882,0.01389333,0.862843,0.026128331,0.0013622465,0.0005517277,0.00027079714,0.00021544786,0.0008026806,0.09313352,0.00007626982],"about_ca_topic_score_codex":0.00566085,"about_ca_topic_score_gemma":0.010358434,"teacher_disagreement_score":0.012697086,"about_ca_system_score_codex":0.0025736107,"about_ca_system_score_gemma":0.0074126734,"threshold_uncertainty_score":0.049937904},"labels":[],"label_agreement":null},{"id":"W2007231551","doi":"10.2217/cer.13.92","title":"Comparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors","year":2014,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Fulguration; Medicine; Resection; Bladder tumor; Surgery; Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.13018667208462448,"score_gpt":0.4399852707932906,"score_spread":0.3097985987086661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007231551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7859259,0.16346447,0.0004830411,0.031244176,0.0027262599,0.0004985573,0.0017195175,0.000038870654,0.013899132],"genre_scores_gemma":[0.96506375,0.02144554,0.00080301147,0.008344827,0.0022807017,0.00025785438,0.00056565006,0.000008758253,0.0012297909],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99591726,0.0028644414,0.00041961015,0.00019361154,0.00047561596,0.00012957855],"domain_scores_gemma":[0.98052764,0.015502034,0.0021473719,0.0004153888,0.0006628816,0.0007446868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005059972,0.0003033263,0.0013813055,0.00058745197,0.00017545608,0.000696619,0.00058267807,0.0016566947,0.0035352376],"category_scores_gemma":[0.02535535,0.00014258228,0.0020950274,0.0010891733,0.0005160674,0.0009918294,0.00025316796,0.0012734418,0.00033891076],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44529083,0.0035387524,0.044505853,0.004067039,0.0053036003,0.0010980592,0.00026107175,0.0010927941,0.0012864614,0.0019849485,0.016353408,0.47521725],"study_design_scores_gemma":[0.19246739,0.3549074,0.3285565,0.0046425005,0.024468292,0.007768585,0.0010527472,0.0053101806,0.006731423,0.0048655057,0.068818346,0.0004111463],"about_ca_topic_score_codex":0.0009267521,"about_ca_topic_score_gemma":0.0019152364,"teacher_disagreement_score":0.005059972,"about_ca_system_score_codex":0.001693102,"about_ca_system_score_gemma":0.0008765975,"threshold_uncertainty_score":0.026759982},"labels":[],"label_agreement":null},{"id":"W2028846339","doi":"10.2217/cer.12.63","title":"The utilization of telephone follow-up in the advanced cancer population: a review of the literature","year":2012,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; CINAHL; MEDLINE; Population; Cochrane Library; Cancer; Clinical trial; Palliative care; Randomized controlled trial; Patient satisfaction; Family medicine; Physical therapy; Surgery; Psychological intervention; Internal medicine; Nursing","score_opus":0.24741432605784686,"score_gpt":0.5369253003219292,"score_spread":0.28951097426408234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028846339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008248875,0.99871063,0.00003129348,0.00014190435,0.000042824136,0.000029257075,0.000048217902,0.0000020626946,0.00016895538],"genre_scores_gemma":[0.008283925,0.99103606,0.0002133201,0.0002505816,0.00005268223,0.00008505623,0.00004214932,0.0000017483172,0.000034481975],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925178,0.002758203,0.00256698,0.00062090415,0.0013762728,0.00015972606],"domain_scores_gemma":[0.92030895,0.06678945,0.009090943,0.0004419743,0.0029585971,0.00041000344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007985448,0.0007792655,0.0037884547,0.01090026,0.0005776808,0.0026318943,0.0016937082,0.0020766626,0.0031818545],"category_scores_gemma":[0.047224455,0.0007462003,0.0030257613,0.013923786,0.000868888,0.0027484896,0.00091981696,0.001105552,0.00033373758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025422877,0.000045851233,0.001793445,0.8016444,0.0016705851,0.00028270995,0.0006364126,0.00010224966,0.0001311715,0.0002732874,0.0025457526,0.19061996],"study_design_scores_gemma":[0.00018762438,0.0005070218,0.014210804,0.9319003,0.017727798,0.0025102752,0.0014063452,0.000121205274,0.00020215921,0.00033603943,0.030835148,0.000055333545],"about_ca_topic_score_codex":0.0062391832,"about_ca_topic_score_gemma":0.014629295,"teacher_disagreement_score":0.01090026,"about_ca_system_score_codex":0.0032331897,"about_ca_system_score_gemma":0.006986393,"threshold_uncertainty_score":0.04223156},"labels":[],"label_agreement":null},{"id":"W2030471933","doi":"10.2217/cer.12.72","title":"Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials","year":2012,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Adverse effect; Placebo; Nausea; Internal medicine; Vomiting; Adverse Event Reporting System; Oncology; Confounding; Bisphosphonate; Osteoporosis; Pathology; Alternative medicine","score_opus":0.4541017486537403,"score_gpt":0.6110403243727319,"score_spread":0.1569385757189916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030471933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043666544,0.9931492,0.000662655,0.00022976607,0.00017722805,0.00065675046,0.00020779145,0.0000116272595,0.0005383384],"genre_scores_gemma":[0.06803673,0.9244179,0.0035308467,0.0008516643,0.00032610114,0.0020157269,0.00046022824,0.000012387849,0.0003483503],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.97596866,0.012331323,0.0066880593,0.0014546167,0.0032733062,0.00028396034],"domain_scores_gemma":[0.9568717,0.029031483,0.011447421,0.00051474257,0.0018340623,0.0003006168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030717932,0.0010157857,0.005817513,0.0033261282,0.00032594692,0.0016822579,0.0013064296,0.0010596208,0.0029002537],"category_scores_gemma":[0.053623643,0.0004967606,0.006997789,0.0037236274,0.0005932836,0.0011304191,0.0007938709,0.0011814636,0.00017232458],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013637995,0.00025820534,0.0063134744,0.38078693,0.05116759,0.00015929826,0.0001865029,0.0008983471,0.0010734972,0.0009518817,0.0031577367,0.5414086],"study_design_scores_gemma":[0.04079059,0.02065722,0.06419973,0.37097195,0.38048756,0.0037073644,0.0007822251,0.0015539855,0.0045727785,0.00523089,0.106826976,0.0002186587],"about_ca_topic_score_codex":0.00070968625,"about_ca_topic_score_gemma":0.0016973653,"teacher_disagreement_score":0.030717932,"about_ca_system_score_codex":0.0015983566,"about_ca_system_score_gemma":0.00235156,"threshold_uncertainty_score":0.16245383},"labels":[],"label_agreement":null},{"id":"W2034390498","doi":"10.2217/cer.12.37","title":"Optimizing the design of pragmatic trials: key issues remain","year":2012,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Intervention (counseling); Context (archaeology); Task (project management); Risk analysis (engineering); Clinical trial; Clinical study design; Management science; Research design; Nursing","score_opus":0.9072114903384465,"score_gpt":0.670455447640037,"score_spread":0.23675604269840955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034390498","genre_codex":"commentary","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072253235,0.12868221,0.40169802,0.40653598,0.016552446,0.025027424,0.0006374341,0.0010973953,0.012543768],"genre_scores_gemma":[0.110217065,0.029591374,0.74223185,0.05955179,0.008286277,0.048081506,0.00029384348,0.00048425165,0.001262099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.2453896,0.68006134,0.04583089,0.0064143157,0.020801252,0.0015025657],"domain_scores_gemma":[0.117320076,0.82083285,0.020743586,0.022084441,0.014614495,0.0044045383],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6401635,0.0036140552,0.0138239,0.004670619,0.0029699623,0.012436716,0.0075382995,0.016283104,0.005326637],"category_scores_gemma":[0.8005401,0.0036632174,0.004769789,0.0055688843,0.017783413,0.022566972,0.007349722,0.019213242,0.0030988937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062738946,0.0009454692,0.0040122145,0.050080802,0.0067819706,0.0007189468,0.009817134,0.012271635,0.00130847,0.25094444,0.063002266,0.59384274],"study_design_scores_gemma":[0.006305412,0.001918384,0.004267593,0.037626136,0.0021521475,0.00096883636,0.0029543838,0.016974272,0.0009770205,0.8120576,0.11309661,0.00070156675],"about_ca_topic_score_codex":0.0024832757,"about_ca_topic_score_gemma":0.0037804008,"teacher_disagreement_score":0.35983652,"about_ca_system_score_codex":0.009480978,"about_ca_system_score_gemma":0.023745472,"threshold_uncertainty_score":0.4437425},"labels":[],"label_agreement":null},{"id":"W2049305235","doi":"10.2217/cer.12.71","title":"Use of relative effectiveness information in reimbursement and pricing decisions in Europe","year":2012,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Reimbursement; Process (computing); Medicine; Comparative effectiveness research; Actuarial science; Public economics; Economics; Health care; Computer science; Alternative medicine; Economic growth","score_opus":0.34571217471328664,"score_gpt":0.45467960943436125,"score_spread":0.10896743472107462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049305235","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16741742,0.29419318,0.23720983,0.06103348,0.0028978158,0.00067880296,0.0076194014,0.00035748028,0.22859268],"genre_scores_gemma":[0.91866845,0.02454032,0.04647811,0.0051519084,0.0015962174,0.00025538236,0.0017644117,0.00011449389,0.0014308202],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.7353851,0.21312815,0.014696729,0.006072956,0.028943496,0.0017736001],"domain_scores_gemma":[0.68446636,0.27179077,0.020672122,0.010368056,0.011644291,0.0010584587],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21830185,0.00068920257,0.003686697,0.017008461,0.0007781008,0.010125923,0.0028218883,0.0044436287,0.0049023856],"category_scores_gemma":[0.380977,0.0007273303,0.003377715,0.014423708,0.0057776463,0.014891862,0.0044755447,0.0036069793,0.00048433544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018385086,0.00019439949,0.016693043,0.0030952503,0.001880457,0.00022344047,0.0011113933,0.030348118,0.00015955418,0.69405645,0.01273679,0.23766252],"study_design_scores_gemma":[0.0009327449,0.0015627258,0.047506273,0.010495893,0.0026159177,0.0013184354,0.0012217852,0.040302325,0.0025285766,0.7887217,0.102182396,0.0006112425],"about_ca_topic_score_codex":0.0048607956,"about_ca_topic_score_gemma":0.0016665657,"teacher_disagreement_score":0.21830185,"about_ca_system_score_codex":0.0070412722,"about_ca_system_score_gemma":0.0042997557,"threshold_uncertainty_score":0.963973},"labels":[],"label_agreement":null},{"id":"W2065741177","doi":"10.2217/cer.14.41","title":"Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients","year":2014,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Cancer; Medical physics; Oncology; Internal medicine; Nursing","score_opus":0.7458504868248589,"score_gpt":0.6286639508228942,"score_spread":0.11718653600196471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065741177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072888314,0.998314,0.00022506577,0.00024404879,0.000040481922,0.000041766125,0.000061301595,0.0000017521202,0.00034276824],"genre_scores_gemma":[0.0088231135,0.9890565,0.0014133758,0.00023059805,0.000050318344,0.00016236084,0.00017790403,0.0000030116755,0.00008277529],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9929488,0.0030592424,0.0014687703,0.00053048367,0.0018278166,0.00016490229],"domain_scores_gemma":[0.98689276,0.009145161,0.0015768145,0.00023077041,0.0020415403,0.00011297322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016096355,0.00067369564,0.0027935063,0.0056076106,0.0002560599,0.0017500027,0.0015552739,0.0010049633,0.00069171],"category_scores_gemma":[0.029390713,0.0005273022,0.0021053634,0.0063273297,0.0007088366,0.0014931692,0.0009860186,0.0016357765,0.00022208049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015514302,0.000070589835,0.005523,0.06434866,0.0019177748,0.000080851256,0.00029048233,0.00047666795,0.000259327,0.0027234615,0.0039059191,0.9202482],"study_design_scores_gemma":[0.00047365465,0.001332035,0.13372222,0.28132886,0.01814247,0.004904916,0.0019416044,0.0017225654,0.0018822354,0.007514588,0.5466469,0.00038795365],"about_ca_topic_score_codex":0.005303605,"about_ca_topic_score_gemma":0.0062111793,"teacher_disagreement_score":0.016096355,"about_ca_system_score_codex":0.0019116619,"about_ca_system_score_gemma":0.005190606,"threshold_uncertainty_score":0.0851267},"labels":[],"label_agreement":null},{"id":"W2090075299","doi":"10.2217/cer.13.91","title":"The vexing problem of defining the meaning, role and measurement of values in treatment decision-making","year":2014,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Meaning (existential); Value (mathematics); Medicine; Process (computing); Reductionism; Management science; Epistemology; Psychology; Computer science; Psychotherapist; Economics","score_opus":0.5259805117371518,"score_gpt":0.602337979086101,"score_spread":0.07635746734894922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090075299","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063733673,0.078748465,0.24047258,0.63744473,0.0066683004,0.00027434016,0.00014527603,0.00014576537,0.029727163],"genre_scores_gemma":[0.41625866,0.045621496,0.38713315,0.13263099,0.011997752,0.0024131981,0.00022829733,0.00039328253,0.0033231715],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.6485368,0.28828734,0.017734574,0.013439844,0.029231979,0.0027694658],"domain_scores_gemma":[0.5149178,0.41540554,0.015627572,0.026318993,0.023785545,0.003944519],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29271057,0.0021240553,0.005172975,0.00806177,0.009021256,0.02344153,0.008316026,0.016662953,0.003066654],"category_scores_gemma":[0.3409036,0.002328386,0.002308188,0.007051378,0.13418475,0.0525138,0.02353556,0.047792215,0.0011835553],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006592529,0.00004379079,0.0004102021,0.0009338289,0.00008589304,0.000039343344,0.009015827,0.0005972534,0.0000938087,0.93014276,0.0055927476,0.052978523],"study_design_scores_gemma":[0.000032939864,0.000052288226,0.00020488368,0.0018476497,0.00002665644,0.000118522956,0.0036349345,0.0008405948,0.0001472209,0.97123057,0.021787543,0.00007613503],"about_ca_topic_score_codex":0.007568601,"about_ca_topic_score_gemma":0.004969372,"teacher_disagreement_score":0.29271057,"about_ca_system_score_codex":0.018745715,"about_ca_system_score_gemma":0.025968825,"threshold_uncertainty_score":0.8722138},"labels":[],"label_agreement":null},{"id":"W2096357246","doi":"10.2217/cer.12.24","title":"Which design for which question? An exploration toward a translation table for comparative effectiveness research","year":2012,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Comparative effectiveness research; Table (database); Medicine; Value (mathematics); Data science; Computer science; Alternative medicine; Machine learning; Data mining; Pathology","score_opus":0.9231174789930429,"score_gpt":0.7216988848994658,"score_spread":0.2014185940935771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096357246","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049280096,0.10298907,0.7420636,0.11010433,0.008323055,0.009282545,0.0004592939,0.00038872485,0.021461401],"genre_scores_gemma":[0.058065504,0.03226849,0.8716655,0.017192882,0.0010371306,0.01844884,0.00022804193,0.00019295244,0.00090067525],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.41689035,0.5310341,0.027009303,0.005720795,0.018429857,0.0009156219],"domain_scores_gemma":[0.34253892,0.60194826,0.012256816,0.019228794,0.022845874,0.0011813052],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.49508575,0.002084487,0.0044176187,0.008711771,0.0034317235,0.017368501,0.005450019,0.0054219915,0.0072639054],"category_scores_gemma":[0.5426263,0.0015773305,0.0033858712,0.011975877,0.015662039,0.029659318,0.0065145846,0.010091435,0.0018288296],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042301108,0.00006710744,0.0004586932,0.029523008,0.0003533379,0.00026137408,0.032247864,0.00076193135,0.0005541789,0.5680819,0.010980067,0.35628745],"study_design_scores_gemma":[0.0008148451,0.00066378934,0.0007729251,0.078559764,0.0007277045,0.0008596726,0.026889198,0.0044760057,0.0013061909,0.6257268,0.25899047,0.00021251316],"about_ca_topic_score_codex":0.0013782812,"about_ca_topic_score_gemma":0.0016041268,"teacher_disagreement_score":0.5049143,"about_ca_system_score_codex":0.010494388,"about_ca_system_score_gemma":0.022427646,"threshold_uncertainty_score":0.6226492},"labels":[],"label_agreement":null},{"id":"W2105538774","doi":"10.2217/cer.12.79","title":"Comparing radial and femoral access for coronary angiography and interventions","year":2013,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Vascular Procedures and Complications","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; McMaster University","funders":"","keywords":"Medicine; Radial artery; Percutaneous coronary intervention; Cardiac catheterization; Femoral artery; Percutaneous; Bivalirudin; Vascular access; Hemostasis; Cardiology; Internal medicine; Surgery; Radiology; Artery; Myocardial infarction","score_opus":0.5502028699496919,"score_gpt":0.5854484250669251,"score_spread":0.03524555511723315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105538774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027462482,0.9993699,0.000033938086,0.00004998662,0.00004193153,0.000013440624,0.000021013397,0.0000010139019,0.00019416033],"genre_scores_gemma":[0.0035676702,0.995965,0.00020018485,0.00008538157,0.00005282522,0.000026449778,0.00004559881,0.0000011274485,0.0000556421],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99788266,0.00066972844,0.00062451995,0.00019548138,0.0005647801,0.00006275819],"domain_scores_gemma":[0.99349,0.0049957996,0.00080808403,0.0000676463,0.0005481465,0.000090424975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030022697,0.0007618146,0.0032918996,0.005183129,0.00023286106,0.001110074,0.0011944165,0.0008742769,0.006230332],"category_scores_gemma":[0.008599109,0.0003520197,0.0029606505,0.0047027,0.00046454484,0.0011435956,0.0005685973,0.0008953025,0.00040272184],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008676298,0.00010219274,0.0008283523,0.35564515,0.0042037545,0.00010423286,0.00009827864,0.00016975164,0.0004117959,0.00111457,0.0044488106,0.63200545],"study_design_scores_gemma":[0.0024547547,0.0028406084,0.028656702,0.5356419,0.067130774,0.0050123865,0.0008644301,0.0005155131,0.001725626,0.0033421773,0.35166624,0.0001489332],"about_ca_topic_score_codex":0.0017107781,"about_ca_topic_score_gemma":0.0040431265,"teacher_disagreement_score":0.006230332,"about_ca_system_score_codex":0.0010063214,"about_ca_system_score_gemma":0.0019736306,"threshold_uncertainty_score":0.020842493},"labels":[],"label_agreement":null},{"id":"W2109513430","doi":"10.2217/cer.15.36","title":"Improving the evidence base for better comparative effectiveness research","year":2015,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Comparative effectiveness research; Medicine; Evidence-based medicine; Management science; Outcomes research; Quality (philosophy); MEDLINE; Engineering ethics; Alternative medicine; Data science; Epistemology; Computer science; Pathology","score_opus":0.92690975542635,"score_gpt":0.6926157293442052,"score_spread":0.23429402608214478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109513430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021485092,0.9701507,0.005358334,0.018848367,0.002402984,0.0002587369,0.00016675338,0.000046146197,0.0025531643],"genre_scores_gemma":[0.010651384,0.93940073,0.028619433,0.015459608,0.0041302755,0.00079126435,0.0004972031,0.000054144595,0.000395953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8678312,0.080261566,0.021789344,0.0045887907,0.024137612,0.0013915362],"domain_scores_gemma":[0.41365096,0.5246349,0.022042934,0.012603293,0.02453186,0.0025360272],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17546932,0.002351428,0.01153259,0.025836656,0.0013654513,0.011195295,0.005179263,0.0104622515,0.025791164],"category_scores_gemma":[0.34327424,0.0020495076,0.0096391905,0.014008849,0.0042008474,0.015137111,0.006419362,0.016650653,0.0038647421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034124896,0.00026360096,0.0006828694,0.28825864,0.0042067915,0.00021267503,0.0004147864,0.0012285755,0.00052115653,0.07037889,0.031655718,0.6018351],"study_design_scores_gemma":[0.00050340284,0.00030054228,0.0031309116,0.556237,0.006761908,0.00065867906,0.0004841234,0.00063780625,0.0004587353,0.094476625,0.3361951,0.00015512385],"about_ca_topic_score_codex":0.002931099,"about_ca_topic_score_gemma":0.0034935141,"teacher_disagreement_score":0.82453066,"about_ca_system_score_codex":0.010106727,"about_ca_system_score_gemma":0.030077918,"threshold_uncertainty_score":0.92798156},"labels":[],"label_agreement":null},{"id":"W2113687724","doi":"10.2217/cer.15.34","title":"Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients","year":2015,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Paliperidone Palmitate; Medicine; Schizophrenia (object-oriented programming); Medicaid; Health care; Paliperidone; Formulary; Marginal structural model; Pharmacy; Health economics; Psychiatry; Emergency medicine; Antipsychotic; Internal medicine; Family medicine; Confounding; Public health","score_opus":0.2815064902716655,"score_gpt":0.5329407486024871,"score_spread":0.25143425833082156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113687724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983215,0.0011956001,0.000020065725,0.00014101753,0.000008874542,0.0000064774895,0.00011350111,0.0000012262416,0.00019175016],"genre_scores_gemma":[0.99948907,0.00022826418,0.0000441938,0.00004656875,0.000008442147,0.000005907006,0.0001262285,5.478925e-7,0.000050724186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868804,0.0007006703,0.00011899273,0.00011655284,0.0001711307,0.00020468267],"domain_scores_gemma":[0.9980446,0.0005170259,0.0009448263,0.000043245233,0.00008880787,0.0003616155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015202289,0.0002140226,0.00053016224,0.0002663953,0.0002619447,0.00053627894,0.0001963861,0.00040468862,0.001195831],"category_scores_gemma":[0.0048744436,0.00012763534,0.0015375278,0.00032484965,0.00022127245,0.0004689416,0.00048822834,0.0007342621,0.000074583746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055035684,0.0025500602,0.8793461,0.0003866905,0.0027113957,0.00015518662,0.00018837166,0.0017040112,0.0010470478,0.0001858455,0.0003894655,0.056300223],"study_design_scores_gemma":[0.0011111513,0.015380755,0.9790912,0.000086048574,0.0012955351,0.00014821143,0.00033951568,0.001640993,0.0004122489,0.00018910125,0.00028324587,0.000021853892],"about_ca_topic_score_codex":0.005353377,"about_ca_topic_score_gemma":0.0104815755,"teacher_disagreement_score":0.005353377,"about_ca_system_score_codex":0.0011490111,"about_ca_system_score_gemma":0.0008979214,"threshold_uncertainty_score":0.010644436},"labels":[],"label_agreement":null},{"id":"W2121793416","doi":"10.2217/cer.12.69","title":"Incidence of skeletal morbidity rates over time in patients with multiple myeloma-related bone disease as reported in randomized trials employing bone-modifying agents","year":2012,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Multiple myeloma; Incidence (geometry); Internal medicine; Bone disease; Randomized controlled trial; Surgery; Oncology; Osteoporosis","score_opus":0.24757855998991143,"score_gpt":0.5136934388489022,"score_spread":0.26611487885899077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121793416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002404146,0.9970114,0.00009302007,0.00008958706,0.000073415154,0.00007905434,0.000098309974,0.0000026501727,0.00014836721],"genre_scores_gemma":[0.052040085,0.9461282,0.00079130434,0.00030626231,0.00014886486,0.000301782,0.00018771445,0.0000039627694,0.00009176922],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9827293,0.007595326,0.005149081,0.0013321029,0.0029697835,0.00022437643],"domain_scores_gemma":[0.95480597,0.03192101,0.010898539,0.0004740926,0.001688463,0.00021200653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015964087,0.0007408977,0.0070435833,0.0044297045,0.000284191,0.0018295854,0.0012541375,0.0012698694,0.0020708346],"category_scores_gemma":[0.05215091,0.0005939784,0.006943822,0.0055685677,0.0007169938,0.0010569431,0.00071762205,0.0012933445,0.00012060915],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077773314,0.00015115665,0.009152132,0.6733764,0.074734956,0.00013663602,0.00019288478,0.00047929306,0.000704951,0.0005292725,0.0015138668,0.23125106],"study_design_scores_gemma":[0.010200284,0.008100284,0.08703896,0.35306773,0.50163317,0.0027390025,0.00072157185,0.000665649,0.002115019,0.0013475403,0.032188807,0.00018195898],"about_ca_topic_score_codex":0.0018883338,"about_ca_topic_score_gemma":0.0037039558,"teacher_disagreement_score":0.015964087,"about_ca_system_score_codex":0.0015738928,"about_ca_system_score_gemma":0.002272721,"threshold_uncertainty_score":0.08442718},"labels":[],"label_agreement":null},{"id":"W2123800537","doi":"10.2217/cer.14.5","title":"Accelerated versus standard care in hip fracture patients: does speed save lives?","year":2014,"lang":"en","type":"editorial","venue":"Journal of Comparative Effectiveness Research","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; MEDLINE; Hip fracture; Biostatistics; Pulmonary embolism; Deep vein; Epidemiology; Surgery; Internal medicine; Thrombosis; Osteoporosis","score_opus":0.06034044854847201,"score_gpt":0.45411528233701376,"score_spread":0.3937748337885417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123800537","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013317664,0.060586777,0.00010218157,0.04236038,0.8954746,0.00006156801,0.0001634245,0.000033069136,0.001084812],"genre_scores_gemma":[0.002207305,0.042400587,0.00028990651,0.036524087,0.9161863,0.00013107699,0.000054774686,0.00003370309,0.002172212],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9815129,0.0068820277,0.004759875,0.0011839208,0.0049635684,0.0006976941],"domain_scores_gemma":[0.8271103,0.14124554,0.0065250276,0.0015986769,0.019511797,0.0040086973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03548306,0.0038394476,0.012999251,0.004355559,0.0026419745,0.0075076954,0.005747469,0.020730473,0.0114653],"category_scores_gemma":[0.13024934,0.0017793922,0.005450774,0.004264106,0.003776172,0.005351024,0.0011357496,0.030153267,0.003188699],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015904646,0.0001068066,0.00017043833,0.009403321,0.0009815801,0.00018390785,0.000065757406,0.000089903384,0.00006901795,0.0010665173,0.9608073,0.025464958],"study_design_scores_gemma":[0.0075967694,0.0009564714,0.004160055,0.025283992,0.009407815,0.00071388157,0.0005903466,0.00091594906,0.00042511098,0.005041195,0.9446718,0.00023665116],"about_ca_topic_score_codex":0.005286727,"about_ca_topic_score_gemma":0.012410364,"teacher_disagreement_score":0.03548306,"about_ca_system_score_codex":0.006584773,"about_ca_system_score_gemma":0.0072855386,"threshold_uncertainty_score":0.18765461},"labels":[],"label_agreement":null},{"id":"W2143296285","doi":"10.2217/cer.11.6","title":"Clinical practice change requires more than comparative effectiveness evidence: abdominal aortic aneurysm management in the USA","year":2012,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Abdominal aortic aneurysm; Endovascular aneurysm repair; Comparative effectiveness research; Aortic aneurysm; Abdominal surgery; Clinical trial; Randomized controlled trial; Surgery; General surgery; Health care; Aneurysm; Internal medicine","score_opus":0.432308873191544,"score_gpt":0.5887352008087636,"score_spread":0.15642632761721964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143296285","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04281268,0.45269442,0.0065560983,0.46194702,0.012700962,0.0012283117,0.00085884193,0.00005873968,0.021142848],"genre_scores_gemma":[0.5627267,0.1701963,0.039390452,0.21116328,0.012575391,0.0020249523,0.0010670738,0.000082427156,0.0007735111],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.6249702,0.3047272,0.027438302,0.0066205882,0.034377743,0.0018660268],"domain_scores_gemma":[0.23424858,0.6640421,0.041500065,0.014773866,0.041151818,0.0042834748],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.28565204,0.0009950114,0.0041178884,0.006584985,0.0014157911,0.010208327,0.0030362383,0.009291775,0.006019888],"category_scores_gemma":[0.58830184,0.0006774922,0.0035916928,0.00956092,0.0067413966,0.010299688,0.0038590995,0.005154082,0.00040422962],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008515285,0.0010345929,0.039021827,0.057022426,0.018740436,0.00052785873,0.0021638214,0.00278469,0.00064236636,0.06945218,0.042865727,0.7572288],"study_design_scores_gemma":[0.018090203,0.01183493,0.15611069,0.26212952,0.05464068,0.0028659254,0.010395113,0.008710641,0.002380525,0.21944268,0.2522031,0.0011959636],"about_ca_topic_score_codex":0.008830829,"about_ca_topic_score_gemma":0.015116091,"teacher_disagreement_score":0.28565204,"about_ca_system_score_codex":0.012570001,"about_ca_system_score_gemma":0.020752806,"threshold_uncertainty_score":0.8809182},"labels":[],"label_agreement":null},{"id":"W2289680983","doi":"10.2217/cer.15.66","title":"Better research reporting to improve the utility of routine data for making better treatment decisions","year":2016,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Medicine; Checklist; Comparative effectiveness research; Observational study; Transparency (behavior); Electronic health record; Family medicine; Data collection; Alternative medicine; Medical emergency; Health care; Computer science; Pathology","score_opus":0.9333516952933743,"score_gpt":0.7129547362859485,"score_spread":0.22039695900742573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289680983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024690495,0.5022237,0.09818809,0.30183998,0.027604893,0.0075034834,0.016098505,0.0013808344,0.0426916],"genre_scores_gemma":[0.046381887,0.5160325,0.2996948,0.07655569,0.025017899,0.015531962,0.014149264,0.00091027044,0.005725803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.5144147,0.3258336,0.096200205,0.0073811053,0.054029398,0.0021410114],"domain_scores_gemma":[0.2179556,0.47072947,0.09720195,0.082781054,0.12830587,0.0030260747],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.38990587,0.0016308492,0.0046912823,0.020014353,0.0013733179,0.014616474,0.0055442327,0.006249661,0.019511644],"category_scores_gemma":[0.6625267,0.0020503767,0.0070977956,0.02199428,0.0041595413,0.021028128,0.0066611273,0.010284117,0.008001923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019995644,0.00012949407,0.0032773626,0.066278905,0.001405779,0.00012575653,0.0025679688,0.0006501127,0.0004869349,0.05124512,0.27616113,0.59747154],"study_design_scores_gemma":[0.0005048352,0.0001757531,0.006554884,0.2073834,0.0020356514,0.0005932374,0.0016018136,0.00058826164,0.0010115117,0.046511315,0.7327459,0.00029346245],"about_ca_topic_score_codex":0.007828716,"about_ca_topic_score_gemma":0.007239351,"teacher_disagreement_score":0.61009413,"about_ca_system_score_codex":0.006511308,"about_ca_system_score_gemma":0.041088663,"threshold_uncertainty_score":0.7523547},"labels":[],"label_agreement":null},{"id":"W2424016786","doi":"10.2217/cer-2015-0016","title":"Are drug-coated balloons cost effective for femoropopliteal occlusive disease? A comparison of bare metal stents and uncoated balloons","year":2016,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Medicine; Bare metal; Balloon; Surgery; Stent; Restenosis","score_opus":0.12081910414501004,"score_gpt":0.46378408107019786,"score_spread":0.3429649769251878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424016786","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19948874,0.7900995,0.0018956381,0.0020684719,0.0006259455,0.0004528241,0.0019644822,0.000028196535,0.0033761675],"genre_scores_gemma":[0.90850526,0.08580179,0.002831814,0.0010695402,0.00036550133,0.00024151737,0.0008260811,0.000017369046,0.00034106715],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9909904,0.006295745,0.0010000727,0.0004998423,0.0009102444,0.00030369475],"domain_scores_gemma":[0.9825628,0.014598293,0.0016676586,0.00028104763,0.0005664393,0.00032369306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01040068,0.0009897382,0.0053310674,0.0032791062,0.00019873846,0.002649452,0.0010374424,0.0018023204,0.003003703],"category_scores_gemma":[0.028426444,0.0006096555,0.014251676,0.0026087714,0.000599493,0.0017450126,0.00063391216,0.0013945538,0.00015702368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18345067,0.0007009342,0.03983413,0.11628582,0.4264805,0.00050585775,0.00024091102,0.009577702,0.0020826217,0.0031821325,0.0024013857,0.21525739],"study_design_scores_gemma":[0.047322057,0.0196329,0.12417882,0.01859336,0.76156366,0.0009495258,0.0005173301,0.01096527,0.0016968076,0.0053928574,0.008917415,0.00026990965],"about_ca_topic_score_codex":0.0061792005,"about_ca_topic_score_gemma":0.009535204,"teacher_disagreement_score":0.01040068,"about_ca_system_score_codex":0.0029264023,"about_ca_system_score_gemma":0.0013250672,"threshold_uncertainty_score":0.055004716},"labels":[],"label_agreement":null},{"id":"W2580600991","doi":"10.2217/cer-2016-0093","title":"The comparative effectiveness of antiretroviral therapies for HIV: evidence to inform precision public health","year":2017,"lang":"en","type":"editorial","venue":"Journal of Comparative Effectiveness Research","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"World Health Organization","keywords":"Medicine; Comparative effectiveness research; Human immunodeficiency virus (HIV); Public health; Antiretroviral therapy; Family medicine; Intensive care medicine; Virology; Alternative medicine; Viral load; Pathology","score_opus":0.2714059329206396,"score_gpt":0.5631588489108037,"score_spread":0.2917529159901641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580600991","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003694263,0.025971413,0.00015880866,0.017727097,0.95552343,0.000026863905,0.000086756874,0.000033229775,0.00043546865],"genre_scores_gemma":[0.0006364028,0.021352367,0.00030637486,0.013447009,0.96301866,0.000045340174,0.000038569866,0.000028983746,0.0011262826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96808213,0.011028269,0.0069026737,0.0021412075,0.010970915,0.000874829],"domain_scores_gemma":[0.7060241,0.24595791,0.0070571606,0.0036123218,0.03238476,0.004963725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06373338,0.00604999,0.012680677,0.0070337187,0.002913196,0.0106749125,0.0086353235,0.024819247,0.009521901],"category_scores_gemma":[0.18716636,0.0023196859,0.0077489233,0.004443823,0.0056216274,0.007941964,0.0019193024,0.03240987,0.0042548114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035119758,0.00005971172,0.00009898508,0.005971859,0.0006448727,0.0001760196,0.000059294132,0.00011084291,0.00007963564,0.0018505832,0.969329,0.021268038],"study_design_scores_gemma":[0.0016160418,0.00027711253,0.0015036563,0.013176951,0.0033206858,0.0006971281,0.00029446144,0.0007896731,0.00036563998,0.011601258,0.9661767,0.00018062176],"about_ca_topic_score_codex":0.0029549594,"about_ca_topic_score_gemma":0.0055475594,"teacher_disagreement_score":0.06373338,"about_ca_system_score_codex":0.00528062,"about_ca_system_score_gemma":0.008876056,"threshold_uncertainty_score":0.33705837},"labels":[],"label_agreement":null},{"id":"W2747351937","doi":"10.2217/cer-2017-0043","title":"Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits","year":2017,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Paliperidone Palmitate; Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Medicaid; Paliperidone; Risperidone; Psychiatry; Internal medicine; Health care","score_opus":0.1177252280232934,"score_gpt":0.4255221851048258,"score_spread":0.30779695708153243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747351937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917346,0.00019321198,0.000018020408,0.0000806765,0.00000273267,0.0000069093153,0.00039470423,5.5739054e-7,0.00012974595],"genre_scores_gemma":[0.9992366,0.000080930964,0.000036714096,0.000023683793,0.0000058115847,0.000009696811,0.00057400996,5.2342733e-7,0.00003203394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997982,0.0010454716,0.00023943627,0.00016003771,0.00028722134,0.00028581548],"domain_scores_gemma":[0.99521154,0.0010259169,0.0030111508,0.00010596334,0.00019521524,0.0004502293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020136703,0.00021869576,0.00043884743,0.00092163513,0.00037513967,0.0009484049,0.0003039797,0.0005175854,0.0011918787],"category_scores_gemma":[0.00821372,0.00018219612,0.0013754213,0.0014208541,0.00040364853,0.0007543816,0.00090012455,0.00072200544,0.00007051261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019095603,0.00025571804,0.99353385,0.000035819947,0.000653139,0.0000610629,0.00006183527,0.0007467708,0.0000619548,0.00009123518,0.00013292718,0.0024562585],"study_design_scores_gemma":[0.00008792805,0.000511418,0.9972549,0.000022127751,0.00015784604,0.0000829659,0.0002787664,0.0013737606,0.0000445579,0.00007295244,0.00010167433,0.000011089011],"about_ca_topic_score_codex":0.01662363,"about_ca_topic_score_gemma":0.019086787,"teacher_disagreement_score":0.01662363,"about_ca_system_score_codex":0.0018819467,"about_ca_system_score_gemma":0.0006775096,"threshold_uncertainty_score":0.033053696},"labels":[],"label_agreement":null},{"id":"W2770256141","doi":"10.2217/cer-2017-0011","title":"Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trimetazidine; Medicine; Tolerability; Internal medicine; Cardiology; Angina; Diabetes mellitus; Type 2 diabetes; Coronary artery disease; Ischemia; Adverse effect; Unstable angina; Myocardial infarction; Endocrinology","score_opus":0.03753972083842771,"score_gpt":0.3606793636673458,"score_spread":0.3231396428289181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770256141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977603,0.0017859084,0.00004921732,0.000037056278,0.000014727421,0.00005177886,0.00008562509,0.000003428919,0.00021185867],"genre_scores_gemma":[0.9986979,0.00053964043,0.00016909846,0.00014104915,0.000080647864,0.000050209244,0.00021499598,9.651135e-7,0.00010559985],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99928254,0.0003402344,0.00009366249,0.000098371485,0.00012144094,0.000063869105],"domain_scores_gemma":[0.99813205,0.00054956554,0.00084457785,0.00006551017,0.000111291796,0.00029711652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014604457,0.00036688708,0.0012310041,0.0003176414,0.00032591738,0.0004413135,0.00034556535,0.0006848857,0.0012554564],"category_scores_gemma":[0.0019043747,0.00023894667,0.00076527154,0.0003373699,0.0003192791,0.0003347962,0.00020854459,0.0006162038,0.00015553947],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28342712,0.013422161,0.60987884,0.0012200123,0.0028512808,0.00034909297,0.00028547406,0.000384855,0.0060720043,0.000042900094,0.0005985285,0.08146768],"study_design_scores_gemma":[0.037877697,0.11320497,0.8442118,0.00007994039,0.001255446,0.0005749745,0.0001616452,0.00089874177,0.0010259554,0.00005123182,0.00062395696,0.00003355257],"about_ca_topic_score_codex":0.000543969,"about_ca_topic_score_gemma":0.0010763869,"teacher_disagreement_score":0.0014604457,"about_ca_system_score_codex":0.000303743,"about_ca_system_score_gemma":0.0003316591,"threshold_uncertainty_score":0.007723689},"labels":[],"label_agreement":null},{"id":"W2789990939","doi":"10.2217/cer-2017-0023","title":"Number needed to treat in indirect treatment comparison","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lenvatinib; Number needed to treat; Sorafenib; Oncology; Internal medicine; Odds ratio; Relative risk; Confidence interval","score_opus":0.2184234576921588,"score_gpt":0.5380514190024712,"score_spread":0.31962796131031246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789990939","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027606122,0.043907393,0.7337717,0.012637139,0.034409914,0.11323624,0.009642974,0.0023444528,0.022444038],"genre_scores_gemma":[0.17606777,0.0043202485,0.4994379,0.005287608,0.0017198714,0.30719548,0.002162212,0.0005448581,0.0032640116],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.42490634,0.5100776,0.026287803,0.015594876,0.021600028,0.00153335],"domain_scores_gemma":[0.5462482,0.41826957,0.013364402,0.015762739,0.005237949,0.0011171382],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2301406,0.003629773,0.01357109,0.006585743,0.0012065333,0.005216972,0.005990986,0.008053473,0.029321728],"category_scores_gemma":[0.46924257,0.0014244987,0.014793683,0.005200475,0.0051946538,0.008250588,0.0046045952,0.0128445495,0.0016112659],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06301129,0.0019739782,0.011489028,0.11546066,0.09813533,0.0012436061,0.0032257226,0.02572867,0.0014042754,0.16917846,0.040960196,0.4681888],"study_design_scores_gemma":[0.051867478,0.017505912,0.011858739,0.03594692,0.04943499,0.001984657,0.0016347902,0.15383251,0.00859309,0.5521819,0.11400936,0.0011497032],"about_ca_topic_score_codex":0.00068367634,"about_ca_topic_score_gemma":0.00051675504,"teacher_disagreement_score":0.76985943,"about_ca_system_score_codex":0.0047339667,"about_ca_system_score_gemma":0.004769961,"threshold_uncertainty_score":0.9493737},"labels":[],"label_agreement":null},{"id":"W2794986206","doi":"10.2217/cer-2017-0092","title":"Analysis of indirect treatment comparisons in national health technology assessments and requirements for industry submissions","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scope (computer science); Health technology; Medicine; Comparative effectiveness research; Alternative medicine; Health care; Computer science; Political science","score_opus":0.8138658705718702,"score_gpt":0.6792615665071889,"score_spread":0.13460430406468127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794986206","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1008732,0.030250574,0.60493886,0.029217644,0.0070705693,0.09477468,0.021188408,0.0013520715,0.110333964],"genre_scores_gemma":[0.36175486,0.003995977,0.49040866,0.0054268474,0.0016707876,0.12583824,0.0063071637,0.00073951,0.0038579067],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.05821758,0.7433781,0.09593827,0.008837696,0.092151746,0.0014766329],"domain_scores_gemma":[0.014270279,0.85800576,0.039643694,0.030132493,0.057324834,0.000622989],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.8053089,0.001825201,0.0047728685,0.013290086,0.0036811067,0.014513773,0.0068005645,0.0054301536,0.017421119],"category_scores_gemma":[0.94792336,0.0020106847,0.011051103,0.014888008,0.0059304056,0.011881079,0.010154347,0.008708308,0.0021115649],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009870518,0.00090583006,0.046991896,0.09896103,0.012415208,0.0007044715,0.017850542,0.011884685,0.0018737311,0.14539923,0.04334696,0.60979587],"study_design_scores_gemma":[0.0071447785,0.0112083005,0.17531683,0.1465897,0.015693227,0.0026429363,0.012789183,0.05719589,0.0156721,0.2631976,0.2912828,0.001266594],"about_ca_topic_score_codex":0.001940433,"about_ca_topic_score_gemma":0.0021701853,"teacher_disagreement_score":0.19469112,"about_ca_system_score_codex":0.012040181,"about_ca_system_score_gemma":0.025098152,"threshold_uncertainty_score":0.24008888},"labels":[],"label_agreement":null},{"id":"W2803925386","doi":"10.2217/cer-2018-0015","title":"Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis","year":2018,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Cinacalcet; Observational study; Randomized controlled trial; Discontinuation; Hazard ratio; Meta-analysis; Internal medicine; MEDLINE; Dialysis; Intensive care medicine; Relative risk; Parathyroidectomy; Secondary hyperparathyroidism; Confidence interval; Parathyroid hormone","score_opus":0.1963978398121837,"score_gpt":0.5228953080177915,"score_spread":0.32649746820560777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803925386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019193835,0.995609,0.0013061588,0.00026422966,0.000090624846,0.00033445333,0.00029102876,0.00002623834,0.00015891615],"genre_scores_gemma":[0.12363453,0.8654959,0.0068590003,0.0009100249,0.0003296118,0.0018316342,0.00070665753,0.000034383695,0.0001982506],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97350526,0.015134444,0.0065093488,0.0019626252,0.0025393362,0.0003490667],"domain_scores_gemma":[0.9243851,0.06225323,0.008302898,0.0014461647,0.003236882,0.0003757075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038920954,0.0032306383,0.021018118,0.014768566,0.0006325895,0.003882016,0.0031524997,0.002989639,0.003426193],"category_scores_gemma":[0.08725874,0.002126271,0.03719159,0.0114945695,0.0007948493,0.0021263985,0.0017577317,0.0019644548,0.00034530144],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012430868,0.000038999824,0.0033552973,0.39937,0.5733648,0.000102552505,0.00006982537,0.0014580941,0.00014440378,0.00025098232,0.0005686247,0.020033324],"study_design_scores_gemma":[0.00044098837,0.00020178102,0.0031887125,0.041156102,0.95195526,0.00009091878,0.00003461762,0.0007748287,0.000095826545,0.00053026364,0.0014994619,0.00003124207],"about_ca_topic_score_codex":0.0055850977,"about_ca_topic_score_gemma":0.007912287,"teacher_disagreement_score":0.038920954,"about_ca_system_score_codex":0.0036166385,"about_ca_system_score_gemma":0.0049248114,"threshold_uncertainty_score":0.20583612},"labels":[],"label_agreement":null},{"id":"W2806016224","doi":"10.2217/cer-2017-0029","title":"Comparison of EQ-5D and SF-36 in untreated patients with symptoms of intermittent claudication","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); University of Alberta","funders":"Universiteit Maastricht","keywords":"Medicine; EQ-5D; Valuation (finance); Intermittent claudication; Quality of life (healthcare); Physical therapy; Tariff; Quality-adjusted life year; Health related quality of life; Arterial disease; Disease; Finance; Surgery; Internal medicine; Cost effectiveness","score_opus":0.1271241282527948,"score_gpt":0.43425018516687686,"score_spread":0.30712605691408207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806016224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330306,0.0040734503,0.0006389799,0.00014769839,0.000039642204,0.0000822394,0.00058611715,0.00000408859,0.0011247784],"genre_scores_gemma":[0.9980731,0.0005697852,0.00037662798,0.00009119689,0.000028358832,0.00007237981,0.00064721087,0.0000015178803,0.00013976877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696726,0.00210651,0.00023252955,0.00021477368,0.00037857296,0.000100359306],"domain_scores_gemma":[0.9956182,0.0031823367,0.0006623539,0.00019813036,0.0001901411,0.00014876829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038733094,0.00029039415,0.0009751502,0.0005173341,0.0002119486,0.0004599675,0.00034175362,0.00064194907,0.0015024021],"category_scores_gemma":[0.011890688,0.00015158154,0.0010727242,0.0006125181,0.00041938754,0.00066425104,0.00032844083,0.0005913816,0.00015554317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08742324,0.002919396,0.78767943,0.0014778434,0.008551312,0.00040204776,0.0007727342,0.007228586,0.0021110664,0.0010934217,0.0014470235,0.098893896],"study_design_scores_gemma":[0.0062376917,0.0236005,0.95924413,0.0001962438,0.0014351083,0.0006967081,0.00047019272,0.004499037,0.0005968024,0.0009676119,0.0019910003,0.00006503072],"about_ca_topic_score_codex":0.0012122616,"about_ca_topic_score_gemma":0.001531541,"teacher_disagreement_score":0.0038733094,"about_ca_system_score_codex":0.0006384191,"about_ca_system_score_gemma":0.00030708304,"threshold_uncertainty_score":0.020484209},"labels":[],"label_agreement":null},{"id":"W2808685910","doi":"10.2217/cer-2017-0090","title":"Examples of dramatic failures and their effectiveness in modern surgical disciplines: can we learn from our mistakes?","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Subspecialty; Skepticism; Medicine; Craft; Engineering ethics; Health care; Curiosity; Epistemology; Psychology; Law; Engineering; Pathology; Social psychology","score_opus":0.11592673528596632,"score_gpt":0.4303357293267681,"score_spread":0.3144089940408018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808685910","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21101022,0.043934397,0.04019934,0.5411346,0.007129548,0.0003336963,0.00029046487,0.00071285723,0.15525484],"genre_scores_gemma":[0.9292372,0.011938805,0.020515548,0.027317338,0.0014713395,0.00022785805,0.00008040688,0.00035009524,0.00886141],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.95002437,0.029486882,0.002716308,0.0021119544,0.012762692,0.0028978053],"domain_scores_gemma":[0.8361997,0.103940636,0.017720284,0.016006896,0.020877963,0.0052545564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044724215,0.0007843026,0.00069304416,0.004295901,0.008809951,0.008752517,0.0024688481,0.004639031,0.0050132233],"category_scores_gemma":[0.13171595,0.00065220427,0.0010055716,0.0025145567,0.029248863,0.012978527,0.009344053,0.011515333,0.0009332133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036220707,0.00022030916,0.021083595,0.0034506712,0.0003648812,0.004002333,0.30981588,0.0012664485,0.0018372582,0.28137273,0.12879986,0.24742381],"study_design_scores_gemma":[0.00008715975,0.00047068376,0.027749358,0.0061726472,0.00020204771,0.0073718424,0.24440242,0.0013045175,0.0032769102,0.1656988,0.5428559,0.00040770991],"about_ca_topic_score_codex":0.0031522962,"about_ca_topic_score_gemma":0.006595559,"teacher_disagreement_score":0.044724215,"about_ca_system_score_codex":0.005766137,"about_ca_system_score_gemma":0.0048990506,"threshold_uncertainty_score":0.23652709},"labels":[],"label_agreement":null},{"id":"W2889227700","doi":"10.2217/cer-2018-0020","title":"Relative effectiveness of sunitinib versus everolimus in advanced pancreatic neuroendocrine tumors: an updated matching-adjusted indirect comparison","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Sunitinib; Everolimus; Medicine; Hazard ratio; Internal medicine; Oncology; Neuroendocrine tumors; Urology; Confidence interval; Cancer","score_opus":0.1270138429126655,"score_gpt":0.4709140956346132,"score_spread":0.3439002527219477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889227700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93462867,0.038727988,0.011551813,0.00056916825,0.0010658184,0.0021138936,0.0048083216,0.00014399571,0.0063902526],"genre_scores_gemma":[0.99309784,0.0013864053,0.002948319,0.00020764876,0.00016250889,0.00066953525,0.00091047847,0.000017026457,0.0006002551],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98281616,0.0127133755,0.0014722402,0.0011534226,0.0014337283,0.00041116],"domain_scores_gemma":[0.9868036,0.009745236,0.0018647149,0.00097062875,0.0003668593,0.00024884794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013101188,0.0013547763,0.0035717068,0.0011833829,0.00018917983,0.0011282176,0.0010829696,0.0010154756,0.0056663854],"category_scores_gemma":[0.02471598,0.00040605597,0.007477275,0.0009169473,0.0004567674,0.0011125061,0.0010972254,0.0017736811,0.00027867028],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60743034,0.0010078017,0.0394904,0.01333846,0.22556265,0.00024004727,0.0003140813,0.009277782,0.003238278,0.0031098663,0.0020987524,0.09489161],"study_design_scores_gemma":[0.28498214,0.09974913,0.14160727,0.0017684193,0.4117137,0.0011252275,0.00041329744,0.027622754,0.007797185,0.00907427,0.013820995,0.00032565036],"about_ca_topic_score_codex":0.00092908164,"about_ca_topic_score_gemma":0.00096987386,"teacher_disagreement_score":0.013101188,"about_ca_system_score_codex":0.00069981854,"about_ca_system_score_gemma":0.0005179802,"threshold_uncertainty_score":0.069286525},"labels":[],"label_agreement":null},{"id":"W2889900146","doi":"10.2217/cer-2018-0035","title":"Some issues for the evaluation of noninferiority trials","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"H2020 European Research Council","keywords":"Medicine; Confidence interval; Margin (machine learning); Adjuvant therapy; Placebo; Medical physics; Cancer; Internal medicine; Alternative medicine","score_opus":0.9613010515836794,"score_gpt":0.7999582645757043,"score_spread":0.1613427870079751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889900146","genre_codex":"commentary","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036876723,0.11990063,0.3211085,0.47817567,0.055225473,0.010067465,0.0008753733,0.000811274,0.010147952],"genre_scores_gemma":[0.06962612,0.016601503,0.5699927,0.23869655,0.056144696,0.045752957,0.00036761694,0.00060823944,0.0022096746],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.0726471,0.786211,0.09735988,0.0103933755,0.03204947,0.0013390929],"domain_scores_gemma":[0.015894547,0.93414426,0.014016124,0.01764719,0.017266208,0.0010316132],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.87378496,0.004333627,0.012429397,0.012440915,0.0052556368,0.020130143,0.016041389,0.027638702,0.0068169134],"category_scores_gemma":[0.9390764,0.00392421,0.016598586,0.011686217,0.050518733,0.025179913,0.009910557,0.04141298,0.0025562637],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007666081,0.00040648232,0.0051162844,0.046019036,0.010267917,0.0009753455,0.010990433,0.0037372522,0.0007152499,0.45903894,0.1146961,0.34037086],"study_design_scores_gemma":[0.0061261584,0.0025612628,0.0038129908,0.06561202,0.0032818776,0.0011478958,0.0021259652,0.011344798,0.001857079,0.687676,0.21380937,0.00064449885],"about_ca_topic_score_codex":0.002559288,"about_ca_topic_score_gemma":0.002368615,"teacher_disagreement_score":0.12621504,"about_ca_system_score_codex":0.013436349,"about_ca_system_score_gemma":0.018708635,"threshold_uncertainty_score":0.15564567},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2892182512","doi":"10.2217/cer-2018-0006","title":"M-bioscore: proposing a new statistical model for prognostic factors in metastatic breast cancer patients","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Proportional hazards model; Breast cancer; Oncology; Internal medicine; Hazard ratio; Cohort; Multivariate analysis; Cancer; Multivariate statistics; Metastatic breast cancer; Survival analysis; Confidence interval; Statistics","score_opus":0.1123983302583288,"score_gpt":0.46056779330651276,"score_spread":0.34816946304818397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892182512","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23500372,0.0014631369,0.75116676,0.0027491276,0.00031637514,0.0005471401,0.0051055173,0.0022632664,0.0013849622],"genre_scores_gemma":[0.8454244,0.0004958933,0.1449907,0.0006077095,0.00040045634,0.0008450353,0.005958457,0.00012740253,0.0011499957],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99752825,0.0013217791,0.00015938978,0.0005094707,0.00034551538,0.00013558412],"domain_scores_gemma":[0.99295855,0.0049858806,0.0006548459,0.00043074432,0.0007406483,0.00022933561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077476692,0.0013897701,0.0013615601,0.0026723451,0.0005017553,0.0016307357,0.0015050741,0.0010491622,0.0013300793],"category_scores_gemma":[0.01920633,0.00037484654,0.0021490178,0.0010434556,0.0005479178,0.0009343325,0.0014648715,0.0014184417,0.0006493794],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013466424,0.00056338357,0.33905575,0.00031224283,0.0013181788,0.00029341734,0.0002652456,0.37245893,0.0014882372,0.0055930596,0.013638208,0.26366672],"study_design_scores_gemma":[0.0000500106,0.00019723969,0.009901721,0.000037386082,0.00007312897,0.00010930509,0.000026362759,0.98352605,0.0002276296,0.0048881397,0.0009370713,0.000025967012],"about_ca_topic_score_codex":0.0059929797,"about_ca_topic_score_gemma":0.0049478756,"teacher_disagreement_score":0.0077476692,"about_ca_system_score_codex":0.00081087626,"about_ca_system_score_gemma":0.0018303712,"threshold_uncertainty_score":0.04097408},"labels":[],"label_agreement":null},{"id":"W2895775669","doi":"10.2217/cer-2018-0065","title":"Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasis","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Covariate; Placebo; Meta-analysis; Psychological intervention; Clinical trial; Internal medicine; Physical therapy; Statistics; Alternative medicine; Psychiatry; Dermatology; Pathology","score_opus":0.9347608835346701,"score_gpt":0.7117826814298529,"score_spread":0.22297820210481722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895775669","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15554124,0.06989356,0.7461986,0.017322438,0.0011539913,0.0033318496,0.0008672748,0.0005700347,0.005120962],"genre_scores_gemma":[0.79069066,0.0053707557,0.19946535,0.0014097525,0.00029255496,0.0019922813,0.00024465233,0.00013607112,0.000397862],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.5441919,0.42313376,0.014551667,0.008501246,0.008569838,0.0010516661],"domain_scores_gemma":[0.26242402,0.6884161,0.018141888,0.026019502,0.004410247,0.00058822834],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35446107,0.002266992,0.0056510647,0.0045365663,0.0018458518,0.0057090083,0.0034554556,0.00550235,0.0017341132],"category_scores_gemma":[0.5964376,0.0016194298,0.018664414,0.0043374845,0.0025992994,0.0058165174,0.003265737,0.004862334,0.000141674],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011258245,0.00061378366,0.16623628,0.020145379,0.35574815,0.0055009113,0.0043086656,0.12620875,0.0027501292,0.03351818,0.0050685257,0.26864308],"study_design_scores_gemma":[0.0052815215,0.0033057157,0.045371853,0.011694447,0.2614198,0.005200098,0.0016999263,0.40540916,0.005709118,0.24266882,0.011367577,0.00087187334],"about_ca_topic_score_codex":0.006189581,"about_ca_topic_score_gemma":0.010265467,"teacher_disagreement_score":0.6455389,"about_ca_system_score_codex":0.0028851524,"about_ca_system_score_gemma":0.004568421,"threshold_uncertainty_score":0.79606444},"labels":[],"label_agreement":null},{"id":"W2904705793","doi":"10.2217/cer-2018-0051","title":"Using a society database to evaluate a patient safety collaborative: the Cardiovascular Surgical Translational Study","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Agency for Healthcare Research and Quality; Society of Thoracic Surgeons","keywords":"Medicine; Quality management; Context (archaeology); Intervention (counseling); Patient safety; Propensity score matching; Outcome (game theory); Protocol (science); Health care; Medical emergency; Service (business); Nursing; Alternative medicine; Surgery","score_opus":0.8011968449105192,"score_gpt":0.7514784632609536,"score_spread":0.04971838164956566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904705793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777777,0.00030325865,0.0030228936,0.00044669397,0.0000843968,0.0029792124,0.00371196,0.000031158757,0.0016425933],"genre_scores_gemma":[0.9819083,0.00014845528,0.0059182346,0.0004745144,0.00011583472,0.004968263,0.006192779,0.000020017642,0.00025353068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9037696,0.06847129,0.0105891405,0.0050319186,0.010572103,0.0015659692],"domain_scores_gemma":[0.8801216,0.035662882,0.04049215,0.019042436,0.017606396,0.0070745857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.054321397,0.00088330754,0.0011050422,0.004203473,0.0013687916,0.0028090617,0.0017212713,0.0015910335,0.0020741047],"category_scores_gemma":[0.099606596,0.00054301915,0.0015802777,0.0045022485,0.001475312,0.003709187,0.0049793557,0.0013650105,0.0006147256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087605715,0.007636277,0.9505006,0.00045922864,0.0014257105,0.00008612702,0.0010728473,0.0006334068,0.00029933066,0.0005642786,0.0017765994,0.026785148],"study_design_scores_gemma":[0.008483443,0.020324651,0.9508876,0.00039362628,0.0020437592,0.00031516992,0.003137933,0.005657566,0.0025565543,0.0005385798,0.005508145,0.00015298753],"about_ca_topic_score_codex":0.006692997,"about_ca_topic_score_gemma":0.006016186,"teacher_disagreement_score":0.054321397,"about_ca_system_score_codex":0.003911924,"about_ca_system_score_gemma":0.007181201,"threshold_uncertainty_score":0.2872824},"labels":[],"label_agreement":null},{"id":"W2905207641","doi":"10.2217/cer-2018-0033","title":"Early cost–effectiveness modeling for better decisions in public research investment of personalized medicine technologies","year":2018,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Investment (military); Risk analysis (engineering); Cost effectiveness; Personalized medicine; Process (computing); Medicine; Key (lock); Health care; Cost–benefit analysis; Comparative effectiveness research; Health technology; Investment decisions; Public health; Business; Computer science; Economics; Finance; Computer security","score_opus":0.8503316042240933,"score_gpt":0.6303314722597517,"score_spread":0.22000013196434154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905207641","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02358102,0.0036983683,0.91279393,0.020169714,0.0003095165,0.002775574,0.0018976562,0.00034360233,0.034430593],"genre_scores_gemma":[0.51461875,0.0059553175,0.45934176,0.0029411584,0.0005533408,0.00564318,0.0015977835,0.0001511513,0.009197535],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96893334,0.026578214,0.0007340245,0.0006312606,0.002234782,0.0008883586],"domain_scores_gemma":[0.86290354,0.12729599,0.0032954426,0.0019696245,0.0038796044,0.0006557918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047176898,0.0022965295,0.0030677025,0.0036537831,0.0007545308,0.0058137085,0.0020286215,0.0038712549,0.015439666],"category_scores_gemma":[0.12623227,0.001647776,0.003386719,0.003232177,0.0013985358,0.0072148005,0.0022059483,0.007466093,0.0011376749],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003825887,0.00034566066,0.0024347224,0.00075598556,0.00027940195,0.00015308386,0.00025818718,0.5961886,0.00029428664,0.34305465,0.008384625,0.047468282],"study_design_scores_gemma":[0.00016955216,0.00021697719,0.0013251534,0.000680207,0.0003177288,0.00005820641,0.00018014669,0.6338102,0.00044990162,0.35259882,0.010119852,0.00007328175],"about_ca_topic_score_codex":0.010090992,"about_ca_topic_score_gemma":0.009631868,"teacher_disagreement_score":0.047176898,"about_ca_system_score_codex":0.008717811,"about_ca_system_score_gemma":0.013244123,"threshold_uncertainty_score":0.24949825},"labels":[],"label_agreement":null},{"id":"W2908997167","doi":"10.2217/cer-2018-0113","title":"Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Metastasis; Cancer; Bone metastasis; Asymptomatic; Lung cancer; Radiology; Population; Lung; Oncology; Internal medicine","score_opus":0.1506586076286012,"score_gpt":0.4861626378263604,"score_spread":0.3355040301977592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908997167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551066,0.008575439,0.016120082,0.0067429184,0.00073820003,0.0006939153,0.0030863117,0.00018724024,0.00874918],"genre_scores_gemma":[0.991679,0.00022446636,0.004788641,0.0011906497,0.000111421126,0.00022840817,0.0015665452,0.000026867143,0.00018397307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.84786135,0.11128291,0.011974825,0.01033299,0.016472068,0.0020758342],"domain_scores_gemma":[0.75526464,0.13515836,0.04359362,0.039778944,0.023618117,0.0025862618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14341109,0.00063692685,0.0010750582,0.0014817937,0.0008274916,0.0030098886,0.003651291,0.0028789982,0.0009841969],"category_scores_gemma":[0.24659044,0.00052835775,0.0014755081,0.0020348295,0.0016804881,0.0021757341,0.0019321312,0.0022310736,0.0004609507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022602156,0.00007063685,0.99051255,0.000118762786,0.0004938724,0.00004990689,0.00036638178,0.0002593684,0.00014268792,0.00021086018,0.00082582934,0.006723165],"study_design_scores_gemma":[0.000051459025,0.000703384,0.9855371,0.00039459128,0.00043573635,0.00055298535,0.00081983977,0.0039062584,0.0006119709,0.0006009707,0.0063493927,0.000036326826],"about_ca_topic_score_codex":0.006110684,"about_ca_topic_score_gemma":0.0069590784,"teacher_disagreement_score":0.14341109,"about_ca_system_score_codex":0.0012284396,"about_ca_system_score_gemma":0.00191416,"threshold_uncertainty_score":0.75843936},"labels":[],"label_agreement":null},{"id":"W2909436531","doi":"10.2217/cer-2018-0073","title":"A cost–utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Insulin glargine; Dulaglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Insulin; Exenatide; Endocrinology","score_opus":0.16141366002993843,"score_gpt":0.457361692122425,"score_spread":0.29594803209248655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909436531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91474783,0.032284103,0.0074147223,0.004285027,0.00018000936,0.002653513,0.023286635,0.00017074813,0.014977459],"genre_scores_gemma":[0.9885156,0.0035856224,0.0032361904,0.00029801656,0.000021618884,0.0002629292,0.002857289,0.000015620073,0.0012070045],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99753016,0.001402214,0.00010947597,0.00019380177,0.0004038887,0.00036051613],"domain_scores_gemma":[0.9948861,0.0032031012,0.00043658618,0.00009912397,0.0009683668,0.0004067964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041437102,0.0013245032,0.002140458,0.0018874623,0.0007432777,0.0019106842,0.0017641581,0.0009353707,0.0038756595],"category_scores_gemma":[0.014347553,0.0006100985,0.0041004336,0.0027767087,0.00067550223,0.0005920564,0.0009456934,0.0013299012,0.00013968068],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026548676,0.00086131546,0.0655978,0.0057186615,0.013254393,0.0007890665,0.00019077353,0.8106299,0.0009915743,0.009530711,0.010165694,0.05572142],"study_design_scores_gemma":[0.009792746,0.0043585747,0.0830577,0.0015533124,0.016010571,0.00044498092,0.00071973534,0.8707832,0.00067647215,0.0055870786,0.0066857804,0.00032990688],"about_ca_topic_score_codex":0.9032263,"about_ca_topic_score_gemma":0.8468756,"teacher_disagreement_score":0.096773684,"about_ca_system_score_codex":0.05676259,"about_ca_system_score_gemma":0.04313709,"threshold_uncertainty_score":0.41184336},"labels":[],"label_agreement":null},{"id":"W2914902447","doi":"10.2217/cer-2018-0140","title":"Medicaid spending burden among beneficiaries with treatment-resistant depression","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Mental Health Treatment and Access","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"H2020 European Research Council; Janssen Scientific Affairs","keywords":"Medicaid; Major depressive disorder; Medicine; Depression (economics); Treatment-resistant depression; Psychiatry; Cohort; Incidence (geometry); Emergency medicine; Health care; Internal medicine","score_opus":0.11921362968322262,"score_gpt":0.49022224188282787,"score_spread":0.37100861219960524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914902447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981615,0.00030714556,0.00002026258,0.00021347764,0.0000034645554,0.0000076025485,0.00088022935,0.000001600274,0.00040467115],"genre_scores_gemma":[0.99868566,0.00019579884,0.000037325124,0.00007005994,0.000010375622,0.000009225217,0.00090286543,9.708702e-7,0.00008773836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952126,0.00015233493,0.00006832718,0.000060952192,0.00010932072,0.00008795559],"domain_scores_gemma":[0.9986411,0.0001490726,0.0009437974,0.00003797907,0.000082686405,0.00014537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005496803,0.0001319233,0.00021180617,0.0010154359,0.00035260478,0.0005364438,0.00020948084,0.00037444383,0.001391321],"category_scores_gemma":[0.0029236374,0.00012616225,0.00046534877,0.0009967026,0.00018499047,0.00048941374,0.0006759843,0.00048306148,0.00011225915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010561305,0.00006158945,0.99664754,0.000010573938,0.000083091494,0.000035855122,0.00004226015,0.000046052144,0.00007909131,0.000049818325,0.00028330873,0.0025551245],"study_design_scores_gemma":[0.000004460662,0.000028109966,0.9994795,0.000011705311,0.000023888197,0.00008750106,0.000092101465,0.00012404817,0.000017759718,0.000014508405,0.00011476365,0.0000016931846],"about_ca_topic_score_codex":0.016001405,"about_ca_topic_score_gemma":0.026257552,"teacher_disagreement_score":0.016001405,"about_ca_system_score_codex":0.0005907566,"about_ca_system_score_gemma":0.00035374888,"threshold_uncertainty_score":0.031816542},"labels":[],"label_agreement":null},{"id":"W2946062710","doi":"10.2217/cer-2018-0148","title":"Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Brain metastasis; Oncology; Lung cancer; Internal medicine; Stage (stratigraphy); Metastasis; Adenocarcinoma; Cohort; Cancer; Radiology","score_opus":0.05032851838770644,"score_gpt":0.4331460358121984,"score_spread":0.382817517424492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946062710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535574,0.016831053,0.0020374928,0.016729403,0.00050126284,0.00015775146,0.0048324736,0.00010485809,0.00524836],"genre_scores_gemma":[0.991653,0.0025772848,0.0016548097,0.0016193939,0.00033898337,0.000070768445,0.0019231366,0.000013144853,0.00014944765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666387,0.0011127035,0.0007939971,0.00045552023,0.00069807743,0.00027583822],"domain_scores_gemma":[0.9825963,0.0053065703,0.008327384,0.0008112845,0.0019483578,0.0010102431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032292888,0.00027951563,0.0006800143,0.0008630587,0.0004209075,0.00085430493,0.0006819486,0.00095667766,0.0012723573],"category_scores_gemma":[0.025601078,0.00020616775,0.0004978224,0.0013068371,0.00051864644,0.0015853898,0.00041572217,0.0009850994,0.00056407414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019618565,0.000040398034,0.9720514,0.00027887034,0.000058754467,0.00020313766,0.00008831782,0.00012933069,0.00027450366,0.0000597712,0.0024234166,0.0241959],"study_design_scores_gemma":[0.000027500737,0.0004098022,0.99195236,0.0003984134,0.00014659377,0.0017041124,0.00058905274,0.00075356656,0.0005106782,0.0002804639,0.0032072596,0.00002017846],"about_ca_topic_score_codex":0.003858194,"about_ca_topic_score_gemma":0.008267793,"teacher_disagreement_score":0.003858194,"about_ca_system_score_codex":0.00067806157,"about_ca_system_score_gemma":0.0020283735,"threshold_uncertainty_score":0.01707834},"labels":[],"label_agreement":null},{"id":"W2953676957","doi":"10.2217/cer-2019-0052","title":"Cost–effectiveness of lenalidomide plus low-dose dexamethasone for newly diagnosed multiple myeloma patients ineligible for stem cell transplantation in China","year":2019,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; Lenalidomide; Cost effectiveness; Quality-adjusted life year; Transplantation; Bortezomib; Dexamethasone; Autologous stem-cell transplantation; China; Internal medicine; Oncology; Risk analysis (engineering)","score_opus":0.23850686821996936,"score_gpt":0.48982209004031313,"score_spread":0.25131522182034377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953676957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008586878,0.9903369,0.00008240411,0.000370963,0.000056359488,0.0000634882,0.000080456695,0.00000282413,0.00041970523],"genre_scores_gemma":[0.12515895,0.87352324,0.00050720095,0.00027586374,0.00009552162,0.00012829174,0.00013609546,0.000002151408,0.00017265219],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998938,0.00057002535,0.00016374509,0.000061201434,0.00019550495,0.000071516595],"domain_scores_gemma":[0.99910814,0.00055264484,0.00021256591,0.000008269221,0.00008272901,0.000035605168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024927112,0.0008755098,0.0027040138,0.0021912395,0.00018036408,0.0010235324,0.0010300296,0.00080159836,0.0022750336],"category_scores_gemma":[0.004205276,0.00034133912,0.0046996614,0.00172119,0.00023236824,0.00060092943,0.0004272183,0.00073271454,0.000061966],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058557345,0.00037037273,0.0067770374,0.3440288,0.036174294,0.0003492799,0.00013368171,0.0067617497,0.0006084211,0.003160699,0.0039400486,0.5918399],"study_design_scores_gemma":[0.020185849,0.011939697,0.11439867,0.32607678,0.40300807,0.0027809702,0.0010230866,0.022442585,0.0036699194,0.007880773,0.08626428,0.00032932055],"about_ca_topic_score_codex":0.015257617,"about_ca_topic_score_gemma":0.021237472,"teacher_disagreement_score":0.015257617,"about_ca_system_score_codex":0.0037126918,"about_ca_system_score_gemma":0.005069314,"threshold_uncertainty_score":0.030337632},"labels":[],"label_agreement":null},{"id":"W2969452269","doi":"10.2217/cer-2019-0091","title":"Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Duchesnay (Canada)","funders":"","keywords":"Medicine; Pharmacy; Menopause; Healthcare system; Internal medicine; Gynecology; Health care; Family medicine","score_opus":0.04406549513679099,"score_gpt":0.40015497872199624,"score_spread":0.35608948358520526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969452269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773383,0.0015476658,0.000031410564,0.000048036876,0.0000038862977,0.000014339761,0.00025624371,7.8067154e-7,0.00036382346],"genre_scores_gemma":[0.99923694,0.00032900317,0.000048603608,0.000029232264,0.000011040007,0.000009536398,0.000215199,4.3651713e-7,0.000119971766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988004,0.0005578415,0.00015905546,0.00012990794,0.0002756987,0.0000770548],"domain_scores_gemma":[0.99763703,0.0007736213,0.0013032991,0.000071388386,0.00008141978,0.00013313467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016381923,0.000112314825,0.00041556905,0.0005374052,0.00025201248,0.0005792241,0.00024208876,0.00029796216,0.0017641464],"category_scores_gemma":[0.004588799,0.00009723939,0.00054366136,0.0008198055,0.00020012145,0.0003675391,0.0003247354,0.0004003465,0.00010772138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058510266,0.0004165609,0.97024035,0.0001876565,0.0008138036,0.00003657943,0.00008214165,0.00018324425,0.00015820717,0.000056427994,0.000110682704,0.021863408],"study_design_scores_gemma":[0.00035655685,0.0030794612,0.99429333,0.000059496197,0.0004982012,0.00026035763,0.00022086385,0.00049590564,0.00018953963,0.000045619232,0.00049282255,0.000007943295],"about_ca_topic_score_codex":0.0019519187,"about_ca_topic_score_gemma":0.0028263142,"teacher_disagreement_score":0.0019519187,"about_ca_system_score_codex":0.0004762525,"about_ca_system_score_gemma":0.00026104244,"threshold_uncertainty_score":0.008663654},"labels":[],"label_agreement":null},{"id":"W2982129066","doi":"10.2217/cer-2019-0043","title":"Population-based assessment of the National Comprehensive Cancer Network recommendations for baseline imaging of rectal cancer","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Cancer; Metastasis; Lung cancer; Radiology; Population; Oncology; Cohort; Internal medicine","score_opus":0.18378541269258641,"score_gpt":0.5422935991056796,"score_spread":0.35850818641309323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982129066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892456,0.001441404,0.0009173689,0.00041498322,0.000029156605,0.000075824784,0.0063416455,0.000039251787,0.0014947498],"genre_scores_gemma":[0.9963638,0.00014685231,0.00051716174,0.00006234049,0.000014161971,0.000034054123,0.0027867104,0.0000043517666,0.00007050965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962452,0.0014788513,0.00047917408,0.0006957595,0.00093489944,0.00016609223],"domain_scores_gemma":[0.9856241,0.0035524326,0.007829929,0.00078088033,0.0017492058,0.00046353473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005559887,0.00024553612,0.00048149066,0.0017292557,0.00022876631,0.00088024384,0.0006941506,0.00077298185,0.0006997065],"category_scores_gemma":[0.023258708,0.00021686805,0.0006181953,0.0017412117,0.00024089884,0.00079718605,0.000538308,0.00065561384,0.00019682286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005035901,0.000011766137,0.9982095,0.000015157781,0.000084550404,0.000007896285,0.000023003062,0.00012670546,0.000027262886,0.000011828275,0.00022586051,0.0012062126],"study_design_scores_gemma":[0.000004280586,0.000049423154,0.9988839,0.0000114392415,0.00002517549,0.00006356985,0.000052283012,0.000650417,0.000019613646,0.000017179951,0.00021909745,0.0000036586075],"about_ca_topic_score_codex":0.008524342,"about_ca_topic_score_gemma":0.009377504,"teacher_disagreement_score":0.008524342,"about_ca_system_score_codex":0.00081767724,"about_ca_system_score_gemma":0.0005144699,"threshold_uncertainty_score":0.029403865},"labels":[],"label_agreement":null},{"id":"W2990463671","doi":"10.2217/cer-2019-0111","title":"The lateral and medial approach in total arthroplasty for valgus knee: a meta-analysis of current literature","year":2019,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Valgus; Total knee arthroplasty; Valgus deformity; Meta-analysis; Range of motion; Cochrane Library; Osteoarthritis; Physical therapy; Arthroplasty; Randomized controlled trial; Physical medicine and rehabilitation; Surgery; Internal medicine","score_opus":0.3371849787735286,"score_gpt":0.5177686102147684,"score_spread":0.1805836314412398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990463671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004254214,0.9952082,0.00011378668,0.00007535824,0.000062309475,0.00008806541,0.00007622836,0.00000497371,0.00011687663],"genre_scores_gemma":[0.087670274,0.9101866,0.0009107876,0.000298818,0.00019820119,0.00032545067,0.00021000543,0.00000949868,0.00019034246],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9961423,0.0014780097,0.0013132985,0.00039485,0.0005347774,0.00013681863],"domain_scores_gemma":[0.9892468,0.0077788467,0.0019280278,0.00017445102,0.0006788428,0.00019315051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00682862,0.0017973302,0.01126302,0.0054728347,0.0004969661,0.00263848,0.0014560056,0.0015495156,0.004095757],"category_scores_gemma":[0.015387953,0.0008775532,0.018415906,0.0050700135,0.0005106046,0.0014942938,0.00091871945,0.001358678,0.00023046188],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056048455,0.000106964624,0.004991653,0.5814774,0.37033635,0.00018744485,0.00014467676,0.00023546394,0.00040580283,0.00015643571,0.0005085784,0.03584441],"study_design_scores_gemma":[0.0010229297,0.0006592844,0.00702491,0.051108234,0.9373607,0.0002164461,0.00013825113,0.000121050965,0.00016575491,0.00015880754,0.0019984888,0.000025104608],"about_ca_topic_score_codex":0.002910422,"about_ca_topic_score_gemma":0.008293622,"teacher_disagreement_score":0.01126302,"about_ca_system_score_codex":0.0013226488,"about_ca_system_score_gemma":0.001932019,"threshold_uncertainty_score":0.03611362},"labels":[],"label_agreement":null},{"id":"W3009343637","doi":"10.2217/cer-2019-0187","title":"Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials","year":2020,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Randomized controlled trial; Meta-analysis; Cochrane Library; Mesenchymal stem cell; Clinical trial; Internal medicine; Bone marrow; Visual analogue scale; Surgery; Pathology","score_opus":0.4233379971369119,"score_gpt":0.5279693907700566,"score_spread":0.10463139363314466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009343637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011638219,0.98502225,0.0013986848,0.00026138534,0.0003129889,0.00044010457,0.0005995988,0.00005128506,0.00027548935],"genre_scores_gemma":[0.44736913,0.5378071,0.0071962276,0.0017845086,0.0007814761,0.002800145,0.0016775789,0.000093653354,0.00049015565],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9738116,0.01523415,0.005692513,0.0029337497,0.0017909092,0.00053715595],"domain_scores_gemma":[0.9689621,0.023540044,0.004719788,0.0011705804,0.0012293947,0.0003780877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027582016,0.0046746484,0.02771109,0.0067451876,0.0007323383,0.004242461,0.0028274325,0.003113648,0.00338319],"category_scores_gemma":[0.043744504,0.0023367372,0.06867949,0.0068309004,0.0009232118,0.0022926629,0.0014117884,0.002707747,0.0003219923],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004803374,0.000028098077,0.0029851047,0.081103496,0.90580535,0.000058986963,0.000021491995,0.0006009952,0.00017543757,0.00006666999,0.00020086375,0.0041501746],"study_design_scores_gemma":[0.0010719844,0.00028165587,0.0015603767,0.0036374063,0.99270755,0.000035597117,0.000013900378,0.00016986016,0.00008584753,0.00009695198,0.00032771422,0.000011157856],"about_ca_topic_score_codex":0.004000278,"about_ca_topic_score_gemma":0.0054467353,"teacher_disagreement_score":0.02771109,"about_ca_system_score_codex":0.0023473338,"about_ca_system_score_gemma":0.0022839492,"threshold_uncertainty_score":0.14586943},"labels":[],"label_agreement":null},{"id":"W3012991619","doi":"10.2217/cer-2020-0032","title":"Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Internal medicine; Serous fluid; Oncology; Cytotoxic T cell; Cancer; Retrospective cohort study","score_opus":0.12655509568559534,"score_gpt":0.4576220673763797,"score_spread":0.33106697169078436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012991619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97032475,0.020754157,0.0002901297,0.0013529755,0.000044681925,0.000067943634,0.003400021,0.0000073630354,0.0037579872],"genre_scores_gemma":[0.994441,0.0041406252,0.00022632275,0.00010395762,0.00003437318,0.00002029459,0.00086057413,0.0000019004946,0.00017094478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982066,0.00073469424,0.00025253167,0.0000870784,0.00046073785,0.00025834033],"domain_scores_gemma":[0.99704593,0.0007518839,0.0016266938,0.00004546205,0.00035856952,0.00017143803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008068848,0.00018818908,0.00030004827,0.0012427144,0.0002882322,0.0010309608,0.00038140843,0.00044593922,0.0017097765],"category_scores_gemma":[0.008268117,0.00016021641,0.0009466936,0.00232923,0.00032215382,0.0003614889,0.00048657026,0.00046533477,0.000081366255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011053396,0.00013804906,0.922876,0.0011455042,0.0024495055,0.0011095018,0.00022568613,0.0073925564,0.0003241399,0.0011166756,0.002669727,0.05944732],"study_design_scores_gemma":[0.000070433554,0.00029250048,0.9881516,0.00051560986,0.0007137647,0.002281242,0.0007926096,0.0026190674,0.00016169781,0.00022539725,0.0041495487,0.000026517071],"about_ca_topic_score_codex":0.07495349,"about_ca_topic_score_gemma":0.12451312,"teacher_disagreement_score":0.07495349,"about_ca_system_score_codex":0.0071985126,"about_ca_system_score_gemma":0.0018586728,"threshold_uncertainty_score":0.14903444},"labels":[],"label_agreement":null},{"id":"W3014980098","doi":"10.2217/cer-2019-0179","title":"Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Adenocarcinoma; Hazard ratio; Proportional hazards model; Oncology; Internal medicine; Population; Stage (stratigraphy); Cancer; Survival analysis; Carcinoma; Surgery; Confidence interval","score_opus":0.19626007860773395,"score_gpt":0.48208794353406725,"score_spread":0.2858278649263333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014980098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998209,0.0008408724,0.0001024401,0.00010508143,0.000009349974,0.0000097400025,0.0004112153,0.0000030805666,0.00030910756],"genre_scores_gemma":[0.9992704,0.0002661556,0.000037862246,0.000030659707,0.000020178486,0.00000621177,0.00033691214,0.0000012573198,0.000030523897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989784,0.00041149612,0.0000941677,0.00022052399,0.00019180041,0.00010353203],"domain_scores_gemma":[0.99703974,0.0006015135,0.0016334342,0.00021958908,0.00022516167,0.00028063598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001274347,0.00027446775,0.00039018592,0.00064309326,0.00029238884,0.00072062685,0.0003636934,0.0004956217,0.00090933836],"category_scores_gemma":[0.005280347,0.00021780969,0.0006427284,0.0010560921,0.0004162206,0.00078958116,0.0005515976,0.000663766,0.0001786644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010596979,0.00004216462,0.99805427,0.000026432814,0.00014550713,0.000060727063,0.000043385236,0.00006345579,0.000065988104,0.00001851391,0.00009810198,0.0012754143],"study_design_scores_gemma":[0.000009523687,0.000120275756,0.9989773,0.000010506512,0.000052785217,0.0002423509,0.00013328965,0.00023315595,0.000020361364,0.000025918402,0.00017043616,0.0000042400056],"about_ca_topic_score_codex":0.0027441957,"about_ca_topic_score_gemma":0.004038164,"teacher_disagreement_score":0.0027441957,"about_ca_system_score_codex":0.00040665953,"about_ca_system_score_gemma":0.00035625178,"threshold_uncertainty_score":0.006739497},"labels":[],"label_agreement":null},{"id":"W3081136664","doi":"10.2217/cer-2020-0095","title":"Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy","year":2020,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Calgary; Alberta Children's Hospital; Western University","funders":"National Institutes of Health; Ministero della Salute; Cytokinetics; Parent Project Muscular Dystrophy; Fondazione Telethon; PTC Therapeutics; Muscular Dystrophy Association; Sarepta Therapeutics; Ionis Pharmaceuticals; FibroGen; AveXis; Biogen; Bristol-Myers Squibb","keywords":"Medicine; Duchenne muscular dystrophy; Placebo; Internal medicine; Randomized controlled trial; Ambulatory; Nonsense mutation; Meta-analysis; Subgroup analysis; Physical therapy; Mutation; Genetics","score_opus":0.5116218416020909,"score_gpt":0.5738630164585028,"score_spread":0.062241174856411896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081136664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022487996,0.973076,0.0013674207,0.00046893262,0.00043303962,0.00045011222,0.00083068386,0.00008281432,0.00080308394],"genre_scores_gemma":[0.6219299,0.36514735,0.005450652,0.0020731813,0.00073995406,0.0017971514,0.0018184094,0.0001014369,0.0009419566],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98002166,0.013882354,0.0030440623,0.0015404462,0.0011320839,0.00037942306],"domain_scores_gemma":[0.9765217,0.018286169,0.0029060943,0.0010566028,0.0009553533,0.00027408436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022683922,0.0037892682,0.016640091,0.0042330506,0.0006733927,0.004007291,0.0020843965,0.0027810188,0.00366774],"category_scores_gemma":[0.03732771,0.0017642883,0.05243363,0.0041777366,0.0007114354,0.0016428751,0.001408059,0.0028583573,0.00036506308],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006770128,0.000034547953,0.0028298702,0.046078384,0.93731517,0.000055232696,0.00003235427,0.0007091407,0.00019936243,0.000101132224,0.00041023167,0.0054645417],"study_design_scores_gemma":[0.0015913964,0.0002791338,0.002500497,0.0031322008,0.9912254,0.000036624584,0.000018068846,0.00027801347,0.00010013421,0.0001910775,0.00063444854,0.000012890974],"about_ca_topic_score_codex":0.0045147254,"about_ca_topic_score_gemma":0.00811578,"teacher_disagreement_score":0.022683922,"about_ca_system_score_codex":0.0019915674,"about_ca_system_score_gemma":0.0014929232,"threshold_uncertainty_score":0.119965434},"labels":[],"label_agreement":null},{"id":"W3084779451","doi":"10.2217/cer-2020-0155","title":"Patient and caregiver experiences at a specialized primary care center for autistic adults","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Health care; Medical home; Autism; Special needs; Patient satisfaction; Population; Family medicine; Healthcare delivery; Primary care; Psychiatry; Nursing; Environmental health","score_opus":0.11677642429807876,"score_gpt":0.4300710642970473,"score_spread":0.3132946399989685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084779451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890256,0.00017158373,0.00002117236,0.000203374,0.000005617885,0.00001282679,0.00004352626,0.0000021072476,0.00063730386],"genre_scores_gemma":[0.99946195,0.00013842554,0.00007461433,0.00016868564,0.000005025865,0.000011786194,0.00003171087,7.247672e-7,0.00010706678],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99878293,0.0006923029,0.00011043336,0.00006670914,0.00012311428,0.00022442371],"domain_scores_gemma":[0.99599504,0.0011193749,0.0013278691,0.00009136512,0.0002720813,0.0011941884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010823837,0.00015543701,0.0003145444,0.0003077677,0.0019841818,0.0009265565,0.00028344794,0.00041752963,0.002784426],"category_scores_gemma":[0.0054546967,0.00018031937,0.00023724364,0.00030522028,0.00054513995,0.00047692054,0.0012059939,0.000610551,0.00014782099],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007778255,0.0013462446,0.87159747,0.0004338484,0.00016006088,0.0031838147,0.08539871,0.00020539312,0.0011006454,0.00025918012,0.0048984075,0.030638332],"study_design_scores_gemma":[0.000097613345,0.0015364214,0.81251436,0.00030688115,0.000086978725,0.00399494,0.1765384,0.00033488942,0.00035425217,0.000121894445,0.0040703174,0.000043068103],"about_ca_topic_score_codex":0.008581881,"about_ca_topic_score_gemma":0.023562418,"teacher_disagreement_score":0.008581881,"about_ca_system_score_codex":0.0012810627,"about_ca_system_score_gemma":0.0015591298,"threshold_uncertainty_score":0.017063856},"labels":[],"label_agreement":null},{"id":"W3088056570","doi":"10.2217/cer-2020-0124","title":"Experiences of cancer patients with outpatient care in the USA: a population-based study","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Medical Expenditure Panel Survey; Logistic regression; Health care; Odds ratio; Odds; Family medicine; Cancer; Population; Outpatient clinic; Gerontology; Environmental health; Internal medicine; Health insurance","score_opus":0.2881492551541447,"score_gpt":0.5823500811200549,"score_spread":0.29420082596591024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088056570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916446,0.000102599384,0.000023560126,0.00008708335,0.0000026438668,0.000009015439,0.00028745006,0.0000012358863,0.0003219957],"genre_scores_gemma":[0.9995173,0.00007099578,0.00003377299,0.00007358164,0.0000043334926,0.000011234235,0.00022183145,7.7884044e-7,0.000066223765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911505,0.00033014073,0.000116854266,0.000099997844,0.00020411995,0.00013384815],"domain_scores_gemma":[0.99791414,0.0003327979,0.0010642633,0.00006014562,0.00023135047,0.00039730006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009214617,0.00012632621,0.0003050969,0.00075274246,0.0005243809,0.00079222163,0.00026761545,0.00045742994,0.0015180532],"category_scores_gemma":[0.0032485502,0.00018919734,0.00037033894,0.0014293636,0.00032986328,0.0006656719,0.00069021416,0.0006569749,0.00016780195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002969572,0.0000719542,0.998016,0.000012752411,0.00003202652,0.000035149274,0.00048993895,0.000008735031,0.000038882514,0.000008000968,0.00016634843,0.0010904933],"study_design_scores_gemma":[0.0000029825608,0.000090426445,0.9978484,0.000009550486,0.000010570728,0.00014180483,0.0016480952,0.00004066773,0.000013440384,0.000005885836,0.00018477207,0.0000034786929],"about_ca_topic_score_codex":0.011278324,"about_ca_topic_score_gemma":0.019202814,"teacher_disagreement_score":0.011278324,"about_ca_system_score_codex":0.0005591252,"about_ca_system_score_gemma":0.00052924186,"threshold_uncertainty_score":0.022425354},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W3094115567","doi":"10.2217/cer-2020-0122","title":"Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Ofatumumab; Medicine; Natalizumab; Ocrelizumab; Alemtuzumab; Multiple sclerosis; Internal medicine; Meta-analysis; Oncology; Disease; Immunology; Rituximab","score_opus":0.6942617178013222,"score_gpt":0.5352789439256699,"score_spread":0.1589827738756523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094115567","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12000929,0.8717339,0.0032395404,0.0007487991,0.00076288945,0.0005396884,0.0017097663,0.00010470006,0.0011514598],"genre_scores_gemma":[0.8829942,0.110161975,0.0032742585,0.0007752284,0.00046981804,0.0006541588,0.0010945398,0.000047678903,0.00052817806],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98973197,0.0069843438,0.0010607438,0.0012896846,0.0006557409,0.00027751838],"domain_scores_gemma":[0.9845579,0.012330833,0.0016490582,0.000637182,0.00056762574,0.0002574509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014274861,0.0025535368,0.012170474,0.0026506684,0.00048560597,0.0022482087,0.0016092905,0.002162539,0.0030366397],"category_scores_gemma":[0.021414777,0.0010221744,0.034183826,0.002487102,0.0005939824,0.0011767917,0.001202477,0.0021738415,0.00019480922],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019797014,0.00005479672,0.0072157574,0.023074996,0.94332457,0.00006521001,0.000021457618,0.0012124168,0.000258418,0.00010854087,0.00024794196,0.004618879],"study_design_scores_gemma":[0.0035314814,0.000584109,0.0045570857,0.0010437303,0.9888388,0.000041753465,0.000012823294,0.0006717382,0.000114985145,0.00017960758,0.00041168832,0.000012309434],"about_ca_topic_score_codex":0.0048717177,"about_ca_topic_score_gemma":0.006111524,"teacher_disagreement_score":0.014274861,"about_ca_system_score_codex":0.0012632927,"about_ca_system_score_gemma":0.0009700444,"threshold_uncertainty_score":0.075493634},"labels":[],"label_agreement":null},{"id":"W3109637262","doi":"10.2217/cer-2020-0079","title":"Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Socioeconomic status; Pancreatic cancer; Logistic regression; Odds ratio; Epidemiology; Internal medicine; Proportional hazards model; Cancer registry; Cancer; Pancreatectomy; Surgery; Demography; Pancreas; Population; Environmental health","score_opus":0.1825159377404781,"score_gpt":0.5083818008052303,"score_spread":0.3258658630647522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109637262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976046,0.00051992765,0.00006735268,0.00023579349,0.000015200331,0.000007036056,0.00053252093,0.0000023368825,0.0010152301],"genre_scores_gemma":[0.999451,0.00011015683,0.000025499083,0.000022898117,0.0000130299195,0.000004272703,0.00028959673,7.483734e-7,0.00008282672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994141,0.00017968669,0.0000734043,0.000062853185,0.00015084037,0.00011912603],"domain_scores_gemma":[0.99856263,0.0001998326,0.0007975159,0.00004639851,0.00013559031,0.00025798922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071784813,0.00020831407,0.0001895563,0.0006424586,0.00037906517,0.0004981599,0.0002386543,0.00024335674,0.0024357026],"category_scores_gemma":[0.004673901,0.0000947551,0.00039801022,0.00071703625,0.00021578476,0.00049249135,0.000689041,0.00042472038,0.00023600481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004567551,0.00001904847,0.99874276,0.000005694407,0.00003535004,0.00004081691,0.000017683038,0.000024760839,0.00002850518,0.00001061087,0.00009354692,0.00093544344],"study_design_scores_gemma":[0.0000029467221,0.00004183935,0.9993874,0.000007597084,0.000015206598,0.00014074787,0.0001037127,0.000120322955,0.000016599777,0.00002034299,0.00014116001,0.0000019918202],"about_ca_topic_score_codex":0.003113713,"about_ca_topic_score_gemma":0.0042387163,"teacher_disagreement_score":0.003113713,"about_ca_system_score_codex":0.00032916118,"about_ca_system_score_gemma":0.00031465926,"threshold_uncertainty_score":0.008148253},"labels":[],"label_agreement":null},{"id":"W3121768136","doi":"10.2217/cer-2020-0187","title":"Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Health care; Logistic regression; Health Information National Trends Survey; Family medicine; Medical prescription; Odds ratio; Population; Odds; Cohort; National Health Interview Survey; Demography; Gerontology; Nursing; Health information; Environmental health; Internal medicine","score_opus":0.07384825278749714,"score_gpt":0.48197826962356877,"score_spread":0.40813001683607164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121768136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986511,0.00015085061,0.00007748206,0.00014142631,0.000005086782,0.000022351785,0.0006165167,0.0000028589336,0.00033226132],"genre_scores_gemma":[0.9992987,0.00010740034,0.00008083711,0.00010356256,0.000007283017,0.0000255306,0.0003126168,0.0000012921232,0.00006273281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991449,0.000265454,0.00011886973,0.0001536576,0.00019780935,0.000119221564],"domain_scores_gemma":[0.9977081,0.0003816476,0.001240552,0.00012802603,0.00023553452,0.0003062142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093899557,0.00020924967,0.00033215462,0.000833772,0.00068796356,0.0009804318,0.00045671494,0.0006320815,0.0016954989],"category_scores_gemma":[0.0042198775,0.00034541602,0.0006531843,0.0016963232,0.00034906235,0.0010357891,0.00079508417,0.0009688645,0.00021609977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021263544,0.00007229471,0.9987638,0.000010711035,0.000050535295,0.000020995325,0.00016921094,0.000013707034,0.000038749044,0.000010027581,0.00016677307,0.00066204235],"study_design_scores_gemma":[0.000005100688,0.00006739529,0.9985689,0.000013994885,0.000029023586,0.000106755964,0.00080279884,0.00014427204,0.000018951969,0.00001364739,0.00022423464,0.0000048344095],"about_ca_topic_score_codex":0.013133028,"about_ca_topic_score_gemma":0.019049847,"teacher_disagreement_score":0.013133028,"about_ca_system_score_codex":0.0004562028,"about_ca_system_score_gemma":0.0006360612,"threshold_uncertainty_score":0.026113153},"labels":[],"label_agreement":null},{"id":"W3127294621","doi":"10.2217/cer-2020-0173","title":"Factors affecting treatment selection and overall survival for first-line EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Osimertinib; Lung cancer; Oncology; Internal medicine; Retrospective cohort study; Tyrosine-kinase inhibitor; Tyrosine kinase; Cohort; Cancer; Targeted therapy; Erlotinib; Epidermal growth factor receptor","score_opus":0.11775978284061421,"score_gpt":0.46844371141222735,"score_spread":0.3506839285716131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127294621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986706,0.00037426042,0.000052480886,0.00016392171,0.0000044426743,0.000007235268,0.0004472227,0.0000015562331,0.0002784578],"genre_scores_gemma":[0.99954504,0.00007102904,0.000030429615,0.00003234588,0.0000059539016,0.0000030544675,0.00027384277,7.3275766e-7,0.000037536985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891996,0.00029786394,0.000122557,0.00018593456,0.00023011585,0.00024365932],"domain_scores_gemma":[0.99478614,0.0013535566,0.0029639248,0.00014549641,0.0002727366,0.00047798475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009796475,0.00011972934,0.00023754715,0.00050061685,0.00041553774,0.0006070397,0.0003844806,0.00045307298,0.0016991291],"category_scores_gemma":[0.005741026,0.00010496832,0.00054191577,0.0009768035,0.00033980465,0.00032457014,0.00026582167,0.00051490974,0.00010467066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041001156,0.000010733987,0.9992787,0.0000031963827,0.00002206146,0.00001455914,0.000012694518,0.000023940042,0.000024229794,0.0000067352853,0.000053566444,0.0005084102],"study_design_scores_gemma":[0.000004250258,0.000039185717,0.99943894,0.0000049459077,0.000021236463,0.00009586736,0.00009043224,0.00015972996,0.000022051385,0.000013712297,0.000107878106,0.0000018143065],"about_ca_topic_score_codex":0.043012545,"about_ca_topic_score_gemma":0.06838344,"teacher_disagreement_score":0.043012545,"about_ca_system_score_codex":0.0013149813,"about_ca_system_score_gemma":0.0015798256,"threshold_uncertainty_score":0.08552438},"labels":[],"label_agreement":null},{"id":"W3128163814","doi":"10.2217/cer-2020-0137","title":"Heterogeneity in renal end points of cardiovascular outcomes trials in Type 2 diabetes","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; End stage renal disease; Renal function; Type 2 diabetes; Clinical endpoint; Internal medicine; Intensive care medicine; Clinical trial; Creatinine; Diabetes mellitus; Urology; Disease; Endocrinology","score_opus":0.20559037985098247,"score_gpt":0.4711150407476389,"score_spread":0.2655246608966564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128163814","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08856471,0.83530074,0.035550155,0.0072203293,0.0034563802,0.012327108,0.00394783,0.00021493752,0.013417829],"genre_scores_gemma":[0.9131582,0.05101812,0.013656004,0.005571509,0.0014386015,0.011642615,0.0024064681,0.00013497182,0.00097352813],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.5375138,0.33999372,0.09149012,0.008777755,0.020220142,0.0020044565],"domain_scores_gemma":[0.51340735,0.43128324,0.034784317,0.012853252,0.0067420243,0.0009298391],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25584778,0.0016462457,0.008030848,0.0045835376,0.0007071,0.0058589056,0.0018652849,0.0030548964,0.0031682672],"category_scores_gemma":[0.3992307,0.0010100136,0.015154984,0.0054298704,0.0022938617,0.0039060959,0.0025941099,0.0025389546,0.00028871268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055936385,0.00035955268,0.028860731,0.23474728,0.53219014,0.0007498183,0.0017648706,0.0037801878,0.0020089652,0.011414466,0.0046124,0.123575196],"study_design_scores_gemma":[0.055610605,0.00955295,0.093241155,0.079820246,0.6434341,0.001934274,0.0013445154,0.0046015894,0.0039538727,0.06237068,0.04363533,0.00050068385],"about_ca_topic_score_codex":0.0009344985,"about_ca_topic_score_gemma":0.001803078,"teacher_disagreement_score":0.7441522,"about_ca_system_score_codex":0.00230242,"about_ca_system_score_gemma":0.0020083284,"threshold_uncertainty_score":0.91767216},"labels":[],"label_agreement":null},{"id":"W3129342924","doi":"10.2217/cer-2020-0272","title":"Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Fulvestrant; Palbociclib; Hazard ratio; Oncology; Internal medicine; Breast cancer; Hormone receptor; Gynecology; Cancer; Confidence interval; Metastatic breast cancer; Estrogen receptor","score_opus":0.09824933317196574,"score_gpt":0.46670897891742386,"score_spread":0.3684596457454581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129342924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961701,0.011845649,0.01257244,0.00052461313,0.0006044747,0.0030637658,0.0037050995,0.00012629147,0.0058566276],"genre_scores_gemma":[0.99265784,0.0006586554,0.0035987732,0.00023410954,0.0000659481,0.0011255919,0.00087475043,0.000011661097,0.00077269855],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.976497,0.019631578,0.0012003843,0.0010159874,0.0011249688,0.00053005584],"domain_scores_gemma":[0.9911377,0.005667256,0.001818658,0.0008686328,0.00030297265,0.0002048624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014479567,0.001071862,0.0019497835,0.00076261174,0.00022580226,0.0009387299,0.00095786876,0.00087487896,0.0068588094],"category_scores_gemma":[0.02503992,0.00038000062,0.0064982264,0.0007079121,0.00055205385,0.00080937525,0.0012730185,0.0016234491,0.00040390642],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6852097,0.0025110687,0.03711687,0.004932427,0.11596654,0.000116960044,0.00030719067,0.015223486,0.0026584112,0.0034617896,0.002062293,0.13043326],"study_design_scores_gemma":[0.27472693,0.232332,0.20156504,0.0014529336,0.20261063,0.00070585683,0.00054941024,0.041463412,0.01268558,0.01443693,0.017176138,0.00029509963],"about_ca_topic_score_codex":0.0014776426,"about_ca_topic_score_gemma":0.0016517878,"teacher_disagreement_score":0.014479567,"about_ca_system_score_codex":0.001034045,"about_ca_system_score_gemma":0.00093023764,"threshold_uncertainty_score":0.07657617},"labels":[],"label_agreement":null},{"id":"W3129382481","doi":"10.2217/cer-2020-0267","title":"Efficacy classification of modern therapies in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Cladribine; Ofatumumab; Multiple sclerosis; Relapsing remitting; Internal medicine; Placebo; MEDLINE; Oncology; Intensive care medicine; Alternative medicine; Rituximab; Pathology; Immunology","score_opus":0.436733189315095,"score_gpt":0.47966743189235955,"score_spread":0.042934242577264525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129382481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12362354,0.83220565,0.017232236,0.0059189806,0.001506867,0.0022765775,0.005425417,0.00013841793,0.01167239],"genre_scores_gemma":[0.9157778,0.049545605,0.026497988,0.0021962079,0.0017050015,0.0015687682,0.0020616527,0.000055560562,0.00059135706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9325558,0.043182522,0.009858851,0.0033082154,0.010497822,0.0005968122],"domain_scores_gemma":[0.87215406,0.09136452,0.025028411,0.005113975,0.0056185503,0.0007204478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055382803,0.001156044,0.0037493939,0.008147874,0.00053479633,0.0026133112,0.001307612,0.0011234991,0.003633327],"category_scores_gemma":[0.08289308,0.00040727796,0.007011062,0.0035364963,0.0018657953,0.0018718078,0.0015385755,0.0019475474,0.00032108923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039895106,0.0006752434,0.16052467,0.11449853,0.11518362,0.00013253352,0.0013917728,0.006329713,0.0020055017,0.012040237,0.010926271,0.53639674],"study_design_scores_gemma":[0.024135543,0.023496179,0.5245421,0.082083166,0.16896793,0.0021800576,0.0014237006,0.022257539,0.005922892,0.069779836,0.074593365,0.00061768055],"about_ca_topic_score_codex":0.0009961909,"about_ca_topic_score_gemma":0.0013490919,"teacher_disagreement_score":0.055382803,"about_ca_system_score_codex":0.0021271077,"about_ca_system_score_gemma":0.0011285864,"threshold_uncertainty_score":0.29289573},"labels":[],"label_agreement":null},{"id":"W3159940388","doi":"10.2217/cer-2020-0279","title":"Current practice of stakeholder engagement: researchers’ experiences in North America, DACH countries and China","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stakeholder; Stakeholder engagement; China; Descriptive statistics; Medicine; Variance (accounting); Public relations; Political science; Accounting; Business","score_opus":0.7311056339849136,"score_gpt":0.5893864776314628,"score_spread":0.14171915635345078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159940388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9227556,0.009933156,0.0015222176,0.050822973,0.00020991995,0.00043823064,0.000086207845,0.000033456658,0.01419822],"genre_scores_gemma":[0.9920465,0.0018943613,0.0007998566,0.0042876736,0.000032601096,0.00027081196,0.000024089006,0.00000949951,0.0006346393],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.868506,0.11181858,0.004215624,0.0023779024,0.006471902,0.006609948],"domain_scores_gemma":[0.8385968,0.09991764,0.016376503,0.006436198,0.013566176,0.02510667],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.105279684,0.00037181584,0.001029061,0.0017657198,0.011498801,0.0069611976,0.0015276887,0.0028654074,0.002776719],"category_scores_gemma":[0.09368552,0.00045943857,0.00052710925,0.0037122103,0.012987472,0.0041292515,0.011188741,0.0023455645,0.0001719556],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002489469,0.0002139809,0.07241299,0.0014358753,0.00008890776,0.0010999021,0.86417866,0.00014592758,0.0011198777,0.006112179,0.004002895,0.048939977],"study_design_scores_gemma":[0.00006402129,0.00032110044,0.04029703,0.0018470928,0.000036075464,0.000670511,0.9159824,0.00023186718,0.0004183133,0.002130892,0.03790686,0.000093749215],"about_ca_topic_score_codex":0.026759613,"about_ca_topic_score_gemma":0.03502896,"teacher_disagreement_score":0.8947203,"about_ca_system_score_codex":0.012457898,"about_ca_system_score_gemma":0.05427088,"threshold_uncertainty_score":0.55677885},"labels":[],"label_agreement":null},{"id":"W3164315881","doi":"10.2217/cer-2021-0069","title":"Propensity score matching versus coarsened exact matching in observational comparative effectiveness research","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Physicians' Services Incorporated Foundation","keywords":"Propensity score matching; Observational study; Medicine; Randomized controlled trial; Matching (statistics); Comparative effectiveness research; Clinical trial; Balance (ability); Statistics; Physical therapy; Internal medicine; Mathematics; Alternative medicine; Pathology","score_opus":0.8095129096967779,"score_gpt":0.6082277517660837,"score_spread":0.20128515793069424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164315881","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16529652,0.011184355,0.811191,0.002011851,0.0005354608,0.0062150983,0.00089394755,0.00032984803,0.0023419515],"genre_scores_gemma":[0.68680614,0.0015373548,0.30733433,0.00053260237,0.00018164296,0.0028609866,0.00041679243,0.000034088906,0.00029605732],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.84985375,0.13049619,0.007526895,0.0049886233,0.0065082535,0.0006262965],"domain_scores_gemma":[0.7896785,0.16548425,0.022314971,0.0184597,0.0032468936,0.00081567094],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13672589,0.0010276219,0.0021836814,0.0030390108,0.00062192045,0.0016520977,0.0016414226,0.0011717578,0.0035101569],"category_scores_gemma":[0.33167684,0.0005579936,0.0029869725,0.0042103506,0.0018364874,0.0029391213,0.0035316616,0.0016101656,0.00014822918],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017740456,0.00081291044,0.079465926,0.008780451,0.016169257,0.00020810495,0.0015791717,0.13240173,0.0017670846,0.11127606,0.0034329675,0.6263659],"study_design_scores_gemma":[0.011862557,0.012119357,0.08239315,0.0030811636,0.012921519,0.0006705862,0.000619623,0.3738008,0.005694079,0.483889,0.012568156,0.00037992597],"about_ca_topic_score_codex":0.0015926218,"about_ca_topic_score_gemma":0.0014112017,"teacher_disagreement_score":0.8632741,"about_ca_system_score_codex":0.0016733826,"about_ca_system_score_gemma":0.0029102142,"threshold_uncertainty_score":0.7230842},"labels":[],"label_agreement":null},{"id":"W3166331404","doi":"10.2217/cer-2020-0251","title":"Patterns and association of vaccination among adults with a history of cancer in the USA: a population-based study","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Vaccination; Hepatitis B; Logistic regression; Shingles; Demography; Odds ratio; Population; Cohort; Immunology; Internal medicine; Environmental health","score_opus":0.07739618956074105,"score_gpt":0.4322549109253295,"score_spread":0.35485872136458846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166331404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973507,0.00031683402,0.0000997575,0.00011645828,0.0000093779245,0.000012008593,0.0015325792,0.000005236084,0.0005571189],"genre_scores_gemma":[0.9986291,0.00013999513,0.000085114356,0.00006946188,0.0000106738835,0.00001033773,0.0009244792,0.0000017297745,0.00012899797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994492,0.00012490552,0.000076718155,0.00015012466,0.00012616701,0.000072811934],"domain_scores_gemma":[0.9987356,0.00014994596,0.0006112665,0.00011084658,0.00020997785,0.00018234826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059640355,0.00016294494,0.00027670767,0.00068061077,0.0003603871,0.00053682463,0.0003638394,0.00055312755,0.0010177022],"category_scores_gemma":[0.0021565433,0.00025575442,0.00039884998,0.0011302475,0.00016497291,0.0004888568,0.00038790598,0.00065187056,0.00023003074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016615122,0.000019379197,0.99943215,0.000004019399,0.000037423513,0.0000075831563,0.000024788354,0.000007843953,0.000041835876,0.0000035295739,0.000086092354,0.00031863817],"study_design_scores_gemma":[0.0000012860665,0.000021694346,0.9997272,0.0000029773073,0.000011472288,0.00003515482,0.000053194894,0.000050138624,0.000008993511,0.0000039494366,0.000082706334,0.0000011713702],"about_ca_topic_score_codex":0.018755304,"about_ca_topic_score_gemma":0.025419846,"teacher_disagreement_score":0.018755304,"about_ca_system_score_codex":0.00026382375,"about_ca_system_score_gemma":0.00032132043,"threshold_uncertainty_score":0.0372923},"labels":[],"label_agreement":null},{"id":"W3174892139","doi":"10.2217/cer-2020-0278","title":"Gender, socioeconomic status and emergency department visits among cancer survivors in the USA: a population-based study","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Emergency department; Socioeconomic status; Logistic regression; Demography; Population; Odds ratio; Cohort; Cohort study; Environmental health; Internal medicine; Psychiatry","score_opus":0.2850653871005384,"score_gpt":0.5466509751092106,"score_spread":0.26158558800867215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174892139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835086,0.00023621146,0.00005522167,0.00008233437,0.000009694177,0.000008617715,0.0009427284,0.0000025867132,0.00031176733],"genre_scores_gemma":[0.9989998,0.0001470863,0.000063895975,0.00006908058,0.000011068568,0.000012317125,0.00058088725,0.0000012260675,0.00011463159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975914,0.000049102855,0.000030512625,0.000054900203,0.000053634787,0.000052756895],"domain_scores_gemma":[0.999432,0.000051152023,0.00028337832,0.000038312846,0.00008534509,0.000109714834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004188889,0.00020299296,0.000212592,0.0006913699,0.00041109064,0.00044582467,0.0002478205,0.0003682093,0.0011207178],"category_scores_gemma":[0.0012546524,0.00020882314,0.000409154,0.0009853945,0.00015612863,0.0004716192,0.00037922652,0.00045238875,0.00018620392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016797558,0.000017095048,0.9992623,0.0000037694604,0.000027266793,0.000018054936,0.00003467783,0.0000054289544,0.000036210276,0.000003674851,0.000109674016,0.0004650549],"study_design_scores_gemma":[0.0000019413774,0.000025522027,0.99953866,0.000005363188,0.000015671882,0.000066290384,0.00015451226,0.00004274445,0.000011477422,0.000007950936,0.00012826228,0.0000016439245],"about_ca_topic_score_codex":0.011165167,"about_ca_topic_score_gemma":0.023465957,"teacher_disagreement_score":0.011165167,"about_ca_system_score_codex":0.00022588299,"about_ca_system_score_gemma":0.00031014474,"threshold_uncertainty_score":0.022200346},"labels":[],"label_agreement":null},{"id":"W3186137785","doi":"10.2217/cer-2021-0059","title":"Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina; Health Sciences Centre; Sunnybrook Health Science Centre; Toronto General Hospital; University Health Network; University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Estimator; Hypoglycemia; Estimation; Diabetes mellitus; Construct (python library); Statistics; Econometrics; Endocrinology; Mathematics; Economics; Computer science","score_opus":0.5231676622634022,"score_gpt":0.5650792269013128,"score_spread":0.04191156463791068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186137785","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015126836,0.9944891,0.001902291,0.00058865943,0.00011711251,0.00008441848,0.00051210355,0.000008259662,0.00078539585],"genre_scores_gemma":[0.037179243,0.95795643,0.0035073531,0.00040863696,0.0001773078,0.00021246217,0.00037982184,0.000011780181,0.00016704632],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98076975,0.012272575,0.0032926565,0.00078464224,0.0026973078,0.00018313894],"domain_scores_gemma":[0.8990224,0.091563284,0.005309384,0.0007963251,0.0030829431,0.00022573005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024461474,0.0014470257,0.00586884,0.010168736,0.00028029995,0.0030122674,0.0017945033,0.0013756112,0.0031362306],"category_scores_gemma":[0.093818575,0.0008793913,0.0077271867,0.0104578,0.0007417338,0.0016831693,0.0009903602,0.001317907,0.00024919165],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008840803,0.000087968634,0.0071078376,0.41831824,0.03687828,0.00015537096,0.00024464462,0.0056018294,0.00015407837,0.009317272,0.0073879617,0.51386243],"study_design_scores_gemma":[0.00053790724,0.00093705213,0.047675032,0.6900958,0.109256886,0.0013048834,0.0005590809,0.0067869863,0.00073049765,0.017856449,0.124027744,0.00023174872],"about_ca_topic_score_codex":0.006976737,"about_ca_topic_score_gemma":0.007959359,"teacher_disagreement_score":0.024461474,"about_ca_system_score_codex":0.0039474573,"about_ca_system_score_gemma":0.00420225,"threshold_uncertainty_score":0.12936622},"labels":[],"label_agreement":null},{"id":"W3188666308","doi":"10.2217/cer-2021-0150","title":"Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Rivaroxaban; Polypharmacy; Atrial fibrillation; Warfarin; Obesity; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.08725138394218204,"score_gpt":0.4219668102787172,"score_spread":0.33471542633653517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188666308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662685,0.0017490325,0.000068902824,0.00026959882,0.000010483131,0.000014444401,0.0006749407,0.0000012861452,0.0005845181],"genre_scores_gemma":[0.99854857,0.000589186,0.000109071945,0.000069042995,0.000023393359,0.000011298521,0.0005803674,8.8873725e-7,0.00006806288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982705,0.00084889395,0.00021678227,0.00013600566,0.00032750817,0.00020020099],"domain_scores_gemma":[0.996693,0.000829574,0.00199646,0.00008010722,0.00013654731,0.00026437864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014599535,0.0002376976,0.0004611151,0.0013492692,0.00022069851,0.00091526186,0.00024890268,0.0004246457,0.0016056984],"category_scores_gemma":[0.0067981887,0.00019104638,0.0014932525,0.0013702537,0.00029278352,0.0005144633,0.00067632,0.00050625554,0.00009152393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009186316,0.00020087925,0.98865926,0.00011168944,0.0010947854,0.000096265336,0.000044791494,0.0004518165,0.00008695123,0.00016547326,0.00029102873,0.007878528],"study_design_scores_gemma":[0.00007914551,0.0003532183,0.9969387,0.0000543941,0.00036018438,0.00034809118,0.00013558142,0.0013239371,0.000051198473,0.00010715467,0.00023992114,0.000008537531],"about_ca_topic_score_codex":0.008445355,"about_ca_topic_score_gemma":0.012692109,"teacher_disagreement_score":0.008445355,"about_ca_system_score_codex":0.0010957395,"about_ca_system_score_gemma":0.00066987734,"threshold_uncertainty_score":0.016792417},"labels":[],"label_agreement":null},{"id":"W3199921489","doi":"10.2217/cer-2021-0113","title":"Outcomes of patients with nonmetastatic gastric adenocarcinoma according to perioperative treatment strategy: a real-world, population-based study","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Perioperative; Hazard ratio; Internal medicine; Proportional hazards model; Gastrectomy; Cancer; Population; Radiation therapy; Surveillance, Epidemiology, and End Results; Oncology; Surgery; Cancer registry; Confidence interval","score_opus":0.10723860011433634,"score_gpt":0.4420697015525942,"score_spread":0.33483110143825784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199921489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986064,0.00040600082,0.00007852769,0.000059016744,0.0000061298,0.000011753542,0.0006109619,0.0000022328893,0.00021904241],"genre_scores_gemma":[0.9991341,0.00015532524,0.000045306962,0.000031989042,0.000010201268,0.000010748782,0.0005750924,0.0000010966946,0.000036142188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929094,0.00018889978,0.00011633794,0.00018462302,0.00011438572,0.00010471898],"domain_scores_gemma":[0.998334,0.00021484673,0.0010001449,0.00010111389,0.00015178414,0.00019813399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000763743,0.0002648275,0.00042782817,0.00090481096,0.00031980211,0.00065695896,0.00041006066,0.0005401596,0.00084864174],"category_scores_gemma":[0.0026536249,0.00029814913,0.0006979623,0.0014767437,0.00034763466,0.0010701225,0.00059856265,0.0006209331,0.0001822246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006936244,0.000029700695,0.9990613,0.000013140497,0.000079318255,0.000038731836,0.000044324355,0.000031021125,0.000046365447,0.00000997406,0.00006147135,0.0005153763],"study_design_scores_gemma":[0.000009513804,0.000121765064,0.9987784,0.00000806201,0.000058473513,0.00027413268,0.00031815234,0.00022062162,0.000023671375,0.000026072534,0.00015552765,0.0000056121376],"about_ca_topic_score_codex":0.0027787862,"about_ca_topic_score_gemma":0.0039694486,"teacher_disagreement_score":0.0027787862,"about_ca_system_score_codex":0.0003428769,"about_ca_system_score_gemma":0.0003244009,"threshold_uncertainty_score":0.0055251718},"labels":[],"label_agreement":null},{"id":"W3202268091","doi":"10.2217/cer-2021-0203","title":"Letter in reply","year":2021,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine","score_opus":0.6833183359875381,"score_gpt":0.5728567734507829,"score_spread":0.11046156253675521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202268091","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027875922,0.0011032714,0.00007067326,0.9555576,0.035871837,0.00004901504,0.00016919119,0.000029354174,0.006870254],"genre_scores_gemma":[0.0010294404,0.00029289039,0.0000720922,0.97248274,0.012859758,0.00007093737,0.000028811904,0.000016141958,0.01314719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891361,0.0029584393,0.0012443188,0.0012503605,0.003320363,0.0020903903],"domain_scores_gemma":[0.9757051,0.014153826,0.0010837439,0.00071718835,0.004471582,0.003868618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013263151,0.0011327923,0.0034147615,0.0020180524,0.0068512037,0.009713557,0.00358027,0.08928505,0.018710693],"category_scores_gemma":[0.0641671,0.0014688799,0.0021078687,0.0016088593,0.003382203,0.004996305,0.0031092048,0.048232663,0.011613197],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047758687,0.00001869296,0.00024131672,0.000035294328,0.000014841302,0.0002449213,0.000059114765,0.000018796984,0.00003130266,0.0013109257,0.99589133,0.0020856508],"study_design_scores_gemma":[0.00018793673,0.000057583133,0.0018561111,0.0004076478,0.00006929397,0.00043836777,0.000558339,0.00026392395,0.00015242487,0.007394787,0.98851997,0.00009369888],"about_ca_topic_score_codex":0.021212472,"about_ca_topic_score_gemma":0.04233027,"teacher_disagreement_score":0.08928505,"about_ca_system_score_codex":0.00960208,"about_ca_system_score_gemma":0.013623315,"threshold_uncertainty_score":0.0701431},"labels":[],"label_agreement":null},{"id":"W3203002280","doi":"10.2217/cer-2021-0013","title":"Prognostic and predictive value of microsatellite instability status among patients with colorectal cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Microsatellite instability; Internal medicine; Colorectal cancer; Chemotherapy; Oncology; Stage (stratigraphy); Proportional hazards model; Predictive value; Multivariate analysis; Cancer; Adenocarcinoma; Microsatellite","score_opus":0.04044524166403691,"score_gpt":0.38173063036785504,"score_spread":0.34128538870381814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203002280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906665,0.0005123798,0.000025914911,0.000048855032,0.000004870721,0.0000029641303,0.00012742197,0.000001463851,0.00020947354],"genre_scores_gemma":[0.99977905,0.000062151186,0.000024924466,0.0000061275714,0.000005745812,0.0000013519514,0.00009072479,3.2451473e-7,0.00002970214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997776,0.00005733556,0.000039077466,0.000040088868,0.00005126892,0.0000345921],"domain_scores_gemma":[0.99850035,0.00043730016,0.0007026465,0.000037074922,0.000100312536,0.0002223452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003913605,0.00012296233,0.00017444849,0.00061875733,0.00019279728,0.00026982286,0.00014382489,0.00023974788,0.0011015512],"category_scores_gemma":[0.003238688,0.000082525956,0.00023974171,0.00063291786,0.00016775556,0.00022707974,0.0001904304,0.0002469099,0.00007623067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012278777,0.0000092454175,0.9985996,0.0000053877047,0.000020458112,0.000027818252,0.000009915773,0.000039869854,0.00006560482,0.000005171156,0.000027458316,0.0010667519],"study_design_scores_gemma":[0.0000068427553,0.00008607833,0.9993218,0.0000045604747,0.00003085753,0.00016739957,0.00004681998,0.00019347153,0.000047782818,0.0000143909365,0.00007791197,0.0000020423502],"about_ca_topic_score_codex":0.0017884703,"about_ca_topic_score_gemma":0.003264264,"teacher_disagreement_score":0.0017884703,"about_ca_system_score_codex":0.00019712279,"about_ca_system_score_gemma":0.0001871498,"threshold_uncertainty_score":0.0036850572},"labels":[],"label_agreement":null},{"id":"W3206442947","doi":"10.2217/cer-2021-0121","title":"Real-world evidence: a practical toolbox for collecting health state utilities","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Toolbox; Credibility; Reimbursement; Medicine; Data science; Evidence-based medicine; Health care; Computer science; Alternative medicine","score_opus":0.8581222248983025,"score_gpt":0.6763503743707396,"score_spread":0.18177185052756284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206442947","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020322762,0.0028067927,0.9387527,0.012294509,0.00044023336,0.010435076,0.011565887,0.008238961,0.013433545],"genre_scores_gemma":[0.007735444,0.0021364305,0.9744066,0.001081944,0.00020748457,0.009664212,0.0029008884,0.00059544586,0.0012714402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.83743376,0.11453512,0.029902058,0.0029411938,0.014473481,0.00071451045],"domain_scores_gemma":[0.54158694,0.3450154,0.022743678,0.038345687,0.048347477,0.0039608036],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17280687,0.0026479608,0.0033854397,0.014877158,0.0014296352,0.012418239,0.004070422,0.0032783926,0.028001782],"category_scores_gemma":[0.41256064,0.0031584501,0.0040103216,0.010626988,0.0024720374,0.013996801,0.010033595,0.0085884165,0.014157417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006312245,0.00031090496,0.0042410223,0.0076701124,0.00068117416,0.00045574937,0.0035756459,0.0070800493,0.001331705,0.08780363,0.19199368,0.6942252],"study_design_scores_gemma":[0.0013080478,0.0009830912,0.01036551,0.01884061,0.00058242976,0.0016361331,0.003119785,0.032342758,0.0056368904,0.31129593,0.61303675,0.00085213594],"about_ca_topic_score_codex":0.0021674559,"about_ca_topic_score_gemma":0.003502886,"teacher_disagreement_score":0.82719314,"about_ca_system_score_codex":0.003054054,"about_ca_system_score_gemma":0.01581068,"threshold_uncertainty_score":0.91390103},"labels":[],"label_agreement":null},{"id":"W3209536742","doi":"10.2217/cer-2021-0018","title":"Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy","year":2021,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute for Health and Care Research; PTC Therapeutics","keywords":"Deflazacort; Medicine; Prednisone; Nonsense mutation; Duchenne muscular dystrophy; Prednisolone; Muscular dystrophy; Internal medicine; Placebo; Pediatrics; Physical therapy; Mutation; Genetics; Pathology","score_opus":0.35404409198600484,"score_gpt":0.5138161215238461,"score_spread":0.1597720295378413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209536742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016737924,0.99760795,0.00013371764,0.0001314244,0.00009612105,0.00005076603,0.0001237977,0.000008795461,0.00017365218],"genre_scores_gemma":[0.069802776,0.92753273,0.00090378476,0.00056559243,0.00021132569,0.000222153,0.0004210492,0.000013710519,0.0003269523],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9979517,0.0011557153,0.00039040242,0.00021802897,0.0002006783,0.00008348645],"domain_scores_gemma":[0.99646664,0.0027289826,0.00042314114,0.0000803276,0.00023195465,0.00006891442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046367026,0.0016864329,0.00952177,0.0017359853,0.0002204436,0.0015602249,0.0011566784,0.0013259345,0.0035432745],"category_scores_gemma":[0.0073848823,0.0006359781,0.014090517,0.0020692705,0.00024283731,0.00066132797,0.0006141634,0.0012224336,0.0002940401],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01385198,0.000106214604,0.0017721573,0.36590457,0.5006479,0.00015608783,0.000057044293,0.0009292314,0.00077963807,0.0003966965,0.0026781012,0.11272038],"study_design_scores_gemma":[0.0047782944,0.0014632579,0.0075787827,0.031161832,0.940293,0.00026022652,0.000059319136,0.00044001095,0.00047590616,0.00072622235,0.0127198445,0.000043308883],"about_ca_topic_score_codex":0.0023699235,"about_ca_topic_score_gemma":0.0058639427,"teacher_disagreement_score":0.00952177,"about_ca_system_score_codex":0.001182504,"about_ca_system_score_gemma":0.0011447094,"threshold_uncertainty_score":0.02452153},"labels":[],"label_agreement":null},{"id":"W3211800240","doi":"10.2217/cer-2021-0221","title":"Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Fulvestrant; Nausea; Breast cancer; Quality of life (healthcare); Internal medicine; Oncology; Palbociclib; Cancer; Metastatic breast cancer; Estrogen receptor","score_opus":0.13336599440221616,"score_gpt":0.5031046785495277,"score_spread":0.3697386841473115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211800240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98258454,0.012711975,0.00056644157,0.00023650119,0.00017980122,0.00037485285,0.0011464399,0.000018503564,0.0021810608],"genre_scores_gemma":[0.9965553,0.0014573461,0.0004556659,0.00012354991,0.00007085198,0.00030424955,0.0005301014,0.0000038756184,0.0004991022],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963743,0.0028550816,0.00016053181,0.00018985482,0.00028010758,0.00014003114],"domain_scores_gemma":[0.9972971,0.0016755065,0.0006897058,0.00011710799,0.00007956362,0.00014113559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038116053,0.0008442091,0.0016858404,0.0005255197,0.00011900282,0.00074994616,0.0005489523,0.0005663114,0.0047495477],"category_scores_gemma":[0.005651121,0.00026083618,0.0031220273,0.0005189343,0.00037825838,0.0006030196,0.00075983745,0.0013323291,0.00028759125],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86658496,0.0023488426,0.02772597,0.004195225,0.033956006,0.00006321594,0.00010077055,0.0027037887,0.0011730434,0.0004899121,0.00062256923,0.06003561],"study_design_scores_gemma":[0.32139468,0.32476753,0.2481789,0.0011243445,0.077970326,0.0005782105,0.00049923593,0.012570172,0.004351393,0.0019577574,0.006460216,0.00014727066],"about_ca_topic_score_codex":0.0009461435,"about_ca_topic_score_gemma":0.0015518072,"teacher_disagreement_score":0.0047495477,"about_ca_system_score_codex":0.0007463191,"about_ca_system_score_gemma":0.0004986169,"threshold_uncertainty_score":0.020157993},"labels":[],"label_agreement":null},{"id":"W4206181287","doi":"10.2217/cer-2021-0139","title":"SPECT/CT versus planar imaging to determine treatment strategy for non-small-cell lung cancer: a cost–effectiveness analysis","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; St. Joseph's Hospital; Western University","funders":"GE Healthcare","keywords":"Scintigraphy; Lung cancer; Lung; Lung volumes; Pneumonectomy; Quality-adjusted life year; Predictive value of tests","score_opus":0.14473501541538358,"score_gpt":0.4838716371160943,"score_spread":0.33913662170071074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206181287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94989467,0.01790911,0.017597536,0.0015923525,0.00018379219,0.003047053,0.002097791,0.00006704038,0.0076106805],"genre_scores_gemma":[0.9927927,0.0020314723,0.0038611575,0.00018084621,0.000030086185,0.00042815894,0.00038044454,0.000007999843,0.00028728717],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9940952,0.0045950883,0.00027131947,0.00027567547,0.00048330458,0.00027932352],"domain_scores_gemma":[0.9884404,0.0101117855,0.0007515832,0.00014549555,0.00026228413,0.00028849934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008549514,0.0014049166,0.0018648303,0.0024040067,0.0002337319,0.0016011999,0.00095926685,0.0012477725,0.0043700477],"category_scores_gemma":[0.022790823,0.0005958575,0.005091152,0.0012712828,0.0006307849,0.0012283413,0.00090287405,0.0011922631,0.00018639826],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10036143,0.0043954174,0.041016474,0.004268143,0.018868485,0.0005237274,0.00012284785,0.70502627,0.002105029,0.006616649,0.0013850956,0.11531043],"study_design_scores_gemma":[0.018331833,0.049222577,0.044729132,0.0016632368,0.031192556,0.0011933232,0.00038146155,0.8386192,0.0030870023,0.007339728,0.00400378,0.00023606706],"about_ca_topic_score_codex":0.0063257855,"about_ca_topic_score_gemma":0.0042148153,"teacher_disagreement_score":0.008549514,"about_ca_system_score_codex":0.004993596,"about_ca_system_score_gemma":0.002230716,"threshold_uncertainty_score":0.045214653},"labels":[],"label_agreement":null},{"id":"W4206611799","doi":"10.2217/cer-2021-0258","title":"Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Prehabilitation; Medicine; Mobilization; Perioperative; Intensive care medicine; Physical medicine and rehabilitation; Adverse effect; Physical therapy; Surgery; Internal medicine","score_opus":0.18433600964542252,"score_gpt":0.43885297524285716,"score_spread":0.25451696559743464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206611799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017729298,0.9932526,0.00019679248,0.00270824,0.00033002178,0.00011210075,0.00006441771,0.0000060218495,0.0015568704],"genre_scores_gemma":[0.034464333,0.9592123,0.0024476326,0.002273575,0.000994179,0.00027349184,0.00012694825,0.00001153632,0.00019601396],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9894162,0.0058341767,0.0022233778,0.0007169538,0.0014346216,0.000374598],"domain_scores_gemma":[0.9037289,0.08148225,0.0069798394,0.0011750924,0.005614182,0.0010197225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019631308,0.0008597456,0.0027580815,0.0022919266,0.0005104345,0.004169361,0.0021188285,0.002008246,0.010521458],"category_scores_gemma":[0.054471724,0.000494002,0.0027984495,0.0031344395,0.0017357483,0.0031651272,0.001823875,0.0023265225,0.0009650877],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024265458,0.00083366234,0.0034740986,0.16017549,0.0023459436,0.00005308577,0.0003477768,0.00020097222,0.00014950593,0.0037935993,0.003393691,0.8228056],"study_design_scores_gemma":[0.0027169492,0.0059703896,0.039892316,0.72237694,0.01742416,0.0006829774,0.002717312,0.00070624077,0.0008665534,0.011361488,0.19511119,0.0001733973],"about_ca_topic_score_codex":0.003365712,"about_ca_topic_score_gemma":0.007323503,"teacher_disagreement_score":0.019631308,"about_ca_system_score_codex":0.0022187603,"about_ca_system_score_gemma":0.005821453,"threshold_uncertainty_score":0.103821516},"labels":[],"label_agreement":null},{"id":"W4210548176","doi":"10.2217/cer-2021-0133","title":"A real-world, population-based study for the outcomes of patients with metastatic colorectal cancer to the liver with distant lymph node metastases treated with metastasectomy","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metastasectomy; Medicine; Hazard ratio; Colorectal cancer; Lymph node; Propensity score matching; Internal medicine; Oncology; Cancer; Surgery; Confidence interval","score_opus":0.12725708432665986,"score_gpt":0.3983784441271667,"score_spread":0.2711213598005069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210548176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978236,0.00036127897,0.00023810817,0.00007864241,0.00001154342,0.000029258475,0.0011517662,0.0000035966016,0.00030215565],"genre_scores_gemma":[0.99869114,0.000100037054,0.00009678278,0.00005069863,0.000021440084,0.000028188586,0.0009356449,0.0000017701011,0.00007434605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987281,0.00045070943,0.00013893336,0.00035997434,0.00020694992,0.00011534359],"domain_scores_gemma":[0.99757594,0.00037338358,0.0013016555,0.00023442686,0.00020877934,0.0003057523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015047208,0.0003632464,0.0005286061,0.0009205114,0.0004484355,0.00077696604,0.0004449085,0.00073996844,0.0014226557],"category_scores_gemma":[0.0035581666,0.00035085494,0.0008705093,0.001751246,0.00037466435,0.0010561887,0.0005679276,0.0007787967,0.00032927227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016192318,0.000056299978,0.99868804,0.000017948194,0.00019574516,0.000053884723,0.000042130036,0.0000405907,0.0001089915,0.000017716808,0.00010148407,0.00051530317],"study_design_scores_gemma":[0.000036366528,0.00023477388,0.998565,0.0000073979045,0.00009113034,0.00030288784,0.00015101119,0.0003009604,0.000023545497,0.000029969204,0.00024922434,0.000007597473],"about_ca_topic_score_codex":0.0029113782,"about_ca_topic_score_gemma":0.003884146,"teacher_disagreement_score":0.0029113782,"about_ca_system_score_codex":0.00047675165,"about_ca_system_score_gemma":0.00040433288,"threshold_uncertainty_score":0.007957816},"labels":[],"label_agreement":null},{"id":"W4212770753","doi":"10.2217/cer-2021-0261","title":"Systematic literature review of evidence in amyloid light-chain amyloidosis","year":2022,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Systematic review; Randomized controlled trial; Observational study; Amyloidosis; MEDLINE; Intensive care medicine; Quality of life (healthcare); Pathology; Nursing","score_opus":0.22678034929922558,"score_gpt":0.49261936796091677,"score_spread":0.2658390186616912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212770753","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047391787,0.99769455,0.00018396035,0.00028474274,0.00015202507,0.00041420895,0.0004258222,0.000010121139,0.00036065863],"genre_scores_gemma":[0.0063753314,0.99148035,0.0007299768,0.000399564,0.00007304207,0.0005870954,0.00023098092,0.000005751327,0.00011800355],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9881654,0.0045385966,0.004217008,0.00071396935,0.0020390232,0.00032609064],"domain_scores_gemma":[0.9596065,0.030436287,0.005537666,0.0005483361,0.00344938,0.00042166124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012321485,0.0021934698,0.01011105,0.018010018,0.0007674635,0.0037350792,0.00233014,0.00224823,0.008712191],"category_scores_gemma":[0.05718563,0.0011342808,0.007608198,0.015193486,0.001066922,0.0028287987,0.002132837,0.0015522777,0.000637344],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098438424,0.000009418127,0.00019371358,0.96849567,0.004018659,0.000064036845,0.00008411963,0.00006741929,0.00008205119,0.00022824343,0.001133322,0.025524873],"study_design_scores_gemma":[0.00013868524,0.00011693301,0.0012170131,0.94112766,0.039460238,0.0002139833,0.00017056493,0.000056948018,0.0001077335,0.00038455534,0.016982011,0.000023633229],"about_ca_topic_score_codex":0.008149211,"about_ca_topic_score_gemma":0.021345029,"teacher_disagreement_score":0.018010018,"about_ca_system_score_codex":0.0052387225,"about_ca_system_score_gemma":0.017533781,"threshold_uncertainty_score":0.06516302},"labels":[],"label_agreement":null},{"id":"W4212996296","doi":"10.2217/cer-2021-0163","title":"Patterns of emergency department visits preceding colorectal cancer diagnosis: a population-based study","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Emergency department; Context (archaeology); Odds ratio; Colorectal cancer; Comorbidity; Logistic regression; Population; Internal medicine; Charlson comorbidity index; Ambulatory; Cancer; Pediatrics","score_opus":0.11538822911581846,"score_gpt":0.4640978761601192,"score_spread":0.34870964704430074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212996296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857056,0.00020871185,0.00004897652,0.00005499084,0.0000034990508,0.000014555053,0.0007835499,0.0000042169995,0.00031089995],"genre_scores_gemma":[0.9992118,0.00010169777,0.00006540465,0.000028491326,0.0000049192763,0.000006414288,0.00050542265,0.0000010663254,0.000074808595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939346,0.00008089444,0.000057082794,0.0001325253,0.00019739548,0.00013862425],"domain_scores_gemma":[0.99880147,0.00010914858,0.0006274996,0.000046798858,0.00019487031,0.00022020125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046657133,0.00021075783,0.00025159112,0.0010919262,0.00046173678,0.0007074613,0.0005538841,0.00044064366,0.00095787825],"category_scores_gemma":[0.0018902916,0.0002441071,0.00034992097,0.0020087853,0.00035276805,0.00042172885,0.0005032166,0.00047010576,0.00012150076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018424573,0.000012332886,0.99940765,0.0000055165497,0.000019805533,0.00002751103,0.000050075825,0.000016859374,0.00003622466,0.000004466284,0.000069011054,0.00033224016],"study_design_scores_gemma":[0.000002025198,0.000021909656,0.9995703,0.0000042595007,0.0000066506104,0.000080940554,0.00016461636,0.000061153674,0.000007016029,0.0000039034185,0.00007542065,0.0000018090298],"about_ca_topic_score_codex":0.24724956,"about_ca_topic_score_gemma":0.3830506,"teacher_disagreement_score":0.24724956,"about_ca_system_score_codex":0.0017377621,"about_ca_system_score_gemma":0.0015995511,"threshold_uncertainty_score":0.49162078},"labels":[],"label_agreement":null},{"id":"W4221007314","doi":"10.2217/cer-2022-0043","title":"R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Medicine; Reimbursement; Health technology; Comparative effectiveness research; Health economics; Health care; Alternative medicine; Public health; Economic growth; Nursing; Pathology","score_opus":0.7989013653416447,"score_gpt":0.6486979193858494,"score_spread":0.15020344595579527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221007314","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040059452,0.52192533,0.002459269,0.37689486,0.092524976,0.00010932143,0.00030061515,0.00016677668,0.005218284],"genre_scores_gemma":[0.004408507,0.6832997,0.009857157,0.17815652,0.1167945,0.00020653408,0.00053086446,0.00027747735,0.006468647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.980875,0.0060876696,0.0036323555,0.0009065084,0.0075952355,0.0009031422],"domain_scores_gemma":[0.8390781,0.10476606,0.0113046365,0.0037543788,0.03465641,0.006440457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.048300233,0.0017440253,0.0034943875,0.007066264,0.0016563083,0.010705543,0.0030702122,0.012727369,0.014904767],"category_scores_gemma":[0.13165423,0.0012380283,0.0030962597,0.0066934754,0.003754973,0.02199977,0.0043239347,0.020081447,0.0054288353],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013284446,0.00007917676,0.00046094033,0.0029691681,0.00009822764,0.00019877795,0.00013500557,0.00022673674,0.00041964249,0.0067389775,0.69724554,0.2912949],"study_design_scores_gemma":[0.000049511284,0.00017015115,0.0020443888,0.012389053,0.000119075456,0.0005987521,0.00028174475,0.0002808817,0.00022121803,0.010061865,0.9736813,0.00010221242],"about_ca_topic_score_codex":0.0035124782,"about_ca_topic_score_gemma":0.010719056,"teacher_disagreement_score":0.048300233,"about_ca_system_score_codex":0.004739195,"about_ca_system_score_gemma":0.009132159,"threshold_uncertainty_score":0.2554391},"labels":[],"label_agreement":null},{"id":"W4225010633","doi":"10.2217/cer-2021-0205","title":"Sex-based differences in the outcomes of patients with lung carcinoids","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Hazard ratio; Lung cancer; Epidemiology; Lung; Incidence (geometry); Population; Multivariate analysis; Carcinoid tumors; Gastroenterology; Oncology; Confidence interval","score_opus":0.08334786066464446,"score_gpt":0.43232584226208215,"score_spread":0.3489779815974377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225010633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975695,0.0010711908,0.000086755,0.00012411636,0.000017506074,0.0000045641896,0.00052176806,0.000003431037,0.0006011249],"genre_scores_gemma":[0.9994573,0.000143282,0.000018147839,0.000019872075,0.000015617225,0.000002120543,0.00028676944,0.0000011504942,0.000055807657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995388,0.00012826303,0.00005488732,0.00009440761,0.000092254086,0.0000914217],"domain_scores_gemma":[0.99762934,0.000417182,0.0014034502,0.00009578125,0.00017959859,0.00027469426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000738259,0.00020591785,0.00021875666,0.0005941865,0.00017087115,0.00048144063,0.00017487684,0.000276738,0.0015834633],"category_scores_gemma":[0.0040625753,0.00009850605,0.000373953,0.00051354343,0.00022171595,0.00054766715,0.00037092264,0.00033838858,0.0002218534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010416066,0.000007970886,0.998676,0.0000073562173,0.000038150618,0.000060314273,0.000019514906,0.000031073967,0.000069935435,0.000015295995,0.000059660506,0.0009104853],"study_design_scores_gemma":[0.000007314772,0.000074533586,0.9989385,0.000007931187,0.00001948462,0.00049805077,0.00009354215,0.00012427839,0.00004737539,0.00004093942,0.00014512928,0.0000027764165],"about_ca_topic_score_codex":0.0008521001,"about_ca_topic_score_gemma":0.0012219964,"teacher_disagreement_score":0.0015834633,"about_ca_system_score_codex":0.000200953,"about_ca_system_score_gemma":0.00018368893,"threshold_uncertainty_score":0.005297184},"labels":[],"label_agreement":null},{"id":"W4229044080","doi":"10.2217/cer-2021-0314","title":"Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Drug overdose; Quarter (Canadian coin); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Emergency medicine; Medical emergency; Environmental health; Poison control; Virology; Infectious disease (medical specialty); Disease; Outbreak; Geography; Internal medicine","score_opus":0.07913024373929181,"score_gpt":0.4399704730732,"score_spread":0.36084022933390814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229044080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98219436,0.002571776,0.0001573836,0.0056539085,0.00008724102,0.00002387624,0.0038053254,0.000007020265,0.0054991376],"genre_scores_gemma":[0.9946444,0.0022598759,0.00015332988,0.0006589918,0.000070191236,0.0000120621,0.0017525065,0.0000025658483,0.0004462099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994686,0.00019104582,0.0000548842,0.00003573448,0.00013411623,0.00011554454],"domain_scores_gemma":[0.99795544,0.0003178987,0.0010288274,0.000041526604,0.00038625463,0.0002700388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007612968,0.0001331394,0.00015993709,0.0008343263,0.00034262188,0.0007990615,0.00021313247,0.00035187847,0.0021145751],"category_scores_gemma":[0.003891265,0.000085257925,0.0003820247,0.0009649148,0.00026938153,0.0006870679,0.0007339802,0.0005996976,0.00014131848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027620926,0.00014661896,0.9654044,0.000093650524,0.00018523345,0.00030069827,0.00019043659,0.0008831244,0.00013976943,0.00071875984,0.0051769046,0.02648426],"study_design_scores_gemma":[0.000010486977,0.00009275069,0.9945898,0.000121825025,0.000053681928,0.0002245617,0.0008793397,0.00081843033,0.00008816022,0.00020796449,0.0029012621,0.000011672232],"about_ca_topic_score_codex":0.03243818,"about_ca_topic_score_gemma":0.07515297,"teacher_disagreement_score":0.03243818,"about_ca_system_score_codex":0.0016440426,"about_ca_system_score_gemma":0.0011925453,"threshold_uncertainty_score":0.06449878},"labels":[],"label_agreement":null},{"id":"W4229451358","doi":"10.2217/cer-2021-0278","title":"Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Medical prescription; Health insurance; Health care; Pediatrics; Internal medicine; Pharmacology","score_opus":0.1627061552598147,"score_gpt":0.46460012567932396,"score_spread":0.30189397041950927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229451358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784716,0.009516745,0.0008304068,0.006433008,0.00005116856,0.000060563994,0.00022011365,0.0000069436333,0.0044094077],"genre_scores_gemma":[0.9976605,0.0011336114,0.0005218806,0.00042143642,0.00009184586,0.000013956309,0.00004217166,0.0000023146201,0.00011228898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98941934,0.006620792,0.0009721869,0.0008472762,0.0014351064,0.0007052953],"domain_scores_gemma":[0.9041277,0.06585982,0.025236635,0.0022166872,0.00113664,0.001422456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008697729,0.00014272088,0.0005441059,0.0010349201,0.00091350585,0.002078093,0.00038118107,0.0014712443,0.004040529],"category_scores_gemma":[0.06401703,0.00020832916,0.00092156266,0.0015402202,0.0012831643,0.0020632972,0.0009554251,0.0015865896,0.00012407714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003717483,0.0005235971,0.9063417,0.00059768016,0.0005216909,0.0028500988,0.0012705071,0.0009066289,0.00045240752,0.0070480676,0.0013362305,0.074434005],"study_design_scores_gemma":[0.00030413992,0.0012661406,0.96523064,0.0010507853,0.0009597611,0.007869647,0.0030579215,0.005789315,0.00082651566,0.006218102,0.00734378,0.00008326331],"about_ca_topic_score_codex":0.006166513,"about_ca_topic_score_gemma":0.0059486693,"teacher_disagreement_score":0.008697729,"about_ca_system_score_codex":0.0018283606,"about_ca_system_score_gemma":0.0017593371,"threshold_uncertainty_score":0.045998573},"labels":[],"label_agreement":null},{"id":"W4280554311","doi":"10.2217/cer-2022-0040","title":"Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus","year":2022,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"National Institute for Health and Care Research; AstraZeneca","keywords":"Medicine; Belimumab; Lupus erythematosus; Monoclonal; Immunology; Internal medicine; Dermatology; Monoclonal antibody; Antibody; B-cell activating factor","score_opus":0.21922028441166244,"score_gpt":0.48646745943190944,"score_spread":0.267247175020247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280554311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022042813,0.97552073,0.0006077353,0.00022315921,0.00026929154,0.00036236172,0.00012352958,0.000011251149,0.00083909836],"genre_scores_gemma":[0.3736964,0.6215627,0.0023920038,0.0004913871,0.00028976373,0.00083480176,0.00024403696,0.000008159116,0.00048071213],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99338806,0.0053590355,0.000527914,0.00021802667,0.00041276787,0.000094084906],"domain_scores_gemma":[0.9923764,0.006492249,0.0007615611,0.00008476659,0.00019852284,0.00008650591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00681652,0.00085083966,0.004860735,0.0008263419,0.00012569717,0.0008142665,0.0008567582,0.0010234343,0.0032356062],"category_scores_gemma":[0.012689132,0.00037857727,0.004712146,0.000672874,0.0003618411,0.00051713665,0.00038807036,0.001195905,0.00014574538],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09983694,0.0006472628,0.0020639384,0.36616626,0.13827586,0.00017827928,0.00019424179,0.0029794227,0.0013537761,0.0020722465,0.0017523643,0.3844795],"study_design_scores_gemma":[0.16225392,0.071404666,0.030200021,0.10829645,0.56569535,0.0015898137,0.00060784275,0.008303873,0.003982859,0.0051662056,0.04231455,0.00018446453],"about_ca_topic_score_codex":0.0011008516,"about_ca_topic_score_gemma":0.0016547502,"teacher_disagreement_score":0.00681652,"about_ca_system_score_codex":0.001022304,"about_ca_system_score_gemma":0.0011260529,"threshold_uncertainty_score":0.036049664},"labels":[],"label_agreement":null},{"id":"W4283806096","doi":"10.2217/cer-2021-0239","title":"Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Chemotherapy; Internal medicine; Oncology; Perioperative; Oxaliplatin; Proportional hazards model; Adjuvant; Cancer; Adjuvant chemotherapy; Surgery; Breast cancer","score_opus":0.14820642662481062,"score_gpt":0.4268300897564154,"score_spread":0.2786236631316048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283806096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745864,0.0018355931,0.0000517596,0.000092901646,0.000008322406,0.0000036817462,0.0001475283,0.0000013120135,0.00040020968],"genre_scores_gemma":[0.99950254,0.00027040817,0.000030927662,0.000015907266,0.000009309933,0.0000025098864,0.00013393493,4.3091202e-7,0.000033912915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996568,0.000116903466,0.000052761963,0.000038908984,0.00007153182,0.00006308954],"domain_scores_gemma":[0.99868816,0.00041760982,0.00064853404,0.00003377788,0.00008286333,0.00012913239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049457356,0.000092676884,0.00019911343,0.0003145408,0.0001495371,0.00026144294,0.00009355434,0.000107489795,0.0007518686],"category_scores_gemma":[0.0029071565,0.0000545999,0.00035284844,0.0003461526,0.0001512153,0.00025293345,0.0002100158,0.00022648899,0.000050363353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005088504,0.000035465797,0.9923683,0.00003897274,0.0001368541,0.000052976997,0.000022263399,0.00011454244,0.00013426572,0.000024442115,0.00008590983,0.0064772298],"study_design_scores_gemma":[0.000013407248,0.00034324045,0.99860686,0.000018454652,0.00016083106,0.0002003804,0.00008772842,0.00019973094,0.00014222192,0.000026705182,0.00019761836,0.0000029344103],"about_ca_topic_score_codex":0.0014810947,"about_ca_topic_score_gemma":0.0036881857,"teacher_disagreement_score":0.0014810947,"about_ca_system_score_codex":0.0003484255,"about_ca_system_score_gemma":0.0003033373,"threshold_uncertainty_score":0.002945006},"labels":[],"label_agreement":null},{"id":"W4288010068","doi":"10.2217/cer-2022-0041","title":"A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladder","year":2022,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Alberta","funders":"","keywords":"Overactive bladder; Medicine; Urination; Accidental; Intensive care medicine; Urology; Alternative medicine; Urinary system; Internal medicine; Pathology","score_opus":0.0675549787563054,"score_gpt":0.4167074654336932,"score_spread":0.3491524866773878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288010068","genre_codex":"dataset","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030670442,0.104975976,0.0069157085,0.096048996,0.009398334,0.00890662,0.5616602,0.004188454,0.17723525],"genre_scores_gemma":[0.25686672,0.18274574,0.04510129,0.12064811,0.019832611,0.021016775,0.2600208,0.0014943737,0.09227366],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997044,0.00086633966,0.0012106005,0.00014639266,0.00059662247,0.00013601381],"domain_scores_gemma":[0.9742688,0.011584631,0.0070736087,0.00029468213,0.0060691196,0.00070916093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021239128,0.0008586629,0.0018619966,0.0033359143,0.00054885476,0.0017336566,0.0007871493,0.0014719849,0.12341992],"category_scores_gemma":[0.025637515,0.0002652078,0.002574114,0.0021544052,0.00025915625,0.0021878956,0.00064401695,0.0019427781,0.019474564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022776327,0.00018017195,0.009301071,0.021501394,0.0005152616,0.00036248376,0.00019778716,0.00033913332,0.00043647108,0.0008037573,0.829118,0.13496687],"study_design_scores_gemma":[0.0029042615,0.0027705813,0.09737256,0.03972296,0.002106039,0.0045309504,0.0014629234,0.0010497123,0.00086675177,0.003976397,0.842861,0.00037578755],"about_ca_topic_score_codex":0.00220197,"about_ca_topic_score_gemma":0.0038331791,"teacher_disagreement_score":0.12341992,"about_ca_system_score_codex":0.0010055533,"about_ca_system_score_gemma":0.0013382114,"threshold_uncertainty_score":0.41288072},"labels":[],"label_agreement":null},{"id":"W4292583104","doi":"10.2217/cer-2022-0074","title":"Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Transthyretin; Amyloidosis; Comorbidity; Demographics; Pediatrics; Internal medicine","score_opus":0.16123731951039613,"score_gpt":0.4917790906481361,"score_spread":0.33054177113773997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292583104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992021,0.0001882087,0.000017912207,0.000041971132,0.0000040413215,0.0000041412213,0.00026111605,0.0000010968549,0.00027945725],"genre_scores_gemma":[0.9996178,0.000048418995,0.000018377128,0.000014485954,0.0000059760378,0.000003319106,0.00023858658,3.1339832e-7,0.00005283871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994516,0.000119772536,0.0000650175,0.000111598136,0.000100463076,0.00015159538],"domain_scores_gemma":[0.9978435,0.0004473593,0.0010347652,0.00005130856,0.00014593104,0.0004771243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044684322,0.00012878748,0.00027571723,0.0005056611,0.00036511337,0.00056578615,0.00018031542,0.0003886307,0.002026196],"category_scores_gemma":[0.002724108,0.00012122,0.0003724292,0.00055266666,0.00017188315,0.0004056604,0.0003615902,0.0005337056,0.00015765589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012808958,0.00004207956,0.9989366,0.0000058031283,0.00001765494,0.00007894577,0.000031525782,0.000023329381,0.000055457473,0.000007503535,0.000046160163,0.0006266781],"study_design_scores_gemma":[0.0000031021823,0.0000910876,0.9995426,0.0000042499205,0.000006385152,0.00019069205,0.000060186172,0.000036328158,0.000020736385,0.0000058887827,0.000037373546,0.000001371846],"about_ca_topic_score_codex":0.0073020416,"about_ca_topic_score_gemma":0.007855454,"teacher_disagreement_score":0.0073020416,"about_ca_system_score_codex":0.0004714118,"about_ca_system_score_gemma":0.00037143767,"threshold_uncertainty_score":0.014519095},"labels":[],"label_agreement":null},{"id":"W4297457303","doi":"10.2217/cer-2021-0274","title":"Developing a cross-validation tool for evaluating economic evidence in rapid literature reviews","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Public Health Ontario","funders":"","keywords":"Credibility; Medicine; Economic evaluation; Quality (philosophy); Systematic review; Management science; Software deployment; Evidence-based medicine; Economic model; Data science; Risk analysis (engineering); MEDLINE; Computer science; Economics; Alternative medicine; Macroeconomics; Pathology","score_opus":0.9502567644813614,"score_gpt":0.7321332976015382,"score_spread":0.2181234668798232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297457303","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038034666,0.004046336,0.9122848,0.0032199204,0.0008836977,0.025623878,0.0019017016,0.0030332545,0.010971857],"genre_scores_gemma":[0.08896482,0.00052239414,0.8891676,0.0004408153,0.00008379779,0.019724885,0.0006308994,0.0001617156,0.00030309358],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.37726232,0.4691824,0.088736266,0.009053146,0.05380839,0.001957542],"domain_scores_gemma":[0.055524006,0.8009775,0.03809155,0.021301467,0.082922824,0.0011826389],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5977936,0.0026601383,0.0034930697,0.029456994,0.0023929372,0.00800708,0.0033581103,0.0029134816,0.005742871],"category_scores_gemma":[0.8530231,0.0022350715,0.009755667,0.014031615,0.0027936578,0.009333431,0.008419659,0.0041960827,0.0012586286],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022915655,0.00080828095,0.06180958,0.03147378,0.008016472,0.0005836694,0.011303679,0.020677432,0.002867658,0.04378617,0.023916801,0.792465],"study_design_scores_gemma":[0.006209097,0.007411853,0.1254436,0.084319346,0.01689285,0.0035331792,0.008858285,0.3437555,0.033191923,0.22011772,0.14745289,0.0028137828],"about_ca_topic_score_codex":0.0016543248,"about_ca_topic_score_gemma":0.0025623583,"teacher_disagreement_score":0.40220642,"about_ca_system_score_codex":0.0049505434,"about_ca_system_score_gemma":0.016384464,"threshold_uncertainty_score":0.49599218},"labels":[],"label_agreement":null},{"id":"W4308668157","doi":"10.2217/cer-2022-0160","title":"Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review","year":2022,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Anticholinergic; Medicine; Overactive bladder; Intensive care medicine; Health care; Anticholinergic agents; Systematic review; Indirect costs; MEDLINE; Internal medicine; Alternative medicine","score_opus":0.15711080105775044,"score_gpt":0.4854165608149944,"score_spread":0.32830575975724396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308668157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012757157,0.9977405,0.00006404883,0.00024690965,0.00006852178,0.00008833565,0.00026921422,0.0000027906897,0.00024396651],"genre_scores_gemma":[0.01185093,0.98738503,0.00024706018,0.00018575595,0.000052296476,0.00010426276,0.00012173869,0.0000015784098,0.000051233153],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995417,0.0014409089,0.0015731964,0.00029252798,0.0010966792,0.00017970327],"domain_scores_gemma":[0.98361903,0.011698969,0.0031483262,0.00012585585,0.0012362336,0.00017160492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051176487,0.0012901722,0.0048535904,0.01161802,0.00052587624,0.0025414312,0.0009864856,0.0015029738,0.0035894867],"category_scores_gemma":[0.026026228,0.00078587595,0.0066250893,0.011532432,0.00049428485,0.0014394342,0.0011806244,0.0009456564,0.00019156403],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023967473,0.00003019591,0.0033299224,0.899475,0.017340941,0.00019188959,0.00014750336,0.0001923359,0.00010537319,0.00043492854,0.0024416414,0.07607064],"study_design_scores_gemma":[0.00020273025,0.00022217222,0.0139343375,0.8671664,0.09496439,0.0009770024,0.00043791163,0.00020132744,0.0001784753,0.0004947384,0.02117291,0.000047587895],"about_ca_topic_score_codex":0.01081301,"about_ca_topic_score_gemma":0.024257418,"teacher_disagreement_score":0.01161802,"about_ca_system_score_codex":0.0034968806,"about_ca_system_score_gemma":0.008942843,"threshold_uncertainty_score":0.027065098},"labels":[],"label_agreement":null},{"id":"W4309827664","doi":"10.2217/cer-2022-0146","title":"Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Refractory (planetary science); Clinical trial; Internal medicine; Lymphoma; Oncology; Diffuse large B-cell lymphoma","score_opus":0.1483897253639382,"score_gpt":0.4705964074388625,"score_spread":0.3222066820749243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309827664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021181514,0.99497706,0.00024393365,0.00026065472,0.00013752893,0.00063246815,0.0012310093,0.000014722197,0.00038441934],"genre_scores_gemma":[0.045322336,0.9496505,0.0012015959,0.0007951628,0.00011675864,0.001762344,0.0009009099,0.000017523462,0.00023278585],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9854328,0.0056471573,0.0059176106,0.0009522432,0.0017219661,0.00032837698],"domain_scores_gemma":[0.9612036,0.027784426,0.007654029,0.00065821025,0.002371593,0.00032821542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01228656,0.0015768709,0.011303171,0.009779498,0.0005872446,0.002784622,0.0017669491,0.0013793627,0.004838388],"category_scores_gemma":[0.053165052,0.00091896154,0.0083641745,0.010597513,0.0009996397,0.0020306595,0.0018080935,0.0010143023,0.00032654754],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037226622,0.000008805904,0.00089460955,0.95317435,0.025675379,0.00006260937,0.00008882391,0.00008873501,0.00012269031,0.00018042533,0.001024582,0.018306822],"study_design_scores_gemma":[0.0010772899,0.0003175683,0.0068144044,0.7160565,0.25611636,0.00036339212,0.0002554119,0.000122064375,0.00027022397,0.0005263785,0.018035728,0.000044669545],"about_ca_topic_score_codex":0.006282122,"about_ca_topic_score_gemma":0.017639993,"teacher_disagreement_score":0.01228656,"about_ca_system_score_codex":0.0041930056,"about_ca_system_score_gemma":0.009489491,"threshold_uncertainty_score":0.0649783},"labels":[],"label_agreement":null},{"id":"W4310361476","doi":"10.2217/cer-2022-0147","title":"Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors","year":2022,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Integrase; Integrase inhibitor; Weight gain; Human immunodeficiency virus (HIV); Antiretroviral therapy; Internal medicine; Demography; Virology; Body weight; Viral load","score_opus":0.05781207410141871,"score_gpt":0.3916310975316421,"score_spread":0.3338190234302234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310361476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983146,0.00053292373,0.00006854095,0.00007655042,0.000008477728,0.000016146323,0.00051353825,0.000001743098,0.00046742667],"genre_scores_gemma":[0.99919015,0.00018550357,0.00009367392,0.000033842396,0.000008717197,0.000013305556,0.00038502866,6.274376e-7,0.00008920392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992943,0.00031633023,0.00010295118,0.000093508825,0.00011455893,0.00007835803],"domain_scores_gemma":[0.9985056,0.00025347917,0.0009822749,0.000044141223,0.00008652839,0.00012808622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010327982,0.00015049908,0.00028298298,0.000600571,0.00020818539,0.0004845968,0.00019778116,0.00033644325,0.0015675604],"category_scores_gemma":[0.0034898624,0.00011107646,0.00046927412,0.00071024516,0.00017170426,0.0005003614,0.00039143435,0.00038776564,0.00014330591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011153223,0.00013423967,0.9898537,0.000067683795,0.00025297777,0.000046961148,0.000121153724,0.00009829731,0.00012227302,0.000027793245,0.00012703172,0.008032528],"study_design_scores_gemma":[0.000027561831,0.00068176846,0.9983993,0.000020380368,0.000071004004,0.00014213937,0.00022353153,0.00014012332,0.00006537179,0.000028255052,0.00019580394,0.0000048427337],"about_ca_topic_score_codex":0.0020643764,"about_ca_topic_score_gemma":0.003251292,"teacher_disagreement_score":0.0020643764,"about_ca_system_score_codex":0.0003092265,"about_ca_system_score_gemma":0.00013404268,"threshold_uncertainty_score":0.0054620504},"labels":[],"label_agreement":null},{"id":"W4311380649","doi":"10.2217/cer-2022-0192","title":"Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus","year":2022,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"National Institute for Health and Care Research; AstraZeneca","keywords":"Belimumab; Medicine; Lupus erythematosus; Dermatology; Immunology; Internal medicine; Antibody","score_opus":0.10524607360021869,"score_gpt":0.4155190755214279,"score_spread":0.3102730019212092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311380649","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012480001,0.0018579193,0.000094557756,0.9609394,0.03362815,0.000048236365,0.0005545619,0.0000314695,0.0015976304],"genre_scores_gemma":[0.0075928895,0.00093447,0.0002693055,0.95187145,0.036380645,0.00016135133,0.00010597485,0.000024474675,0.0026594729],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920591,0.0047048097,0.0012884431,0.00057292625,0.0009311007,0.00044351985],"domain_scores_gemma":[0.96033746,0.032100737,0.0020410544,0.000643717,0.0031522904,0.0017247628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010008074,0.0007537754,0.003099046,0.0009890038,0.0017501302,0.0022356086,0.0018205158,0.03004448,0.0074060913],"category_scores_gemma":[0.059527062,0.00072743313,0.0014736517,0.0010502232,0.0017687399,0.0021063376,0.00090778404,0.018089097,0.003951601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015693818,0.00009391144,0.0014228747,0.00037573787,0.00023577991,0.00071813137,0.00009536313,0.0000798658,0.00012695426,0.0011418671,0.98496675,0.009173442],"study_design_scores_gemma":[0.008276838,0.0011955308,0.0096212635,0.0024202897,0.001908819,0.00360515,0.0009032377,0.001615706,0.00090278604,0.012380146,0.95691514,0.00025502066],"about_ca_topic_score_codex":0.0046619507,"about_ca_topic_score_gemma":0.0059149708,"teacher_disagreement_score":0.03004448,"about_ca_system_score_codex":0.0047693136,"about_ca_system_score_gemma":0.0038819737,"threshold_uncertainty_score":0.052928448},"labels":[],"label_agreement":null},{"id":"W4361208984","doi":"10.57264/cer-2022-0097","title":"Treatment goals for rheumatoid arthritis: patient engagement and goal collection","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Data collection; Ranking (information retrieval); Rheumatoid arthritis; Physical therapy; Identification (biology); Prioritization; Goal setting; Process management; Computer science; Psychology; Social psychology; Internal medicine; Artificial intelligence","score_opus":0.11336434016930408,"score_gpt":0.4292838292109666,"score_spread":0.3159194890416625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361208984","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32713324,0.0020828622,0.5282506,0.023779446,0.00043974948,0.061319727,0.0031109585,0.0021111215,0.051772363],"genre_scores_gemma":[0.49249023,0.0008527042,0.46964243,0.0019159853,0.00010607092,0.03247965,0.0011816551,0.00007581226,0.0012554241],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9012169,0.08448698,0.005284772,0.0016144095,0.006019548,0.0013774086],"domain_scores_gemma":[0.91762817,0.05617798,0.007849371,0.004983969,0.009793606,0.0035669773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.087093465,0.00086316396,0.0010911578,0.0024984977,0.0016898973,0.003987397,0.0014619401,0.0012296805,0.0036429602],"category_scores_gemma":[0.123181775,0.0005810626,0.0017443573,0.001968111,0.000978221,0.0030078029,0.004912158,0.0026141752,0.0011473212],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012108046,0.004342721,0.051758096,0.004327783,0.00034713495,0.0001372379,0.018405171,0.003670921,0.001557562,0.0083870655,0.015051214,0.8908043],"study_design_scores_gemma":[0.004934521,0.023701074,0.37493244,0.014093237,0.0016221246,0.0014707977,0.059775136,0.103288464,0.027770728,0.15080184,0.23623362,0.0013759765],"about_ca_topic_score_codex":0.0011537765,"about_ca_topic_score_gemma":0.002194139,"teacher_disagreement_score":0.087093465,"about_ca_system_score_codex":0.003406089,"about_ca_system_score_gemma":0.011049258,"threshold_uncertainty_score":0.46059978},"labels":[],"label_agreement":null},{"id":"W4367299362","doi":"10.57264/cer-2023-0009","title":"Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant","year":2023,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Palbociclib; Medicine; Fulvestrant; Oncology; Breast cancer; Quality of life (healthcare); Internal medicine; Cancer; Gynecology; Metastatic breast cancer; Estrogen receptor","score_opus":0.12516054244642327,"score_gpt":0.46097057455155016,"score_spread":0.3358100321051269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367299362","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019535238,0.0011201911,0.00008088144,0.974655,0.020060824,0.00003351616,0.0007107199,0.000019232692,0.0013659766],"genre_scores_gemma":[0.011002715,0.000959192,0.00031343967,0.9583652,0.025693716,0.00015472,0.00021277998,0.000019229292,0.0032790324],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965224,0.0016399184,0.0006766086,0.00032936534,0.00053804985,0.00029363364],"domain_scores_gemma":[0.97773117,0.016556326,0.0013591582,0.00044563442,0.0026390078,0.001268623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051737134,0.00054016244,0.002116371,0.0008278685,0.0014196214,0.0016848857,0.0013198195,0.019024648,0.0058195707],"category_scores_gemma":[0.03917212,0.0005180489,0.0012396283,0.001156365,0.0011781831,0.0014154224,0.0007319134,0.0151557885,0.00344032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010568253,0.00010506841,0.004901777,0.00028863642,0.00020274438,0.0013177582,0.00011590296,0.00009320839,0.00018474052,0.0013232805,0.977621,0.012789075],"study_design_scores_gemma":[0.0029581378,0.0008546181,0.020653952,0.0014682335,0.0011767553,0.00624715,0.0013803581,0.001231247,0.00090084894,0.008344229,0.9545505,0.00023397492],"about_ca_topic_score_codex":0.005810716,"about_ca_topic_score_gemma":0.008283153,"teacher_disagreement_score":0.019024648,"about_ca_system_score_codex":0.003938137,"about_ca_system_score_gemma":0.0036033378,"threshold_uncertainty_score":0.028573334},"labels":[],"label_agreement":null},{"id":"W4379093489","doi":"10.57264/cer-2023-0016","title":"Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ofatumumab; Alemtuzumab; Ocrelizumab; Natalizumab; Internal medicine; Placebo; Multiple sclerosis; Lipoarabinomannan; Oncology; Rituximab; Disease; Tuberculosis; Immunology; Alternative medicine; Pathology; Lymphoma","score_opus":0.7093580791148476,"score_gpt":0.5626411172863962,"score_spread":0.1467169618284514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379093489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004759955,0.99327457,0.00065661606,0.00022756797,0.00012458165,0.00019806305,0.0004946248,0.000020620031,0.00024341712],"genre_scores_gemma":[0.24309884,0.7501729,0.0032761185,0.0007211827,0.0003081683,0.0010074645,0.0011096286,0.000032925906,0.00027273572],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9878293,0.007814044,0.0020520547,0.0010591818,0.0009842134,0.00026120068],"domain_scores_gemma":[0.973905,0.021434512,0.002770181,0.0005465464,0.0010975515,0.00024607423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016661797,0.0024541833,0.016026147,0.005793582,0.0004616866,0.002277152,0.0018979044,0.0019038473,0.0042808927],"category_scores_gemma":[0.03489439,0.0011816347,0.02726225,0.0058798115,0.00061465875,0.001473275,0.0013841696,0.0018796829,0.0002763794],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024806163,0.000026634927,0.0032166285,0.23006634,0.7500011,0.000060179842,0.000045805733,0.0006231873,0.00013753276,0.00019252239,0.00049569196,0.012653847],"study_design_scores_gemma":[0.00089604536,0.00017788126,0.0025795097,0.014851485,0.9796847,0.00005743241,0.000026089552,0.00028924271,0.00006661495,0.00026012497,0.0010969477,0.000013936418],"about_ca_topic_score_codex":0.0055834376,"about_ca_topic_score_gemma":0.010609944,"teacher_disagreement_score":0.016661797,"about_ca_system_score_codex":0.0022784697,"about_ca_system_score_gemma":0.002515814,"threshold_uncertainty_score":0.08811706},"labels":[],"label_agreement":null},{"id":"W4385483571","doi":"10.57264/cer-2023-0066","title":"Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sierra Oncology; Incyte; Celgene","keywords":"Medicine; Polycythemia vera; Quality-adjusted life year; Myelofibrosis; Population; Internal medicine; Cost effectiveness; Cohort","score_opus":0.3315524533615838,"score_gpt":0.5218676901699087,"score_spread":0.19031523680832496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385483571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93826866,0.005981638,0.024089416,0.004579887,0.00015707586,0.0007612938,0.007434776,0.00014474081,0.018582528],"genre_scores_gemma":[0.9954548,0.0006425376,0.0016662494,0.00017115954,0.000014054093,0.00012249965,0.0007727482,0.000008941968,0.0011470366],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99924326,0.00045730514,0.000027532618,0.00008415674,0.00006391545,0.00012385467],"domain_scores_gemma":[0.9974476,0.0019318173,0.00026924274,0.000045106168,0.00010955767,0.0001967766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021775828,0.0007728302,0.000864874,0.00067144516,0.00034246923,0.0015919434,0.0010172316,0.0013426642,0.0054446226],"category_scores_gemma":[0.0073047457,0.0006118935,0.0021630474,0.0005521883,0.0004075541,0.0012086729,0.00069401675,0.0014133771,0.0002979931],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002439527,0.00019624532,0.011033043,0.00024398285,0.00054106576,0.0002521145,0.000043246455,0.96818215,0.0002412312,0.00446338,0.0015284105,0.010835573],"study_design_scores_gemma":[0.001151152,0.001291039,0.0089065125,0.00040219352,0.0014774173,0.00040370354,0.00015552851,0.9775947,0.00046692562,0.0057513216,0.0023455813,0.000053971624],"about_ca_topic_score_codex":0.026052028,"about_ca_topic_score_gemma":0.015220657,"teacher_disagreement_score":0.026052028,"about_ca_system_score_codex":0.004746927,"about_ca_system_score_gemma":0.0037588456,"threshold_uncertainty_score":0.051800787},"labels":[],"label_agreement":null},{"id":"W4385684181","doi":"10.57264/cer-2023-0061","title":"Real-world impact of patient-reported outcome measurement on overall survival, healthcare use and treatment discontinuation in cancer patients","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Discontinuation; Emergency department; Proportional hazards model; Retrospective cohort study; Cohort; Internal medicine; Population; Breast cancer; Colorectal cancer; Propensity score matching; Cohort study; Emergency medicine; Cancer; Lung cancer; Confidence interval","score_opus":0.36952984768956515,"score_gpt":0.517947666750521,"score_spread":0.1484178190609558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385684181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509996,0.00079446856,0.0003618165,0.00020148129,0.000024091452,0.000026879265,0.0030320436,0.0000066482007,0.00045267495],"genre_scores_gemma":[0.9978259,0.00013872689,0.00020746714,0.00006123962,0.000021684624,0.000026905283,0.0016474028,0.0000020521377,0.00006846957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955988,0.0019350098,0.0006738074,0.00065681466,0.0007599376,0.00037561622],"domain_scores_gemma":[0.9801626,0.0037598808,0.013025998,0.0013729053,0.00095778616,0.0007209394],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004961654,0.00021552053,0.00043290813,0.0007610578,0.00039221355,0.0010839553,0.0004746619,0.00044713466,0.00070952263],"category_scores_gemma":[0.016087176,0.00020820642,0.0010242478,0.0019438982,0.0003363015,0.0006715252,0.0006476436,0.00088652177,0.00010820815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011252599,0.000015948943,0.99877614,0.00001569539,0.00011256967,0.00001067341,0.000030522562,0.00006107928,0.00002091343,0.00001591339,0.00008409566,0.0007440607],"study_design_scores_gemma":[0.0000071422814,0.00012782418,0.99877673,0.000019311066,0.00007526259,0.0000873048,0.00008393763,0.00040769204,0.000046480433,0.000035889152,0.0003269161,0.000005567313],"about_ca_topic_score_codex":0.010460958,"about_ca_topic_score_gemma":0.013910259,"teacher_disagreement_score":0.99503833,"about_ca_system_score_codex":0.0009393311,"about_ca_system_score_gemma":0.0009813968,"threshold_uncertainty_score":0.02624005},"labels":[],"label_agreement":null},{"id":"W4385851857","doi":"10.57264/cer-2023-0005","title":"QDOT MICRO™ versus THERMOCOOL <sup>®</sup> SMARTTOUCH™ and THERMOCOOL SMARTTOUCH <sup>®</sup> Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Biosense Webster","keywords":"Medicine; Atrial fibrillation; Ablation; Fluoroscopy; Internal medicine; Cardiology; Catheter ablation; Paroxysmal atrial fibrillation; Nuclear medicine; Surgery","score_opus":0.16607501389731916,"score_gpt":0.43216515214763945,"score_spread":0.2660901382503203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385851857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842037,0.009017302,0.0011206352,0.000109319066,0.000096809585,0.00021606938,0.00011939588,0.000010671272,0.0008894123],"genre_scores_gemma":[0.9968021,0.0015701132,0.0009787505,0.00008911209,0.000059017908,0.00010375543,0.00006150098,0.0000024952114,0.00033313636],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99904126,0.0005711222,0.00009658763,0.000114049675,0.00012985541,0.000047188478],"domain_scores_gemma":[0.99811804,0.0010982858,0.00055015617,0.000058035097,0.00006899651,0.000106447675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021513524,0.0001763751,0.0007903335,0.00022447479,0.000066986504,0.00032826018,0.00016796443,0.00026799794,0.0015876951],"category_scores_gemma":[0.003169251,0.00010440232,0.0008319265,0.0001702585,0.00022838515,0.00037500504,0.00018259104,0.00033241155,0.00008426496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52637166,0.0034325225,0.018514007,0.003922996,0.0044373656,0.000046094676,0.00023474186,0.0027825849,0.014029843,0.0011210304,0.0006890485,0.424418],"study_design_scores_gemma":[0.12794153,0.6260232,0.19032395,0.0010401354,0.013808018,0.00081433787,0.00044213957,0.011812025,0.016569331,0.0017331409,0.009370531,0.000121646255],"about_ca_topic_score_codex":0.00023288702,"about_ca_topic_score_gemma":0.00054716994,"teacher_disagreement_score":0.0021513524,"about_ca_system_score_codex":0.0002670122,"about_ca_system_score_gemma":0.0002807782,"threshold_uncertainty_score":0.011377573},"labels":[],"label_agreement":null},{"id":"W4386046576","doi":"10.57264/cer-2022-0175","title":"Cost–consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); EVERSANA (Canada); Queen's University; Memorial University of Newfoundland; University of British Columbia","funders":"","keywords":"Medicine; Ofatumumab; Natalizumab; Relapsing remitting; Ocrelizumab; Multiple sclerosis; Physical therapy; Internal medicine; Disease; Immunology; Rituximab","score_opus":0.4634725382332816,"score_gpt":0.48936304131241415,"score_spread":0.025890503079132543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386046576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791555,0.0023506924,0.0020040951,0.0015717095,0.00003884417,0.00062640273,0.009195593,0.000041472063,0.005015673],"genre_scores_gemma":[0.9954306,0.00061551714,0.0010687764,0.000118141535,0.000007064568,0.000071907285,0.0017383692,0.000006180918,0.00094336685],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99861896,0.0005299031,0.00005051158,0.00011960522,0.00026096217,0.0004201063],"domain_scores_gemma":[0.9967796,0.001325966,0.00043887208,0.00008655876,0.0009010869,0.00046801168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002435516,0.00075988815,0.0008857395,0.0013138409,0.0008422811,0.0014385305,0.0015023391,0.00082408433,0.0037501971],"category_scores_gemma":[0.006742767,0.0005330556,0.0021025524,0.0015476996,0.0006092036,0.0004696223,0.00078652176,0.0011051123,0.000102349615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008361785,0.0006252891,0.14746714,0.00089612533,0.0027314113,0.00083998014,0.0001940859,0.79590523,0.0008012758,0.012145975,0.005784659,0.024246966],"study_design_scores_gemma":[0.0030812514,0.0016409114,0.14963123,0.0003810428,0.00279375,0.0005344097,0.00084367243,0.8300384,0.00079951115,0.0046628737,0.0054164925,0.0001764617],"about_ca_topic_score_codex":0.9572308,"about_ca_topic_score_gemma":0.94317734,"teacher_disagreement_score":0.059640806,"about_ca_system_score_codex":0.059640806,"about_ca_system_score_gemma":0.047963858,"threshold_uncertainty_score":0.43272638},"labels":[],"label_agreement":null},{"id":"W4386439153","doi":"10.57264/cer-2023-0075","title":"Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glycemic; Glycated hemoglobin; Hypoglycemia; Type 2 diabetes; Diabetes mellitus; Continuous glucose monitoring; Type 1 diabetes; Quality-adjusted life year; Internal medicine; Blood Glucose Self-Monitoring; Insulin; Cost effectiveness; Endocrinology","score_opus":0.07002837368940106,"score_gpt":0.3832770973235926,"score_spread":0.31324872363419154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386439153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483208,0.011822144,0.0020660423,0.0039607207,0.00012456658,0.0006165581,0.01806639,0.000084730025,0.014938057],"genre_scores_gemma":[0.99331325,0.0017305062,0.0012827356,0.00023679463,0.00001434103,0.00004557183,0.002462843,0.000009950713,0.0009039584],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99836785,0.0004664376,0.00007971592,0.0001538424,0.00048044056,0.0004516852],"domain_scores_gemma":[0.99778926,0.00070107955,0.00024311697,0.00005670448,0.0007666883,0.00044311196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021504397,0.00058564683,0.0009747694,0.001163214,0.0007943976,0.0022315385,0.0014422339,0.0006091717,0.0028341706],"category_scores_gemma":[0.009358909,0.00031268227,0.0022464348,0.0024672635,0.0005721446,0.0005627488,0.0010489913,0.0010972928,0.00011852513],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017927952,0.000806502,0.5500782,0.002257742,0.005821064,0.0009373355,0.0004276863,0.257003,0.0008226167,0.011815446,0.018564243,0.13353817],"study_design_scores_gemma":[0.004079696,0.0018641966,0.52217096,0.0014745581,0.006118003,0.0006103518,0.0017450264,0.44624156,0.0010082405,0.004979177,0.009399694,0.00030847374],"about_ca_topic_score_codex":0.98295367,"about_ca_topic_score_gemma":0.9814228,"teacher_disagreement_score":0.07390407,"about_ca_system_score_codex":0.07390407,"about_ca_system_score_gemma":0.05580314,"threshold_uncertainty_score":0.53621405},"labels":[],"label_agreement":null},{"id":"W4386757294","doi":"10.57264/cer-2023-0141","title":"R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Hospital Admissions and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Real world evidence; Agency (philosophy); Health technology; Alternative medicine; Real world data; Family medicine; Health care; Data science; Economic growth; Pathology; Internal medicine","score_opus":0.3944640706343192,"score_gpt":0.5920552082771873,"score_spread":0.19759113764286806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386757294","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035320933,0.2916241,0.0032833102,0.6276425,0.07065874,0.00023531169,0.00033859818,0.0002760389,0.0055882265],"genre_scores_gemma":[0.005725848,0.50430834,0.02357531,0.36733517,0.09201766,0.000568611,0.0008763246,0.00048212084,0.0051106466],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9218291,0.030820476,0.01812787,0.0026861506,0.023791077,0.002745324],"domain_scores_gemma":[0.5150769,0.3374583,0.027442077,0.010881622,0.096678406,0.012462631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.140835,0.0021150562,0.0061276783,0.0071665673,0.0024375303,0.019336313,0.005381353,0.01844317,0.017068006],"category_scores_gemma":[0.3367949,0.0018209915,0.005271746,0.009549413,0.006708043,0.032576405,0.007585712,0.029856957,0.0062822383],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001615144,0.00008046725,0.00060454354,0.0058113583,0.00023600036,0.00019103981,0.00021789486,0.00023437434,0.0003566841,0.0083636725,0.65737754,0.32636496],"study_design_scores_gemma":[0.00009690708,0.00017838155,0.0021349103,0.029397994,0.0002641319,0.00058280036,0.0004770159,0.00035934066,0.00024025961,0.013032982,0.9530703,0.00016497927],"about_ca_topic_score_codex":0.0047773574,"about_ca_topic_score_gemma":0.013114012,"teacher_disagreement_score":0.140835,"about_ca_system_score_codex":0.009656303,"about_ca_system_score_gemma":0.02283614,"threshold_uncertainty_score":0.7448156},"labels":[],"label_agreement":null},{"id":"W4388730279","doi":"10.57264/cer-2023-0054","title":"Gastrointestinal manifestations in pediatric and adult patients with Rett syndrome: an analysis of US claims and physician survey data","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Medicine; Rett syndrome; Medical costs; Pediatrics; Health insurance; Medical care; Young adult; Health care; Internal medicine; Family medicine","score_opus":0.06856805424622395,"score_gpt":0.3855690202668885,"score_spread":0.3170009660206645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388730279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985127,0.00022571441,0.000045634733,0.00004251212,0.0000018017122,0.000005379894,0.0010182466,0.0000023329324,0.00014574495],"genre_scores_gemma":[0.9986687,0.00013490957,0.00007093123,0.000022546705,0.0000051612556,0.000007516754,0.0010649848,8.4837404e-7,0.000024529221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891496,0.0003454474,0.00021386139,0.00014195031,0.00028469574,0.00009910466],"domain_scores_gemma":[0.9965969,0.00069237716,0.0021914216,0.000117623254,0.0002029843,0.00019864917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011161711,0.00019726362,0.0002724303,0.0013986869,0.00017666005,0.00046075106,0.00026052626,0.00034422794,0.00079013885],"category_scores_gemma":[0.003767117,0.0001755744,0.0004674307,0.0025670573,0.00020588194,0.00044603995,0.00046596065,0.00031765076,0.000118407756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016568016,0.000006236479,0.99940634,0.000004934129,0.000028763165,0.00003262497,0.000019964307,0.000024550734,0.000019122046,0.000005818856,0.000046256446,0.0003888197],"study_design_scores_gemma":[0.0000022905929,0.000019808189,0.9994149,0.0000046620507,0.000010719532,0.00019034775,0.00007797365,0.00018093853,0.000015812524,0.0000044312205,0.000077021585,0.0000011634694],"about_ca_topic_score_codex":0.008212684,"about_ca_topic_score_gemma":0.008812362,"teacher_disagreement_score":0.008212684,"about_ca_system_score_codex":0.00043951435,"about_ca_system_score_gemma":0.0003455833,"threshold_uncertainty_score":0.016329765},"labels":[],"label_agreement":null},{"id":"W4389803456","doi":"10.57264/cer-2023-0142","title":"Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer Pharmaceuticals; Pfizer","keywords":"Medicine; Blinatumomab; Refractory (planetary science); Lymphoblastic Leukemia; Retrospective cohort study; Internal medicine; Emergency medicine; Pediatrics; Leukemia","score_opus":0.041280349020756044,"score_gpt":0.37272352712147,"score_spread":0.33144317810071394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389803456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986462,0.00055634335,0.000033607805,0.00019893335,0.000005924198,0.0000032149246,0.00035338147,0.0000016118919,0.00020072222],"genre_scores_gemma":[0.99931276,0.00016802759,0.0000372087,0.00005546873,0.0000097442,0.0000038112428,0.0003652011,9.667813e-7,0.000046786834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927336,0.00023150016,0.000100343874,0.00013397241,0.00012831313,0.0001326353],"domain_scores_gemma":[0.9976572,0.00026156954,0.0017901263,0.000051020637,0.00006156764,0.00017852435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057206873,0.00015890917,0.00023488038,0.00038031462,0.00019733794,0.00094729854,0.00029474348,0.00032652606,0.0015649073],"category_scores_gemma":[0.0032416712,0.00015711728,0.00048269372,0.0007125421,0.00019416778,0.00054489006,0.0004382427,0.0006141985,0.00011341993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044217322,0.000060629776,0.99620444,0.000020573918,0.00017694951,0.00005332312,0.00002604617,0.00024473958,0.000102667116,0.000053383974,0.00021128981,0.002403833],"study_design_scores_gemma":[0.000027995475,0.00012859215,0.9977837,0.000016607237,0.000071851,0.00021965866,0.00016626388,0.0010395541,0.000077786644,0.000060882106,0.0004027162,0.00000437864],"about_ca_topic_score_codex":0.0049462793,"about_ca_topic_score_gemma":0.0072666807,"teacher_disagreement_score":0.0049462793,"about_ca_system_score_codex":0.0009635927,"about_ca_system_score_gemma":0.00043300135,"threshold_uncertainty_score":0.009835005},"labels":[],"label_agreement":null},{"id":"W4390743236","doi":"10.57264/cer-2023-0124","title":"Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Glycated hemoglobin; Glycemic; Life expectancy; Diabetes management; Insulin; Marginal cost; Psychological intervention; Quality-adjusted life year; Type 1 diabetes; Diabetes mellitus; Insulin pen; Type 2 diabetes; Intensive care medicine; Cost effectiveness; Internal medicine; Environmental health; Endocrinology; Risk analysis (engineering); Population; Nursing","score_opus":0.1274245942080996,"score_gpt":0.4715588744915871,"score_spread":0.3441342802834875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390743236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58709496,0.1712034,0.023068639,0.016886968,0.0006910273,0.0073708245,0.06024571,0.00032998133,0.13310838],"genre_scores_gemma":[0.9481821,0.028567294,0.010517983,0.0012487114,0.00010697023,0.0006905697,0.007822297,0.00005982293,0.0028043713],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9916732,0.0036929129,0.00030172654,0.00050064246,0.0028649606,0.0009665817],"domain_scores_gemma":[0.9918451,0.0044565774,0.0006974113,0.00019313883,0.0022287287,0.000579098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008143375,0.0016964547,0.0021698526,0.004037272,0.0010977184,0.0029466487,0.0022546903,0.001423153,0.006044144],"category_scores_gemma":[0.024706028,0.0006979207,0.0055891564,0.006849935,0.00084756536,0.0011099417,0.001203835,0.0019786214,0.00019095278],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021127425,0.0013272631,0.06339255,0.017263236,0.019268852,0.00079125765,0.0004813042,0.52723765,0.0013169354,0.055160046,0.041794587,0.2508389],"study_design_scores_gemma":[0.014266158,0.0068431017,0.17842409,0.00795424,0.033858143,0.001017864,0.0011190937,0.6745654,0.0012298936,0.013918955,0.06593201,0.0008710242],"about_ca_topic_score_codex":0.9420181,"about_ca_topic_score_gemma":0.9137051,"teacher_disagreement_score":0.10676492,"about_ca_system_score_codex":0.10676492,"about_ca_system_score_gemma":0.06633812,"threshold_uncertainty_score":0.77463734},"labels":[],"label_agreement":null},{"id":"W4390743877","doi":"10.57264/cer-2023-0147","title":"Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; McMaster University; Impact","funders":"","keywords":"Robustness (evolution); Missing data; External validity; Medicine; Confounding; Sample size determination; Population; Clinical trial; Data collection; Computer science; Statistics; Machine learning","score_opus":0.9834323930954177,"score_gpt":0.8240222415215248,"score_spread":0.15941015157389293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390743877","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067436614,0.06143497,0.8469232,0.07615283,0.0056946767,0.0040208036,0.0008386913,0.0009768279,0.003283788],"genre_scores_gemma":[0.023616359,0.025602015,0.8998586,0.022207908,0.008105449,0.018672373,0.00047026968,0.0007060696,0.0007609798],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.23792715,0.68288696,0.039413802,0.010021574,0.028646575,0.0011039559],"domain_scores_gemma":[0.054111853,0.8778214,0.021314463,0.027484465,0.018000107,0.0012677694],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7145477,0.004599451,0.012916563,0.012949318,0.0025468585,0.028973881,0.012349173,0.015487455,0.0075163487],"category_scores_gemma":[0.87163717,0.0035523302,0.01185446,0.013113759,0.024983298,0.02366494,0.013551558,0.03669367,0.0027122148],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000788065,0.00024704717,0.0046770703,0.03005929,0.00606959,0.0003073297,0.0043881526,0.010400157,0.00058456045,0.5192027,0.047291346,0.37598473],"study_design_scores_gemma":[0.0007083017,0.0005585258,0.0011792262,0.026216133,0.00117509,0.00031549018,0.0008765698,0.021989694,0.00082196645,0.85332745,0.0924892,0.00034246463],"about_ca_topic_score_codex":0.0026432239,"about_ca_topic_score_gemma":0.0015636166,"teacher_disagreement_score":0.2854523,"about_ca_system_score_codex":0.0099908635,"about_ca_system_score_gemma":0.026144756,"threshold_uncertainty_score":0.3520136},"labels":[],"label_agreement":null},{"id":"W4391779405","doi":"10.57264/cer-2023-0159","title":"Study Protocol for the Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence (SISTER) study: a community engaged national randomized trial","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Michael Smith Health Research BC","funders":"National Cancer Institute","keywords":"Medicine; Psychological intervention; Social support; Randomized controlled trial; Social isolation; Endometrial cancer; Intervention (counseling); Qualitative research; Peer support; Family medicine; Gynecology; Cancer; Internal medicine; Nursing; Social psychology; Psychology; Psychiatry","score_opus":0.5696956726535437,"score_gpt":0.6349042265350672,"score_spread":0.06520855388152347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391779405","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072166004,0.00028455904,0.0011859199,0.00019625519,0.0003054987,0.99479324,0.001609608,0.00008576961,0.0008174805],"genre_scores_gemma":[0.0005912317,0.000060400533,0.0009223887,0.000096800286,0.000018142897,0.99797195,0.00008108061,0.0000046636114,0.00025323886],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.97675556,0.014314056,0.0023445974,0.0021995122,0.0025926195,0.0017936324],"domain_scores_gemma":[0.9883994,0.0035585375,0.0023104171,0.001462863,0.0024252438,0.0018434663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03515525,0.005908738,0.010738368,0.0023553115,0.00423708,0.0052541015,0.003732761,0.007387522,0.12394061],"category_scores_gemma":[0.03548417,0.0036094876,0.0053161904,0.0031474973,0.003046369,0.004965905,0.0024279119,0.009781049,0.018228667],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7727413,0.016904682,0.0014713219,0.06027954,0.0037534435,0.00041465764,0.0012022106,0.0019636494,0.001979932,0.00971078,0.06540634,0.06417218],"study_design_scores_gemma":[0.88680035,0.017020475,0.0023217907,0.009771311,0.0015098164,0.00007481278,0.00041262622,0.0021426515,0.0007492202,0.0060512396,0.07301651,0.00012925651],"about_ca_topic_score_codex":0.003078687,"about_ca_topic_score_gemma":0.0060973163,"teacher_disagreement_score":0.12394061,"about_ca_system_score_codex":0.004785758,"about_ca_system_score_gemma":0.017462928,"threshold_uncertainty_score":0.41462266},"labels":[],"label_agreement":null},{"id":"W4393871536","doi":"10.57264/cer-2023-0178","title":"The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; Wilfrid Laurier University; Canadian Institute for Health Information","funders":"","keywords":"Medicine; Reimbursement; Internal medicine; Willingness to pay; Agency (philosophy); Oncology; Health care","score_opus":0.659831116409612,"score_gpt":0.6654963885408027,"score_spread":0.005665272131190724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393871536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011636459,0.9719035,0.0010286105,0.007760932,0.0003237482,0.00037319696,0.002002264,0.000030139587,0.0049411533],"genre_scores_gemma":[0.33767793,0.6478129,0.005625848,0.005408623,0.00059428473,0.0005198305,0.0018761574,0.000060401046,0.0004240868],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.93985885,0.022746686,0.007651425,0.0022769389,0.026558094,0.0009080076],"domain_scores_gemma":[0.63309747,0.2562541,0.03236462,0.0026937341,0.073300295,0.0022896861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09522163,0.00068615115,0.0031501795,0.0068762545,0.00069282687,0.00390958,0.0029876132,0.0013358536,0.0015167783],"category_scores_gemma":[0.2165917,0.0006582343,0.004942955,0.010353386,0.0010934377,0.0020356614,0.00074774394,0.0030338403,0.00018821779],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023673302,0.00010596654,0.040542737,0.12180781,0.010795946,0.00015352746,0.0012745853,0.0026357844,0.00041058855,0.0034297355,0.02702923,0.78944665],"study_design_scores_gemma":[0.0015037495,0.0020188352,0.36074528,0.29894263,0.038021483,0.0010299664,0.002299334,0.0060918364,0.0025481398,0.0035939468,0.282517,0.0006878141],"about_ca_topic_score_codex":0.23027563,"about_ca_topic_score_gemma":0.39978847,"teacher_disagreement_score":0.9730382,"about_ca_system_score_codex":0.02696181,"about_ca_system_score_gemma":0.033836715,"threshold_uncertainty_score":0.5035862},"labels":[],"label_agreement":null},{"id":"W4401428163","doi":"10.57264/cer-2023-0171","title":"Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Grifols; Argenx; Sanofi; Alnylam Pharmaceuticals; UCB Pharma; Alexion Pharmaceuticals; Pfizer; Amgen","keywords":"Medicine; Meta-analysis; Drug; Intensive care medicine; Intravenous drug; Immune system; MEDLINE; Internal medicine; Pharmacology; Immunology; Human immunodeficiency virus (HIV)","score_opus":0.3327499208702503,"score_gpt":0.5498842533511791,"score_spread":0.21713433248092878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401428163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072224885,0.990617,0.00044268387,0.00017424939,0.000083236875,0.00030236825,0.0008154815,0.000014170868,0.0003283106],"genre_scores_gemma":[0.21349739,0.78102314,0.002002916,0.0008745779,0.00015082044,0.0011013764,0.0010434218,0.000022610762,0.0002837682],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.989737,0.0047361613,0.0032428876,0.0008485458,0.0012261012,0.00020933294],"domain_scores_gemma":[0.9683108,0.025250157,0.0043765674,0.00051397906,0.0012911977,0.00025727422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012742362,0.0018654853,0.014594752,0.0059683206,0.0005045653,0.0030149997,0.001685262,0.001789597,0.003871141],"category_scores_gemma":[0.034632444,0.0010054182,0.030578617,0.007096479,0.00064448884,0.0015323267,0.0012165532,0.0016187956,0.0002473161],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019330154,0.000033611534,0.004548239,0.5192292,0.45803,0.00011959507,0.00011753796,0.00033005074,0.00013719045,0.00011994825,0.0005001393,0.01490158],"study_design_scores_gemma":[0.0007214079,0.000297069,0.0060338033,0.05939385,0.9307786,0.00020470243,0.00012667704,0.00019226309,0.000118626325,0.00022056173,0.0018731181,0.000039250088],"about_ca_topic_score_codex":0.0039553097,"about_ca_topic_score_gemma":0.009613469,"teacher_disagreement_score":0.014594752,"about_ca_system_score_codex":0.0023220244,"about_ca_system_score_gemma":0.0022612852,"threshold_uncertainty_score":0.06738883},"labels":[],"label_agreement":null},{"id":"W4401517584","doi":"10.57264/cer-2024-0089","title":"A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Otsuka Pharmaceutical; Servier; Sunovion; Allergan; Purdue University","keywords":"Atomoxetine; Methylphenidate; Medicine; Attention deficit hyperactivity disorder; Term (time); Psychiatry; Atomoxetine hydrochloride","score_opus":0.08488134867198587,"score_gpt":0.43873423418700014,"score_spread":0.35385288551501426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401517584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871891,0.005618081,0.0030829685,0.00015023805,0.00033526926,0.0008990836,0.0012180064,0.000039329127,0.0014680134],"genre_scores_gemma":[0.9961117,0.00042940784,0.001766001,0.0001341975,0.00007010177,0.00046625847,0.00057672424,0.000004600472,0.0004409879],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9930559,0.0047567,0.00063993735,0.00079431117,0.0005343844,0.00021879221],"domain_scores_gemma":[0.99332124,0.0031654213,0.0021303296,0.000803858,0.0003687539,0.00021036548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007975358,0.0010615902,0.0016978597,0.000630439,0.0003040623,0.00081985124,0.00078135304,0.0010772337,0.0037881306],"category_scores_gemma":[0.015551866,0.0004449017,0.0056081773,0.00050681585,0.0005485815,0.000720437,0.0009948807,0.0010909603,0.00029335634],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7453129,0.0020074537,0.077252865,0.0034594352,0.11562314,0.00015055301,0.00027263784,0.003924924,0.0023535232,0.0012258933,0.0012559606,0.04716069],"study_design_scores_gemma":[0.21437544,0.25882393,0.28108397,0.00073468965,0.19948064,0.0007911666,0.00038103896,0.02640549,0.0062631755,0.004678622,0.006706188,0.00027573993],"about_ca_topic_score_codex":0.0015239837,"about_ca_topic_score_gemma":0.0018176767,"teacher_disagreement_score":0.007975358,"about_ca_system_score_codex":0.0006989514,"about_ca_system_score_gemma":0.0006385019,"threshold_uncertainty_score":0.042178214},"labels":[],"label_agreement":null},{"id":"W4401518102","doi":"10.57264/cer-2024-0061","title":"The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agencies","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jungle; Medicine; Desert (philosophy); Real world evidence; Environmental resource management; Environmental planning; Geography; Archaeology; Internal medicine","score_opus":0.5807403555675743,"score_gpt":0.6226783898007007,"score_spread":0.041938034233126364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401518102","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014823899,0.42336634,0.047360107,0.4842417,0.0043685255,0.0016665932,0.0026325663,0.0002797379,0.021260567],"genre_scores_gemma":[0.32131016,0.22423951,0.28796092,0.14832437,0.0043027876,0.008281053,0.0032749665,0.0007507423,0.0015555838],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.2804052,0.4857006,0.104154296,0.017771047,0.10812602,0.0038428816],"domain_scores_gemma":[0.06888565,0.8159786,0.033756036,0.020846743,0.058492202,0.0020408246],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5833259,0.0016884425,0.006351335,0.059180036,0.008127576,0.047214244,0.007034738,0.010830033,0.002852232],"category_scores_gemma":[0.75366175,0.003642294,0.0047393525,0.04706966,0.028227184,0.059397418,0.018349012,0.016868353,0.0008639329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054131687,0.00022986688,0.0093655065,0.07517448,0.0018960973,0.000484931,0.02753755,0.0021669324,0.00075534335,0.2607952,0.060247388,0.5608054],"study_design_scores_gemma":[0.00040207518,0.00048501187,0.010325766,0.2703608,0.0015065925,0.0009345212,0.04133912,0.0022090634,0.000815423,0.28797117,0.3831446,0.0005059138],"about_ca_topic_score_codex":0.009068872,"about_ca_topic_score_gemma":0.015383626,"teacher_disagreement_score":0.41667408,"about_ca_system_score_codex":0.03238318,"about_ca_system_score_gemma":0.08009516,"threshold_uncertainty_score":0.5138334},"labels":[],"label_agreement":null},{"id":"W4401696619","doi":"10.57264/cer-2023-0161","title":"Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Montreal Neurological Institute and Hospital; University of Ottawa","funders":"","keywords":"Medicine; Confidence interval; Population; Internal medicine; Multiple sclerosis; Gastroenterology; Dermatology; Immunology","score_opus":0.4373288476947015,"score_gpt":0.4854581205204904,"score_spread":0.04812927282578894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401696619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97419906,0.008516556,0.009121347,0.00019812418,0.00033467734,0.0021140706,0.0029501915,0.00007520505,0.0024906737],"genre_scores_gemma":[0.9910698,0.00071212417,0.0044530896,0.00013405347,0.00006599643,0.0018012334,0.0011464288,0.000017077284,0.0006002076],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9774228,0.018101502,0.0013629525,0.0014152299,0.0012222916,0.00047523537],"domain_scores_gemma":[0.9864299,0.009091348,0.002762382,0.0009582169,0.00045624882,0.00030193964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015467051,0.0013700527,0.0025893792,0.0010623322,0.00027782985,0.00081128284,0.0011288373,0.00092212483,0.005184123],"category_scores_gemma":[0.02160173,0.00037223985,0.0055464176,0.00092073117,0.00071242393,0.0011052417,0.0013289473,0.001172417,0.00029182655],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8141216,0.0021697911,0.04091695,0.0039805267,0.063879296,0.00009139823,0.00030447895,0.0073593357,0.0021466934,0.0016892323,0.0008570587,0.062483728],"study_design_scores_gemma":[0.23596682,0.3655476,0.22035256,0.00087430637,0.089764476,0.00063459727,0.00062065636,0.054953884,0.010442039,0.011514814,0.008930668,0.0003975122],"about_ca_topic_score_codex":0.0009826762,"about_ca_topic_score_gemma":0.0008699943,"teacher_disagreement_score":0.015467051,"about_ca_system_score_codex":0.00075686077,"about_ca_system_score_gemma":0.0005762351,"threshold_uncertainty_score":0.08179855},"labels":[],"label_agreement":null},{"id":"W4402206567","doi":"10.57264/cer-2024-0010","title":"One-year budget impact of InTandem™: a novel neurorehabilitation system for individuals with chronic stroke walking impairment","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Neurorehabilitation; Medicine; Stroke (engine); Physical medicine and rehabilitation; Chronic stroke; Physical therapy; Rehabilitation; Gerontology","score_opus":0.06186490151134039,"score_gpt":0.4369953450139674,"score_spread":0.37513044350262703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402206567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382373,0.002178044,0.012618476,0.0019251732,0.00012961423,0.0024452982,0.01207561,0.0001391457,0.030251399],"genre_scores_gemma":[0.99203014,0.00068167277,0.0031650236,0.0001589016,0.00001533515,0.0005317426,0.001701319,0.000009560054,0.0017062351],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9963481,0.0020988253,0.00015961517,0.00024185095,0.0004941668,0.0006574065],"domain_scores_gemma":[0.9970777,0.0015282487,0.00057239464,0.00011946162,0.00047183488,0.00023029205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057379156,0.0011922154,0.0007537564,0.001167172,0.00044697974,0.002534782,0.001143436,0.0012930958,0.004532696],"category_scores_gemma":[0.010270779,0.00077838864,0.0022922265,0.0013954192,0.00047722703,0.0023912212,0.0015494388,0.0013849074,0.00041024445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070145912,0.0014609438,0.051345322,0.0013800948,0.0017684806,0.0005509174,0.00021045547,0.84859973,0.0016180176,0.014343534,0.0049066595,0.0668012],"study_design_scores_gemma":[0.0027384004,0.016277757,0.12944001,0.0013575599,0.0053872005,0.0007349283,0.0019423463,0.80626047,0.004997853,0.008165484,0.022394195,0.00030389577],"about_ca_topic_score_codex":0.031061312,"about_ca_topic_score_gemma":0.022928623,"teacher_disagreement_score":0.031061312,"about_ca_system_score_codex":0.011190028,"about_ca_system_score_gemma":0.006288242,"threshold_uncertainty_score":0.08118969},"labels":[],"label_agreement":null},{"id":"W4402428455","doi":"10.57264/cer-2024-0111","title":"A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Palbociclib; Quality of life (healthcare); Clinical trial; Metastatic breast cancer; Breast cancer; Internal medicine; Randomized controlled trial; Oncology; Cancer; Physical therapy","score_opus":0.13816752987078193,"score_gpt":0.5181216320709223,"score_spread":0.37995410220014036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402428455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025577992,0.99502844,0.00015967549,0.00027440774,0.00009003376,0.00040013896,0.0010853476,0.000009037928,0.000395136],"genre_scores_gemma":[0.041998986,0.9543368,0.00089607225,0.00075362273,0.00009761206,0.0010292102,0.0007441211,0.000008459789,0.00013502115],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98960894,0.003513371,0.004397209,0.00077026134,0.0014822142,0.0002280788],"domain_scores_gemma":[0.97471243,0.015985707,0.0066074687,0.0003657387,0.0020533141,0.0002754933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007888457,0.0013350798,0.009719838,0.011513917,0.0006774763,0.0025461426,0.0015498601,0.0012878015,0.0036547347],"category_scores_gemma":[0.033267222,0.000831327,0.008313093,0.012890101,0.0009858871,0.0019453892,0.001434622,0.0011244189,0.00025687244],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029784784,0.000016437923,0.0014462387,0.9591089,0.017132232,0.00007735711,0.00011835643,0.00009208119,0.0001423696,0.00011247131,0.0008563913,0.020599375],"study_design_scores_gemma":[0.000655955,0.00046608623,0.01259377,0.7945005,0.17378876,0.0005151125,0.00031122754,0.00014084541,0.00022224968,0.00030760854,0.016445931,0.00005203171],"about_ca_topic_score_codex":0.008346656,"about_ca_topic_score_gemma":0.023228759,"teacher_disagreement_score":0.011513917,"about_ca_system_score_codex":0.0037841378,"about_ca_system_score_gemma":0.010088653,"threshold_uncertainty_score":0.041718602},"labels":[],"label_agreement":null},{"id":"W4403038201","doi":"10.57264/cer-2024-0179","title":"Access in all areas? A round up of developments in market access and HTA: part 5","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Agency (philosophy); Regulatory agency; Expanded access; Real world evidence; Perspective (graphical); Drug approval; Public administration; Pharmacology; Oncology; Drug; Internal medicine; Political science; Social science","score_opus":0.7758501098985618,"score_gpt":0.6353775750908001,"score_spread":0.14047253480776178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403038201","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012140083,0.32812732,0.0013941384,0.48129192,0.15657505,0.00013200098,0.001018277,0.00032336946,0.02992396],"genre_scores_gemma":[0.008553765,0.4079752,0.0042882077,0.34797964,0.18267702,0.00030542832,0.0022424248,0.00027309233,0.045705277],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962591,0.0006870411,0.00052692194,0.00027497936,0.0017952278,0.0004567206],"domain_scores_gemma":[0.9820509,0.007316323,0.0021059245,0.00062998297,0.0046483986,0.0032484648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008703108,0.001076591,0.0014886318,0.0034131114,0.0012551574,0.006052354,0.002269068,0.007080899,0.029699227],"category_scores_gemma":[0.020772185,0.00074679573,0.0014699936,0.0047396366,0.0019665463,0.013117548,0.004573966,0.010663039,0.006487049],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044577122,0.00006274253,0.00037037785,0.00063280325,0.000014194688,0.00007983054,0.00008126079,0.00008801801,0.00011262143,0.002595738,0.8255764,0.17034131],"study_design_scores_gemma":[0.000017628428,0.00007698636,0.002172569,0.0019959307,0.00002315031,0.00015649703,0.00017891297,0.00007538859,0.000060890074,0.0013903553,0.99382377,0.000028012199],"about_ca_topic_score_codex":0.00814715,"about_ca_topic_score_gemma":0.027174316,"teacher_disagreement_score":0.029699227,"about_ca_system_score_codex":0.0037975896,"about_ca_system_score_gemma":0.006231764,"threshold_uncertainty_score":0.09935385},"labels":[],"label_agreement":null},{"id":"W4403139133","doi":"10.57264/cer-2024-0064","title":"Use of transportability methods for real-world evidence generation: a review of current applications","year":2024,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Medicine; Weighting; Data science; Medical physics; Computer science; Geography","score_opus":0.9525799695547456,"score_gpt":0.7544126675334183,"score_spread":0.19816730202132726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403139133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074975286,0.9655637,0.019890644,0.0060050283,0.0010000009,0.0037570891,0.00063501846,0.00017650794,0.0022221773],"genre_scores_gemma":[0.023949543,0.8877398,0.07165759,0.0025619278,0.0007795464,0.012053959,0.00074896927,0.00019551431,0.00031322174],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.5070455,0.29009956,0.13618207,0.010607052,0.054251652,0.0018141206],"domain_scores_gemma":[0.08475405,0.81949073,0.042237613,0.015951775,0.036735892,0.00083001045],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4394481,0.003569966,0.011292418,0.05095461,0.0027994583,0.018850023,0.008582771,0.007221484,0.0123002585],"category_scores_gemma":[0.7590525,0.004570388,0.017843949,0.04123736,0.0075185294,0.020520685,0.010981866,0.0073759356,0.00227675],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038574333,0.00007114931,0.0017711293,0.54664105,0.007230416,0.00012398452,0.0021762245,0.001009187,0.00020162365,0.008513834,0.0044002933,0.42747545],"study_design_scores_gemma":[0.00026659985,0.00024522134,0.0020665536,0.9279599,0.008671526,0.00030831064,0.0009237775,0.0011605123,0.00041300216,0.010494469,0.047335267,0.00015487743],"about_ca_topic_score_codex":0.007447968,"about_ca_topic_score_gemma":0.00949544,"teacher_disagreement_score":0.5605519,"about_ca_system_score_codex":0.018508764,"about_ca_system_score_gemma":0.048280932,"threshold_uncertainty_score":0.69126034},"labels":[],"label_agreement":null},{"id":"W4404247164","doi":"10.57264/cer-2024-0131","title":"A novel injection device to administer repository corticotropin injection for inflammatory disease treatment: findings from a market research study","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Disease; Intensive care medicine; Pharmacology; Internal medicine; Anesthesia","score_opus":0.5685693505189394,"score_gpt":0.5743089682957716,"score_spread":0.005739617776832184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404247164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926461,0.0020322835,0.0018776137,0.0004570188,0.00004809497,0.00071885914,0.00010330156,0.000022579936,0.002094284],"genre_scores_gemma":[0.9844573,0.0028009962,0.0099792,0.0005880831,0.00013242013,0.00040441513,0.00012236398,0.00003090809,0.0014842937],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961247,0.0022107565,0.00026999286,0.0002683751,0.0009158757,0.00021030857],"domain_scores_gemma":[0.9808852,0.012807351,0.002171578,0.00066192535,0.0029506867,0.00052311696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070715556,0.00038673932,0.00032511333,0.0006408832,0.00049850764,0.0010945523,0.00072646816,0.00091777806,0.0039845686],"category_scores_gemma":[0.016665477,0.00021125838,0.00052951835,0.00040556624,0.0008758006,0.0014344396,0.00048333462,0.0007226305,0.0006096965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015819527,0.021512877,0.15218732,0.0072597964,0.00034905225,0.006800347,0.03765993,0.0005883826,0.074731946,0.0016725095,0.0045422763,0.676876],"study_design_scores_gemma":[0.0034275006,0.27176553,0.507624,0.002631467,0.0011849311,0.026769781,0.055891305,0.0074580307,0.059152037,0.0008971218,0.06276557,0.00043285437],"about_ca_topic_score_codex":0.0006094333,"about_ca_topic_score_gemma":0.00089652656,"teacher_disagreement_score":0.0070715556,"about_ca_system_score_codex":0.0005544234,"about_ca_system_score_gemma":0.00087735587,"threshold_uncertainty_score":0.037398398},"labels":[],"label_agreement":null},{"id":"W4404388316","doi":"10.57264/cer-2024-0118","title":"Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; Otsuka Pharmaceutical; Novo Nordisk; CVS Health; Regeneron Pharmaceuticals; Bayer HealthCare; Sanofi; National Pharmaceutical Council; Centene Corporation; Mallinckrodt Pharmaceuticals; Commonwealth Fund; Alnylam Pharmaceuticals; Kaiser Permanente; GlaxoSmithKline; National Organization for Rare Disorders; Arnold Ventures; AstraZeneca; Patrick and Catherine Weldon Donaghue Medical Research Foundation","keywords":"Medicine; Payment; Finance; Business","score_opus":0.19749568484851615,"score_gpt":0.4900226394215382,"score_spread":0.292526954573022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404388316","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02194332,0.014089973,0.0030258712,0.9271852,0.00080710603,0.00010135564,0.00006356177,0.000043113745,0.032740492],"genre_scores_gemma":[0.71133834,0.019926371,0.008854267,0.2500533,0.0017129964,0.00037930784,0.00007796088,0.00003083955,0.0076266704],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98670864,0.008117112,0.00040648953,0.0005396396,0.0018778916,0.002350187],"domain_scores_gemma":[0.97689086,0.01533942,0.0025156862,0.00037801516,0.0018175554,0.0030585506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026825672,0.00046058922,0.0007387896,0.0017074391,0.003535928,0.015546443,0.0018843677,0.016753623,0.007198046],"category_scores_gemma":[0.036619242,0.00033065895,0.00090402336,0.001712736,0.007110564,0.009549973,0.005468704,0.0067565637,0.00033173087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018519642,0.00045224326,0.0033366543,0.00040442598,0.000070735594,0.00027577823,0.0019351983,0.004905928,0.00052703393,0.8448869,0.055399608,0.08762033],"study_design_scores_gemma":[0.00042893738,0.0006709424,0.013313181,0.0036572628,0.00016683852,0.00024825582,0.012016404,0.012046688,0.0009201055,0.6418247,0.3144992,0.00020741699],"about_ca_topic_score_codex":0.018440006,"about_ca_topic_score_gemma":0.023698764,"teacher_disagreement_score":0.026825672,"about_ca_system_score_codex":0.014088979,"about_ca_system_score_gemma":0.045308616,"threshold_uncertainty_score":0.14186937},"labels":[],"label_agreement":null},{"id":"W4404765290","doi":"10.57264/cer-2024-0212","title":"R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Reimbursement; Medicine; Nice; Excellence; Real world evidence; Position statement; Health care; Evidence-based medicine; Health technology; Family medicine; Alternative medicine; Economic growth; Pathology","score_opus":0.7948179803753248,"score_gpt":0.6600241547357037,"score_spread":0.13479382563962106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404765290","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029537868,0.62974864,0.0018640497,0.28209648,0.08188909,0.00008665461,0.00030607427,0.00013427628,0.003579347],"genre_scores_gemma":[0.0030855825,0.73360527,0.0069479593,0.14802074,0.103235856,0.00022038745,0.0005777591,0.00023191494,0.0040746047],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9827235,0.006283041,0.004479361,0.00080003607,0.005137144,0.0005769628],"domain_scores_gemma":[0.8225112,0.124673985,0.01218672,0.0038730407,0.032425266,0.0043298397],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.040287692,0.0016349349,0.004635105,0.006569597,0.0012320845,0.009243513,0.0030091987,0.009551678,0.011565931],"category_scores_gemma":[0.13657619,0.0013114999,0.0028059538,0.0066475742,0.0038304506,0.016772022,0.0040422142,0.01737892,0.005123787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013150743,0.000051742583,0.0004103537,0.0044838767,0.0001635028,0.00017025664,0.00015222342,0.00023823118,0.00027919488,0.006313636,0.67539537,0.31221],"study_design_scores_gemma":[0.000047367623,0.00012716808,0.001124567,0.015154257,0.00016130145,0.0005139297,0.00021331059,0.00018631222,0.00012478932,0.0094888415,0.97277474,0.00008336864],"about_ca_topic_score_codex":0.00276847,"about_ca_topic_score_gemma":0.0076517225,"teacher_disagreement_score":0.9597123,"about_ca_system_score_codex":0.0042914646,"about_ca_system_score_gemma":0.007659287,"threshold_uncertainty_score":0.2130642},"labels":[],"label_agreement":null},{"id":"W4405127888","doi":"10.57264/cer-2024-0133","title":"Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Neutropenia; Unit cost; Anemia; Internal medicine; Chemotherapy","score_opus":0.22567769074610858,"score_gpt":0.5142588447011285,"score_spread":0.28858115395501993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405127888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.944943,0.02500629,0.0038588853,0.005640349,0.00015716616,0.00022613587,0.0040304353,0.000047696674,0.016090086],"genre_scores_gemma":[0.9951593,0.0020535819,0.0011765353,0.0002561818,0.000057338355,0.000052614323,0.00092768495,0.000011609645,0.00030519464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973974,0.0013795114,0.0002191669,0.00020932707,0.000553427,0.0002411503],"domain_scores_gemma":[0.993682,0.0032178825,0.0021369301,0.00017923873,0.0004908999,0.00029300505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000602,0.0003008202,0.0005780581,0.00093489356,0.00020786942,0.0014874954,0.0005743946,0.00042622694,0.00325411],"category_scores_gemma":[0.015812306,0.0002415647,0.0014877829,0.0015172918,0.00024202277,0.001000474,0.0007182813,0.0011420099,0.00016461812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005598604,0.0008227378,0.47948274,0.0016153908,0.0032376382,0.0011335929,0.0002166434,0.1047988,0.0012083007,0.012598733,0.009432415,0.37985435],"study_design_scores_gemma":[0.0008838494,0.0026275702,0.8372458,0.0015740924,0.002479822,0.0045478735,0.000710976,0.11518902,0.0019489652,0.012471153,0.020189418,0.00013144605],"about_ca_topic_score_codex":0.00707322,"about_ca_topic_score_gemma":0.0074977395,"teacher_disagreement_score":0.00707322,"about_ca_system_score_codex":0.0053315354,"about_ca_system_score_gemma":0.0021826208,"threshold_uncertainty_score":0.038683176},"labels":[],"label_agreement":null},{"id":"W4406964103","doi":"10.57264/cer-2024-0208","title":"Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); EVERSANA (Canada)","funders":"","keywords":"Medicine; Point-of-care testing; Dyslipidemia; Glycated hemoglobin; Indirect costs; Health care; Emergency medicine; Internal medicine; Diabetes mellitus; Type 2 diabetes","score_opus":0.5095168284086294,"score_gpt":0.552470989915553,"score_spread":0.04295416150692355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406964103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9097479,0.0049684327,0.0052400394,0.0038358965,0.00012173304,0.0012954777,0.027569698,0.00014178523,0.047079112],"genre_scores_gemma":[0.9866606,0.0014836825,0.0030565124,0.00025814102,0.000015226393,0.0003292675,0.0052098352,0.000027343545,0.0029594197],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99640024,0.001395098,0.0000941944,0.0002775033,0.00053154334,0.0013013917],"domain_scores_gemma":[0.9953312,0.0019653775,0.00051159546,0.00016678913,0.0014491936,0.00057567086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043975567,0.0019021989,0.0011990971,0.002610263,0.0011063394,0.0026291008,0.0022391363,0.001235911,0.003574267],"category_scores_gemma":[0.010181593,0.000898606,0.003396201,0.004365467,0.0011121898,0.0009838734,0.0014626294,0.0017236975,0.00020531012],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010637909,0.00017110597,0.021081006,0.0003198205,0.00062081235,0.0003568628,0.000091441805,0.9576946,0.00020929342,0.006685061,0.0037077914,0.007998392],"study_design_scores_gemma":[0.0011083102,0.0010349326,0.090233736,0.00072761596,0.0022721484,0.00030821338,0.0016661022,0.8802191,0.00103382,0.004186456,0.01685833,0.000351217],"about_ca_topic_score_codex":0.9523635,"about_ca_topic_score_gemma":0.9057651,"teacher_disagreement_score":0.111837216,"about_ca_system_score_codex":0.111837216,"about_ca_system_score_gemma":0.054586045,"threshold_uncertainty_score":0.8114396},"labels":[],"label_agreement":null},{"id":"W4407666347","doi":"10.57264/cer-2024-0216","title":"The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Modified Rankin Scale; Solitaire Cryptographic Algorithm; Stroke (engine); Revascularization; Stent; Health care; Emergency medicine; Cohort; Surgery; Demography; Ischemic stroke; Internal medicine; Ischemia","score_opus":0.03197199617681526,"score_gpt":0.39066830819294796,"score_spread":0.3586963120161327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407666347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9084973,0.051813953,0.0070651,0.0035212252,0.00015206977,0.0011627232,0.020633398,0.000107165906,0.0070470725],"genre_scores_gemma":[0.9848514,0.0072901556,0.0028522534,0.00028195494,0.00002252678,0.00023479914,0.003890208,0.000017915352,0.0005587147],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9974171,0.0017066583,0.00012882348,0.00020148125,0.000274238,0.00027185434],"domain_scores_gemma":[0.99342346,0.00468328,0.00064580777,0.0001632439,0.00079852855,0.00028561562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006058567,0.0014832393,0.0032384603,0.002627897,0.00052240875,0.0024170037,0.0016535305,0.0012143701,0.0019747627],"category_scores_gemma":[0.012618697,0.00089965895,0.007329884,0.003988264,0.000591562,0.00095560175,0.0012409379,0.0013526401,0.00012523454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006827564,0.00036071788,0.056866832,0.006018809,0.029890953,0.00077835005,0.00014829563,0.87193656,0.0002741994,0.005356416,0.0039616446,0.01757966],"study_design_scores_gemma":[0.004174453,0.0023193378,0.0664712,0.0026078569,0.047707617,0.0008158041,0.00079884706,0.86241525,0.0005561099,0.004454959,0.007384626,0.00029385238],"about_ca_topic_score_codex":0.5494439,"about_ca_topic_score_gemma":0.37897062,"teacher_disagreement_score":0.9803927,"about_ca_system_score_codex":0.019607313,"about_ca_system_score_gemma":0.012316548,"threshold_uncertainty_score":0.90641904},"labels":[],"label_agreement":null},{"id":"W4407705966","doi":"10.57264/cer-2025-0014","title":"R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Real world evidence; Reimbursement; Medicine; Excellence; Real world data; Comparative effectiveness research; Health technology; Health care; Outcomes research; Evidence-based medicine; MEDLINE; Family medicine; Data science; Alternative medicine; Economic growth","score_opus":0.791885116103,"score_gpt":0.6657260335566721,"score_spread":0.1261590825463279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407705966","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041899353,0.34380075,0.0023297863,0.50594795,0.14115147,0.00009840632,0.00042240843,0.00022301175,0.005607165],"genre_scores_gemma":[0.0046894336,0.51243424,0.011093068,0.2471548,0.21539682,0.00030225285,0.0007985021,0.00046122854,0.007669671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9779709,0.0074244477,0.005103556,0.0011298145,0.0075655226,0.000805747],"domain_scores_gemma":[0.7661354,0.15879162,0.0149263395,0.0060286415,0.047133543,0.006984492],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.053426612,0.0015393391,0.0037180083,0.0064234356,0.0017033784,0.012241535,0.0035222918,0.010999022,0.013922024],"category_scores_gemma":[0.18164492,0.0012034958,0.002597825,0.0075339307,0.004314436,0.022361513,0.004508626,0.019609299,0.0053018294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007326294,0.000050446422,0.0004540546,0.0015762274,0.00007950956,0.00011874491,0.00012655974,0.00012088651,0.00014952384,0.0053922837,0.8064838,0.1853748],"study_design_scores_gemma":[0.000035034816,0.0000886023,0.0012804209,0.006201637,0.00007599747,0.0003246955,0.00024210408,0.00013338137,0.00009928383,0.0071776765,0.9842754,0.000065852175],"about_ca_topic_score_codex":0.003449774,"about_ca_topic_score_gemma":0.00985623,"teacher_disagreement_score":0.9465734,"about_ca_system_score_codex":0.0044080936,"about_ca_system_score_gemma":0.00887481,"threshold_uncertainty_score":0.28255028},"labels":[],"label_agreement":null},{"id":"W4407745750","doi":"10.57264/cer-2024-0226","title":"The role of health economic evidence in clinical practice guidelines for colorectal cancer: a comparative analysis across countries","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Colorectal cancer; MEDLINE; Family medicine; Quality-adjusted life year; Health economics; Alternative medicine; Health care; Cancer; Cost effectiveness; Public health; Nursing; Internal medicine; Economic growth; Pathology; Risk analysis (engineering)","score_opus":0.8474889239529361,"score_gpt":0.74698083932145,"score_spread":0.10050808463148608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407745750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035178486,0.94283444,0.0033618384,0.009780939,0.00057110796,0.0016744802,0.0016021847,0.000018026974,0.0049784617],"genre_scores_gemma":[0.6553453,0.32475814,0.01076803,0.003908311,0.0005086399,0.0030862372,0.0013988459,0.00005492376,0.00017150937],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.56979406,0.29643437,0.07828049,0.00785625,0.044997063,0.0026377714],"domain_scores_gemma":[0.2106502,0.66013294,0.077114314,0.008335538,0.04129064,0.0024763234],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23351204,0.0012053732,0.008092345,0.033239763,0.0012826102,0.011322894,0.0031296501,0.003711433,0.004053789],"category_scores_gemma":[0.67383206,0.0012663159,0.008715812,0.039904885,0.0040643583,0.010247567,0.005594353,0.00413407,0.00022134103],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004777752,0.00039189705,0.12249083,0.40597826,0.10291953,0.00048817584,0.0055610207,0.0029004782,0.00016612928,0.015372369,0.0052841613,0.3336694],"study_design_scores_gemma":[0.003158754,0.0018843819,0.16924289,0.63962245,0.119221896,0.0011629718,0.0081616305,0.003927269,0.00047888048,0.016035525,0.036727663,0.00037564524],"about_ca_topic_score_codex":0.009802664,"about_ca_topic_score_gemma":0.011776061,"teacher_disagreement_score":0.76648796,"about_ca_system_score_codex":0.0142608965,"about_ca_system_score_gemma":0.01950432,"threshold_uncertainty_score":0.9452161},"labels":[],"label_agreement":null},{"id":"W4407884630","doi":"10.57264/cer-2024-0193","title":"Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Internal medicine; Clinical trial; Placebo; Confidence interval; Disease; Pathology","score_opus":0.08833058544568213,"score_gpt":0.4340713814230241,"score_spread":0.345740795977342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407884630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9374341,0.011795659,0.029763876,0.00051970634,0.00089812017,0.0056496663,0.006926114,0.00027790482,0.006734822],"genre_scores_gemma":[0.98141026,0.0007089473,0.010731909,0.00037183665,0.00010570827,0.0036476955,0.0016184708,0.000029808767,0.001375336],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9576765,0.034536544,0.0024777714,0.0023567597,0.0019361327,0.001016357],"domain_scores_gemma":[0.96379226,0.026246177,0.00500545,0.0036419157,0.00085557566,0.0004585781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026993392,0.0018286208,0.0022861082,0.0010692558,0.0003084489,0.0011410753,0.0016040022,0.0014702954,0.0077191144],"category_scores_gemma":[0.053673394,0.00052296004,0.008814637,0.0010541555,0.00085301773,0.0012855944,0.0019110381,0.0022412806,0.0004242031],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68791884,0.0024187965,0.044895895,0.008680125,0.15012981,0.00022644785,0.00039947612,0.01383609,0.0045201825,0.005556183,0.002623818,0.07879442],"study_design_scores_gemma":[0.18633395,0.22518389,0.24071147,0.0017477509,0.22659442,0.0006542064,0.00055520446,0.0561354,0.019861782,0.023535527,0.018226655,0.00045962996],"about_ca_topic_score_codex":0.0009804836,"about_ca_topic_score_gemma":0.00084427913,"teacher_disagreement_score":0.026993392,"about_ca_system_score_codex":0.0009323552,"about_ca_system_score_gemma":0.000907012,"threshold_uncertainty_score":0.1427564},"labels":[],"label_agreement":null},{"id":"W4408522992","doi":"10.57264/cer-2024-0225","title":"Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Western University","funders":"","keywords":"Medicine; Tofacitinib; Internal medicine; Maintenance therapy; Ulcerative colitis; Meta-analysis; Randomized controlled trial; Clinical trial; Placebo; Alternative medicine; Chemotherapy; Disease; Rheumatoid arthritis; Pathology","score_opus":0.08189029509954747,"score_gpt":0.4343012535341651,"score_spread":0.3524109584346176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408522992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030712008,0.99466646,0.00090234133,0.00024389796,0.00008001954,0.00030718156,0.00047114494,0.000021060127,0.00023663061],"genre_scores_gemma":[0.1551066,0.8369077,0.00397572,0.0009640103,0.00026594073,0.0014602031,0.0010295847,0.000029340643,0.00026082585],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98321193,0.009515231,0.0036282917,0.0015634173,0.0017513743,0.00032977076],"domain_scores_gemma":[0.9497828,0.040729083,0.0059555373,0.0009791394,0.002222694,0.00033075004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022238426,0.0026774195,0.016287703,0.010124571,0.0005869435,0.0030293062,0.0022724885,0.002237408,0.0035585945],"category_scores_gemma":[0.058356397,0.0014333453,0.035003334,0.008581407,0.00080973934,0.0019616755,0.001532695,0.001946282,0.00030068686],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015648248,0.000038047026,0.003275898,0.44743934,0.52407503,0.00010415351,0.00008539698,0.001442928,0.00017964594,0.000283871,0.00071785704,0.02079304],"study_design_scores_gemma":[0.0004913017,0.00023198685,0.0030547464,0.051397882,0.94180095,0.00009166385,0.000034509663,0.0006002231,0.00009125365,0.0004611397,0.0017160334,0.000028209437],"about_ca_topic_score_codex":0.006171035,"about_ca_topic_score_gemma":0.011525194,"teacher_disagreement_score":0.022238426,"about_ca_system_score_codex":0.0029652074,"about_ca_system_score_gemma":0.004876551,"threshold_uncertainty_score":0.11760938},"labels":[],"label_agreement":null},{"id":"W4409666926","doi":"10.57264/cer-2024-0210","title":"A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Medicine; Business; Internal medicine; Leukemia","score_opus":0.19096360683406274,"score_gpt":0.5109227883965701,"score_spread":0.31995918156250736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409666926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9507824,0.010332515,0.0006324331,0.0005303346,0.00003184867,0.0001645941,0.036387738,0.000015060497,0.0011230594],"genre_scores_gemma":[0.9745268,0.002259105,0.00073342473,0.0001723502,0.000041014297,0.00025954287,0.021926928,0.0000052171426,0.00007546619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906777,0.004316499,0.0020769313,0.0012715373,0.0012518162,0.00040538618],"domain_scores_gemma":[0.975688,0.010664737,0.011268613,0.00086924876,0.0010300636,0.00047938846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005406328,0.0005786968,0.0011538848,0.005822548,0.00029465975,0.0019959062,0.0011485842,0.0009792583,0.0015313436],"category_scores_gemma":[0.02330564,0.00053770497,0.0036628623,0.009582565,0.00039389482,0.0012612003,0.0011745023,0.0007101393,0.0001496097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031123646,0.00018525029,0.9696972,0.0012804505,0.0133419335,0.00012212868,0.00009920965,0.0020203958,0.0000870241,0.00029856752,0.0014653484,0.008290193],"study_design_scores_gemma":[0.0008461383,0.0006090444,0.98148674,0.0009272017,0.0055283676,0.0006660405,0.00059171993,0.006410218,0.000188777,0.00031513028,0.002367775,0.000062968684],"about_ca_topic_score_codex":0.020714346,"about_ca_topic_score_gemma":0.021505056,"teacher_disagreement_score":0.020714346,"about_ca_system_score_codex":0.0021320314,"about_ca_system_score_gemma":0.0014194193,"threshold_uncertainty_score":0.041187525},"labels":[],"label_agreement":null},{"id":"W4409760204","doi":"10.57264/cer-2025-0024","title":"Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Reimbursement; Medicine; Notice; Family medicine; Health care; Negotiation; Orphan drug; Business; Economic growth; Political science; Bioinformatics","score_opus":0.7302214171912577,"score_gpt":0.6442866495813444,"score_spread":0.08593476760991325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409760204","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.109597564,0.07315663,0.0015162746,0.70714116,0.002369898,0.00019700832,0.0012180884,0.00010146421,0.104701824],"genre_scores_gemma":[0.7756513,0.102357015,0.0042485315,0.09333385,0.001109313,0.000078691744,0.0011566078,0.0001604335,0.021904249],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99031514,0.0009594092,0.0002964174,0.00051549036,0.0039980095,0.003915485],"domain_scores_gemma":[0.97810626,0.0019503228,0.0010174531,0.00016781277,0.007891087,0.010867016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066383956,0.0004972405,0.0004294921,0.0020133646,0.013817673,0.011247334,0.002643768,0.0035131841,0.005762918],"category_scores_gemma":[0.009767051,0.0004215361,0.0007619206,0.005120332,0.0062852483,0.0030754427,0.0026082539,0.00691235,0.00037352918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009440887,0.00096619,0.065682724,0.0020963387,0.00018351246,0.006824961,0.03158134,0.0038306676,0.0027778998,0.20513155,0.37664932,0.30333138],"study_design_scores_gemma":[0.00022685264,0.00054300483,0.09408569,0.0021722375,0.00020634005,0.0023027766,0.048142232,0.0027393522,0.0013931965,0.0074037323,0.84033215,0.0004524255],"about_ca_topic_score_codex":0.9924068,"about_ca_topic_score_gemma":0.9961642,"teacher_disagreement_score":0.76870924,"about_ca_system_score_codex":0.23129077,"about_ca_system_score_gemma":0.44507793,"threshold_uncertainty_score":0.89159375},"labels":[],"label_agreement":null},{"id":"W4410077388","doi":"10.57264/cer-2025-0009","title":"Network connectivity, between-study heterogeneity and timepoint challenges in generalized myasthenia gravis: a feasibility assessment of indirect treatment comparisons","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; EVERSANA (Canada)","funders":"","keywords":"Medicine; Dosing; Placebo; Clinical trial; Randomized controlled trial; Population; Clinical study design; Intensive care medicine; Internal medicine; Alternative medicine","score_opus":0.49096799424601734,"score_gpt":0.5658844709347464,"score_spread":0.07491647668872903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410077388","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056730643,0.37464246,0.44873935,0.023479888,0.008122466,0.067037836,0.0056912852,0.00086860976,0.014687529],"genre_scores_gemma":[0.58019143,0.017108835,0.2699491,0.007451968,0.0015907031,0.1207258,0.0016393571,0.00025673688,0.0010859878],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.22237468,0.64587414,0.08336461,0.016164884,0.030502543,0.0017191791],"domain_scores_gemma":[0.09695354,0.82440484,0.04395025,0.022557136,0.011401054,0.00073315925],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5925706,0.0029462215,0.0090615945,0.008184275,0.0019956536,0.009112681,0.00531153,0.005712374,0.007571127],"category_scores_gemma":[0.7450232,0.0018292292,0.021722302,0.008141057,0.006188305,0.008953816,0.007593994,0.0047395686,0.0006115708],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014143792,0.00042929553,0.036554493,0.3652759,0.2281511,0.0008748125,0.0053534033,0.008066402,0.0011892304,0.042518668,0.006581239,0.29086173],"study_design_scores_gemma":[0.016722884,0.013995598,0.053107,0.18745206,0.40288764,0.0019464596,0.003990111,0.029023549,0.006256235,0.20098901,0.08247455,0.0011549771],"about_ca_topic_score_codex":0.0017809642,"about_ca_topic_score_gemma":0.0027665142,"teacher_disagreement_score":0.9909384,"about_ca_system_score_codex":0.005972347,"about_ca_system_score_gemma":0.011721726,"threshold_uncertainty_score":0.50243306},"labels":[],"label_agreement":null},{"id":"W4410237684","doi":"10.57264/cer-2025-0023","title":"Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USA","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Abiraterone acetate; Medicine; Hazard ratio; Prostate cancer; Confidence interval; Proportional hazards model; Cohort; Internal medicine; Oncology; Urology; Gynecology; Cancer; Androgen deprivation therapy","score_opus":0.09190869354461881,"score_gpt":0.45211489764668883,"score_spread":0.36020620410207005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410237684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911016,0.0003323618,0.000023285931,0.000029080276,0.0000036896154,0.000005536624,0.00040086277,0.000001514488,0.00009351219],"genre_scores_gemma":[0.999276,0.00012360043,0.000019281495,0.000026796652,0.000007746022,0.000005836775,0.0005058057,0.0000010693186,0.00003385147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989581,0.0004417637,0.00009561439,0.00022479169,0.00016656976,0.000113128764],"domain_scores_gemma":[0.99772507,0.00059437694,0.0010648515,0.00010658573,0.00017187037,0.00033729203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010295601,0.00023852008,0.0005387926,0.0009216127,0.00029581267,0.00069752906,0.00053399487,0.00042118225,0.0008978841],"category_scores_gemma":[0.0027037852,0.00022490347,0.0010689915,0.0014564623,0.00040125224,0.00040401306,0.00056584575,0.0005818068,0.00013744216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010332338,0.00005065541,0.99681634,0.000023420756,0.0004959962,0.000035784462,0.00006446488,0.00007981353,0.000087957465,0.000009123214,0.00015408425,0.0011491653],"study_design_scores_gemma":[0.00008912358,0.00044190814,0.9983941,0.000010225824,0.00023681333,0.00013415806,0.00020434396,0.00026836718,0.000049064856,0.000018124832,0.00014761806,0.0000061079472],"about_ca_topic_score_codex":0.011655361,"about_ca_topic_score_gemma":0.016636504,"teacher_disagreement_score":0.011655361,"about_ca_system_score_codex":0.0006986983,"about_ca_system_score_gemma":0.0005713391,"threshold_uncertainty_score":0.02317506},"labels":[],"label_agreement":null},{"id":"W4410311277","doi":"10.57264/cer-2025-0063","title":"R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Health technology; Reimbursement; Real world evidence; Checklist; Health economics; Natural experiment; Inflation (cosmology); Health care; Actuarial science; Public health; Nursing; Economic growth; Pathology; Economics","score_opus":0.7745056326895687,"score_gpt":0.663189442031888,"score_spread":0.11131619065768072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410311277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060043525,0.4519955,0.0044576796,0.4034421,0.13095541,0.00030467997,0.0006526081,0.00041030167,0.0071811955],"genre_scores_gemma":[0.004597355,0.5953144,0.021266142,0.24774899,0.12053384,0.0006250366,0.0012525357,0.00057019485,0.0080916155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97029006,0.008270286,0.009519789,0.0011435513,0.009954618,0.00082172063],"domain_scores_gemma":[0.7351172,0.17005743,0.021658974,0.00673848,0.060918316,0.0055096406],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05766714,0.001660087,0.0041398397,0.0087529225,0.0017636755,0.009897331,0.0040022866,0.010147242,0.01082147],"category_scores_gemma":[0.20602432,0.0015599865,0.0032958854,0.008677409,0.004137965,0.017828245,0.0050201374,0.016652057,0.0048046927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079695914,0.000067298985,0.00054167566,0.003613696,0.00012571644,0.00014670865,0.00016151117,0.0001708816,0.00031748225,0.0037039323,0.72623646,0.26483488],"study_design_scores_gemma":[0.000045034467,0.00011975726,0.0015678937,0.0136152385,0.000149837,0.00048285656,0.00022492958,0.00017925068,0.00014776883,0.0051273284,0.9782558,0.0000842412],"about_ca_topic_score_codex":0.004324725,"about_ca_topic_score_gemma":0.012967316,"teacher_disagreement_score":0.94233286,"about_ca_system_score_codex":0.0045651323,"about_ca_system_score_gemma":0.0101826545,"threshold_uncertainty_score":0.30497658},"labels":[],"label_agreement":null},{"id":"W4412155371","doi":"10.57264/cer-2024-0237","title":"Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Hereditary angioedema; Prophylactic treatment; Angioedema; Term (time); Dermatology; Surgery; Internal medicine","score_opus":0.09743824719382202,"score_gpt":0.418657052657323,"score_spread":0.321218805463501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412155371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90615594,0.061007675,0.017615503,0.0011879854,0.0024446952,0.0033901508,0.0025516106,0.0002085541,0.005437912],"genre_scores_gemma":[0.99251866,0.0017581513,0.0033212171,0.00037571095,0.00018663754,0.00089713145,0.00040356442,0.0000104930505,0.0005285423],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9675889,0.026687017,0.0015931792,0.0021351108,0.0015153731,0.0004803862],"domain_scores_gemma":[0.97962725,0.014744619,0.0036123458,0.0012473722,0.0004403263,0.00032797645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02071335,0.0013990047,0.0031798072,0.00080600526,0.00034219673,0.0011279059,0.0010832838,0.0013849662,0.0066401185],"category_scores_gemma":[0.035381947,0.0005556573,0.007714408,0.0006974676,0.00081505056,0.0013414762,0.0010963164,0.0020370064,0.0003008991],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7181773,0.0017040594,0.027409397,0.008222481,0.13657442,0.00010428351,0.00025037077,0.004514542,0.0013118716,0.0020514422,0.0013657415,0.098313995],"study_design_scores_gemma":[0.39802966,0.21049362,0.09033099,0.0019415034,0.24193645,0.0006560562,0.0003559847,0.029581416,0.00515405,0.011308915,0.009936142,0.0002752482],"about_ca_topic_score_codex":0.00118258,"about_ca_topic_score_gemma":0.001057898,"teacher_disagreement_score":0.02071335,"about_ca_system_score_codex":0.00092844723,"about_ca_system_score_gemma":0.00096398074,"threshold_uncertainty_score":0.10954392},"labels":[],"label_agreement":null},{"id":"W4412155435","doi":"10.57264/cer-2025-0053","title":"Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology","year":2025,"lang":"en","type":"editorial","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Flatiron Health; Gilead Sciences; Pfizer","keywords":"Real world evidence; Medicine; Comparative effectiveness research; MEDLINE; Oncology; Medical physics; Internal medicine; Alternative medicine; Pathology","score_opus":0.7535354596229806,"score_gpt":0.6749517803646315,"score_spread":0.07858367925834908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412155435","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009591458,0.29982445,0.036099423,0.62192744,0.009220137,0.0029989567,0.0013493135,0.00023113123,0.018757695],"genre_scores_gemma":[0.30845243,0.16755486,0.21288775,0.28469032,0.00978841,0.0121511435,0.0024277465,0.0006747468,0.0013725752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.34248996,0.50810415,0.08315317,0.017027237,0.04479981,0.004425746],"domain_scores_gemma":[0.04188252,0.85754603,0.031072162,0.030029492,0.035806578,0.0036631252],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.58298916,0.0017164382,0.008000591,0.021480625,0.005928798,0.044593867,0.010759477,0.018551452,0.013480287],"category_scores_gemma":[0.8670233,0.0032083462,0.0060141333,0.018104704,0.03471797,0.085853025,0.026404332,0.024915207,0.001819465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088310556,0.00068021857,0.029773228,0.116497494,0.006171698,0.00064438814,0.021689894,0.0033085227,0.00037939977,0.330258,0.053232078,0.43648192],"study_design_scores_gemma":[0.0007486531,0.0006127368,0.012285109,0.38794327,0.0018298246,0.0006130098,0.019781603,0.002659041,0.0004612485,0.3859842,0.18673767,0.0003436457],"about_ca_topic_score_codex":0.015955176,"about_ca_topic_score_gemma":0.013535905,"teacher_disagreement_score":0.41701084,"about_ca_system_score_codex":0.027390499,"about_ca_system_score_gemma":0.07195589,"threshold_uncertainty_score":0.51424867},"labels":[],"label_agreement":null},{"id":"W4412590588","doi":"10.57264/cer-2025-0113","title":"R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Real world evidence; Reimbursement; Agency (philosophy); Health technology; Position statement; Statement (logic); Linkage (software); Systematic review; Real world data; Food and drug administration; Family medicine; MEDLINE; Health care; Data science; Environmental health; Economic growth; Law","score_opus":0.8514725016603549,"score_gpt":0.6930565999238583,"score_spread":0.15841590173649667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412590588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007169467,0.95076275,0.00040459252,0.035357717,0.012046788,0.00004421676,0.000111436246,0.00003157899,0.001169261],"genre_scores_gemma":[0.00078989,0.96258515,0.0018584993,0.02409147,0.009363923,0.0000949497,0.00018330681,0.0000405424,0.0009923392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892391,0.0038857535,0.002549747,0.00048063393,0.0034520999,0.00039283064],"domain_scores_gemma":[0.89704466,0.07320934,0.008748767,0.0016133471,0.017466407,0.0019175158],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029595165,0.0014957172,0.0044297236,0.007730807,0.0009331044,0.0058976095,0.0021421604,0.0053360304,0.010814056],"category_scores_gemma":[0.0968828,0.0009996644,0.0031069089,0.008992382,0.0018643147,0.011587621,0.003131778,0.009536547,0.003631733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011342681,0.000044601267,0.0002430955,0.02380702,0.00033426876,0.00009810928,0.00017016569,0.00016387788,0.00033521932,0.006651489,0.41793525,0.5501035],"study_design_scores_gemma":[0.000053866486,0.00009674438,0.0010268973,0.051795512,0.00042080833,0.00029869555,0.00017737053,0.00010562853,0.0000843813,0.004975118,0.94090366,0.000061429055],"about_ca_topic_score_codex":0.005683104,"about_ca_topic_score_gemma":0.018979667,"teacher_disagreement_score":0.97040486,"about_ca_system_score_codex":0.0047761197,"about_ca_system_score_gemma":0.011709128,"threshold_uncertainty_score":0.15651608},"labels":[],"label_agreement":null},{"id":"W4413103009","doi":"10.57264/cer-2024-0180","title":"Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Oncology; Population; Progression-free survival; Refractory (planetary science); Randomized controlled trial; Overall survival","score_opus":0.08580465074146751,"score_gpt":0.439554261778722,"score_spread":0.35374961103725444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413103009","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07967187,0.90896726,0.0038242547,0.0019650979,0.00075815734,0.0016659432,0.0018325158,0.000049012797,0.0012658058],"genre_scores_gemma":[0.88046116,0.10019622,0.009459066,0.0028648777,0.0010140125,0.004275881,0.0012637462,0.00004591421,0.00041909853],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.95151556,0.029004108,0.012374133,0.0038138279,0.0026978634,0.00059448223],"domain_scores_gemma":[0.8236157,0.14533523,0.024253156,0.003575791,0.0028245295,0.0003956466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046265148,0.001125505,0.0044428525,0.0023105775,0.00043749102,0.0024353536,0.001211055,0.0019645437,0.002817713],"category_scores_gemma":[0.14006563,0.0006517243,0.011359004,0.0025824786,0.0010291365,0.0017876235,0.0011788702,0.0017810754,0.00017763856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023823487,0.0005530441,0.08824341,0.3584384,0.37882733,0.00017566647,0.00047943887,0.0012447219,0.0011730767,0.002238255,0.0016005196,0.1432027],"study_design_scores_gemma":[0.0129733905,0.0064769504,0.13934423,0.07584326,0.73966527,0.0003973033,0.0005131841,0.0018013649,0.0022516106,0.00485336,0.01575916,0.000120982324],"about_ca_topic_score_codex":0.002185936,"about_ca_topic_score_gemma":0.003294933,"teacher_disagreement_score":0.046265148,"about_ca_system_score_codex":0.0018218941,"about_ca_system_score_gemma":0.003075782,"threshold_uncertainty_score":0.24467635},"labels":[],"label_agreement":null},{"id":"W4413400952","doi":"10.57264/cer-2025-0041","title":"Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; University of Calgary; AstraZeneca (Canada); Toronto Public Health","funders":"","keywords":"Excellence; Agency (philosophy); Health technology; Medicine; Health care; Benchmarking; Relevance (law); Health information technology; Demographics; Evidence-based practice; Public relations; Medical education; Alternative medicine; Political science; Business; Marketing; Social science; Sociology","score_opus":0.7203703134267602,"score_gpt":0.6673336547915845,"score_spread":0.053036658635175704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413400952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000800066,0.68622357,0.17862707,0.11809909,0.0043791994,0.0023578226,0.0005965337,0.00009747808,0.008819161],"genre_scores_gemma":[0.027101252,0.68694824,0.2153009,0.048723925,0.006234923,0.0124416165,0.00051699235,0.0002243975,0.002507764],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.7433861,0.19292803,0.03966884,0.005401985,0.017548323,0.0010667016],"domain_scores_gemma":[0.27396426,0.6944129,0.013928821,0.006513725,0.010612176,0.0005681597],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24595052,0.0018288811,0.0054106065,0.016408373,0.0027742577,0.018014854,0.0056985863,0.01247699,0.0057484717],"category_scores_gemma":[0.39477518,0.0030707638,0.0055062184,0.015240482,0.019543774,0.039289877,0.010896719,0.016812252,0.0014140105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011361948,0.00007338694,0.0010360086,0.053189065,0.0005764727,0.0008692562,0.0061855842,0.0015527655,0.0003744062,0.673912,0.022524027,0.23959348],"study_design_scores_gemma":[0.000052778894,0.00014721189,0.00093321595,0.16072477,0.0004161053,0.0019210298,0.0026835434,0.0019655488,0.00038963213,0.42375648,0.40687534,0.0001343811],"about_ca_topic_score_codex":0.0042193285,"about_ca_topic_score_gemma":0.004898272,"teacher_disagreement_score":0.7540495,"about_ca_system_score_codex":0.012925508,"about_ca_system_score_gemma":0.022112783,"threshold_uncertainty_score":0.9298773},"labels":[],"label_agreement":null},{"id":"W4414477652","doi":"10.57264/cer-2025-0125","title":"The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Continuous glucose monitoring; Glycemic; Type 2 Diabetes Mellitus; Blood Glucose Self-Monitoring; Type 2 diabetes; Microsimulation; Benzhydryl compounds; Diabetes mellitus","score_opus":0.04761061976653703,"score_gpt":0.3797619372710775,"score_spread":0.33215131750454047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414477652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710109,0.0066342494,0.0027739995,0.002696159,0.00007444259,0.0003651194,0.006837001,0.00006932826,0.009538753],"genre_scores_gemma":[0.99661946,0.00088164146,0.00090684695,0.00014041884,0.0000067348283,0.000028033031,0.0008392224,0.000006377654,0.00057126494],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9983083,0.00063503877,0.00007739632,0.00017079568,0.0003344486,0.0004740998],"domain_scores_gemma":[0.99627775,0.0022103332,0.00035160294,0.00008417451,0.0007002743,0.00037591145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024522138,0.00070254394,0.00082331436,0.0007478337,0.0007594346,0.0016331286,0.0014678976,0.00068526174,0.0026039877],"category_scores_gemma":[0.012502133,0.0003442414,0.0019352417,0.0014804616,0.000638658,0.0005608219,0.0008686892,0.0010720525,0.000081133265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008335721,0.0006033644,0.2116646,0.0013723671,0.0035088048,0.00055778754,0.00025760673,0.6907963,0.0007553356,0.012387354,0.0081907045,0.061569907],"study_design_scores_gemma":[0.002260607,0.0015530334,0.18065825,0.00062521046,0.0038275144,0.00026501977,0.0009017923,0.8004001,0.0011294167,0.004087528,0.0040788995,0.00021267233],"about_ca_topic_score_codex":0.9730786,"about_ca_topic_score_gemma":0.960182,"teacher_disagreement_score":0.9730786,"about_ca_system_score_codex":0.06378854,"about_ca_system_score_gemma":0.037049,"threshold_uncertainty_score":0.4628204},"labels":[],"label_agreement":null},{"id":"W4414753286","doi":"10.57264/cer-2025-0148","title":"R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 21","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Health technology; Emulation; Frame (networking); Comparative effectiveness research; Health information technology; MEDLINE; Technology assessment; Real world evidence; Alternative medicine","score_opus":0.7496154867001127,"score_gpt":0.6542149322955111,"score_spread":0.0954005544046016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414753286","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005736014,0.2326482,0.004716753,0.661797,0.08921021,0.00021749994,0.00035713267,0.00029966468,0.010180063],"genre_scores_gemma":[0.008658662,0.4286844,0.025208397,0.38219747,0.14251886,0.00061704026,0.00093385216,0.0006687502,0.010512542],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9593334,0.015178004,0.007832371,0.0016046714,0.014580745,0.0014708388],"domain_scores_gemma":[0.6741517,0.21868819,0.019176435,0.01054367,0.06812446,0.009315544],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.095204994,0.0016381914,0.0039587375,0.0054820245,0.0023036343,0.014551182,0.0044149878,0.013528719,0.014165705],"category_scores_gemma":[0.28562364,0.0012065615,0.003631029,0.00645921,0.0067984425,0.023135224,0.006008677,0.021928037,0.006133033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008866911,0.0000670897,0.00038899167,0.0019866575,0.000088202374,0.00016053085,0.00018997883,0.00028166332,0.00027184782,0.0140447365,0.70063967,0.281792],"study_design_scores_gemma":[0.000042990017,0.00010296545,0.0009692576,0.0072537507,0.00008672479,0.00033027973,0.00021594003,0.00025056218,0.00014785792,0.0132667925,0.97725254,0.00008024289],"about_ca_topic_score_codex":0.004475485,"about_ca_topic_score_gemma":0.014627329,"teacher_disagreement_score":0.904795,"about_ca_system_score_codex":0.0070243436,"about_ca_system_score_gemma":0.020173812,"threshold_uncertainty_score":0.50349814},"labels":[],"label_agreement":null},{"id":"W4414847741","doi":"10.57264/cer-2025-0029","title":"Estimating per-protocol effects in external comparator analyses using real-world data","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of British Columbia","funders":"","keywords":"Emulation; Protocol (science); Randomized controlled trial; Clinical trial; Estimation; Research design; Comparator","score_opus":0.9569598007759129,"score_gpt":0.8145488453194007,"score_spread":0.14241095545651217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414847741","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00466227,0.022483505,0.9102947,0.0038987268,0.0026537976,0.04496487,0.0025852355,0.0010258203,0.0074309474],"genre_scores_gemma":[0.10052566,0.0059434595,0.7722875,0.0027342467,0.00056143507,0.1155281,0.0011446271,0.00040299149,0.0008720034],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.16877775,0.7562369,0.045197345,0.008922764,0.02004174,0.0008234273],"domain_scores_gemma":[0.10206982,0.8144145,0.034865305,0.03784899,0.010356833,0.0004445557],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7036153,0.004985261,0.0118553,0.008071256,0.0013153176,0.010885546,0.0065208836,0.006894024,0.015413577],"category_scores_gemma":[0.8461799,0.0031289759,0.024717348,0.008460078,0.006368246,0.01211369,0.0073225875,0.011562018,0.0022242407],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009854517,0.00077896134,0.00772857,0.1693373,0.078935206,0.00033246807,0.0029316081,0.026292706,0.0011914045,0.18444125,0.010867782,0.5073081],"study_design_scores_gemma":[0.016084835,0.011374317,0.01014592,0.10126947,0.07579553,0.0008713935,0.0011265308,0.088954344,0.009743966,0.5919554,0.091837525,0.0008406536],"about_ca_topic_score_codex":0.0009860134,"about_ca_topic_score_gemma":0.0009627829,"teacher_disagreement_score":0.2963847,"about_ca_system_score_codex":0.0060512293,"about_ca_system_score_gemma":0.010990477,"threshold_uncertainty_score":0.36549515},"labels":[],"label_agreement":null},{"id":"W4414883284","doi":"10.57264/cer-2025-0130","title":"Blood neurofilament light chain as a predictive biomarker for functional outcome of acute ischemic stroke: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Journal of Comparative Effectiveness Research","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Meta-analysis; Stroke (engine); Subgroup analysis; Biomarker; Odds ratio; Publication bias; Logistic regression","score_opus":0.21129556084385506,"score_gpt":0.48919316455284734,"score_spread":0.2778976037089923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414883284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032207,0.99503785,0.0004843993,0.00018209983,0.000098550685,0.00035611552,0.00040459802,0.000022433345,0.00019326116],"genre_scores_gemma":[0.087815285,0.90655744,0.0021862434,0.0007205217,0.00024681212,0.001452789,0.0007137592,0.000023743805,0.00028345332],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927791,0.0028230788,0.0024196613,0.0007586046,0.00093811774,0.00028144688],"domain_scores_gemma":[0.9846732,0.01110043,0.0024824985,0.00039226463,0.0011583251,0.00019327599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012299627,0.0029779943,0.021515377,0.0076356237,0.0007395944,0.003674399,0.0023906345,0.0024186715,0.0035586215],"category_scores_gemma":[0.02959468,0.001461762,0.036863666,0.0077341883,0.0008197122,0.002026632,0.0014258458,0.0016811531,0.00030329448],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001210597,0.000032717868,0.0032156622,0.58727396,0.3945936,0.00013004574,0.00008767295,0.00059248303,0.00024121802,0.00013441754,0.00060535484,0.0118823685],"study_design_scores_gemma":[0.00027969517,0.00016556401,0.0025172664,0.03841174,0.95670813,0.000089771,0.00003642248,0.00019565815,0.00010213846,0.00013951807,0.0013309228,0.000023259046],"about_ca_topic_score_codex":0.00570211,"about_ca_topic_score_gemma":0.013063228,"teacher_disagreement_score":0.021515377,"about_ca_system_score_codex":0.002592572,"about_ca_system_score_gemma":0.0047912886,"threshold_uncertainty_score":0.06504744},"labels":[],"label_agreement":null},{"id":"W4415260542","doi":"10.57264/cer-2025-0149","title":"R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 22","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Public Health Ontario","funders":"","keywords":"Formulary; Health technology; Clinical trial; Health information technology; Health economics; MEDLINE; Comparative effectiveness research; Health data","score_opus":0.744417899109262,"score_gpt":0.6539982115717788,"score_spread":0.0904196875374832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415260542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005769624,0.62462395,0.0030806772,0.30458638,0.062208354,0.00010569825,0.00043645754,0.00015943819,0.004222015],"genre_scores_gemma":[0.006717245,0.7653634,0.010380177,0.13376799,0.078728765,0.0003252572,0.00080857944,0.00033582977,0.0035727182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.983688,0.0068921237,0.0034648175,0.0009368837,0.004425747,0.00059249107],"domain_scores_gemma":[0.7679379,0.17690143,0.012038596,0.0060814065,0.03285908,0.004181591],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.048043597,0.0012626137,0.0033898624,0.00539215,0.0011091491,0.008945962,0.0029519503,0.007169048,0.011743614],"category_scores_gemma":[0.19633438,0.0010533911,0.002859294,0.0066488143,0.0036639192,0.018001756,0.004389718,0.01503452,0.0037074308],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017847272,0.000057257395,0.0005059228,0.0052046175,0.00018911519,0.00014022627,0.00016860386,0.00040628633,0.00029798067,0.011616333,0.54539716,0.43583798],"study_design_scores_gemma":[0.00006440384,0.00012375985,0.00136488,0.015990838,0.000184545,0.00036325364,0.00020662049,0.00033307352,0.00018668137,0.013787778,0.9673043,0.00008985012],"about_ca_topic_score_codex":0.0027183506,"about_ca_topic_score_gemma":0.0065993182,"teacher_disagreement_score":0.9519564,"about_ca_system_score_codex":0.004534181,"about_ca_system_score_gemma":0.009299103,"threshold_uncertainty_score":0.25408185},"labels":[],"label_agreement":null},{"id":"W4417317269","doi":"10.57264/cer-2025-0196","title":"R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 23","year":2025,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Transformative learning; Health technology; MEDLINE; Health information technology; Clinical trial; Evidence-based medicine; Real world evidence","score_opus":0.6211705210896415,"score_gpt":0.6597066368166193,"score_spread":0.03853611572697779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417317269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027109846,0.65469027,0.00429159,0.30808446,0.028906299,0.00009894042,0.00021934968,0.00012912242,0.003308831],"genre_scores_gemma":[0.0066720354,0.78935355,0.018209346,0.1417679,0.040458087,0.0003891018,0.00037433722,0.00030980894,0.0024657864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96877205,0.017330075,0.0049588014,0.0014685474,0.006536779,0.0009338021],"domain_scores_gemma":[0.65783244,0.29336762,0.0116066085,0.007414909,0.025914092,0.0038643489],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08855732,0.0014855993,0.0046539106,0.0053139413,0.0014747615,0.011250081,0.0039508357,0.010449306,0.01762155],"category_scores_gemma":[0.2701551,0.0011202466,0.0040688044,0.006761756,0.0061811185,0.025463207,0.0055386885,0.021724198,0.0044277264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002135665,0.00007092168,0.00034440597,0.010428998,0.00030225117,0.00016876515,0.00030255495,0.0006082072,0.0003141159,0.05007383,0.39833823,0.53883415],"study_design_scores_gemma":[0.00009234398,0.0001467801,0.00094451307,0.03350211,0.0002714601,0.0004166918,0.0003336018,0.0005054416,0.0001873072,0.060328543,0.9031572,0.00011392742],"about_ca_topic_score_codex":0.0035851505,"about_ca_topic_score_gemma":0.0068616555,"teacher_disagreement_score":0.9114427,"about_ca_system_score_codex":0.006420533,"about_ca_system_score_gemma":0.013354941,"threshold_uncertainty_score":0.46834147},"labels":[],"label_agreement":null}]}